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Summary 
Diabetic nephropathy is associated with secondary hypertension ansmg from 
aberrant sodium reabsorption in the kidney. This thesis characterises a novel human 
cell line derived from the human cortical collecting duct (HCD) to assess glucose-
evoked changes in key elements, such as the serum and glucocorticoid inducible 
kinase (SGKI) and the epithelial sodium channel (ENaC), involved in the regulation 
of sodium transport. In addition I have also examined the effects of TGF-f3I and 
[Ci+]i on SGKI and ENaC expression. RT-PCR, western blot analysis, 
immunocytochemistry and single cell imaging were employed to determine presence, 
localisation and function of these elements under various glycaemic conditions. Our 
data suggest that high glucose, TGF-f3I and [Cl+]i up-regulate both SGKI and cr-
ENae protein expression, which in turn stimulates Na+ transport. In pathological 
conditions associated with aberrant Na + reabsorption, excessive levels of Na + may 
further exacerbate the state of hypertrophy, a common manifestation associated with 
diabetic nephropathy. Mechanical stress evoked TRPV4 m~diated changes in [Ca2+]i. 
Propagation of this Ca2+ signal via the gap junction protein connexin 43 (Cx-43) was 
enhanced following glucose treatment, as was Cx-43 expression. Under 
pathophysiological conditions these changes and the increased expression levels of 
our key signaling elements, may lead to deranged Na+ handling and inhibition of cell 
volume recovery mechanisms which together may further enhance the condition of 
diabetic nephropathy in Type 11 diabetes. 
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Chapter 1 
Introduction 
1.1 Non insulin dependent Diabetes Mellitus 
The maintenance of glucose homeostasis depends on a tightly regulated array of 
signalling cascades, all of which control the ability of the cells within the body to 
detect a significant change in blood glucose. Despite the varying demands of food 
and fasting, levels rarely stray outside the physiological range of 3.5-8 mM. Only 
when abnonnalities arise is there inefficient uptake and subsequent metabolism of 
glucose. Consequently, our blood levels rise and we become hyperglycaemic. If left 
untreated, diabetes can result. A disease of multiple aetiology, diabetes has been 
classified into several subtypes that include Type I, Type 11 (otherwise known as 
non-insulin dependent diabetes (NIDDM» and maturity onset diabetes of the young 
(MODY). Whilst Type I diabetes is an auto immune disease in which destruction of 
p cells of the pancreas results in failure to secrete insulin, Type 11 diabetes is a 
complex heterogenous disorder encompassing a wide array of metabolic 
abnonnalities associated with malfunctions in both insulin action and secretion; both 
of which are usually present at the time of diagnosis. (Nesher et al., 1987) 
According to the American Diabetes Association (AD A) (Expert committee 1997) 
Type 11 diabetes is defined as 
"The most common fonn of diabetes, occurring with increasing frequency of age, 
usually associated with insulin resistance and always with either relative, or absolute 
insulin deficiency and not generally requiring insulin treatment for survival" 
Typical risk factors that predispose an indivdual to Type 11 diabetes include age, 
race and background, a family history of diabetes, hypertension, high cholesterol, 
obesity and lifestyle factors; for example low physical activity, high-fat low-
carbohydrate diet, alcohol and smoking 
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Untreated or poorly controlled Type 11 diabetes causes both hyperglycaemia and 
hyperlipidaemia which in turn can lead to the development of a range of secondary 
complications, macrovascular or microvascular, the latter of which includes 
retinopathy, nephropathy and neuropathy. The exact mechanisms of microvascular 
disease are still a matter of debate. The main sites to be affected are the retina, renal 
glomerulus, and the nerve sheath respectively (Wolf et al., 2003). 
1.2 Socioeconomic burden of Type 11 diabetes 
In today's society, Type 11 diabetes is an enormous health problem. Increasing 
prevalence means that approximately 5-7% of the world's population is affected. 
However, this remains a rough approximation, since another 3% of the population 
remain undiagnosed (Bloomgarden 1996). The severity of the condition is dependent 
upon the degree of insulin insensitivity, a determining factor in the pathogenesis of 
the condition which is extremely variable from one individual to another. The 
prevalence of the condition varies considerably throughout the world. The World 
Health Organisation (WHO) estimates that 2% of the UK population are Diabetic, 
whilst the number is thought to be three to four times that in people of African and 
Caribbean ancestry (Gaillard TR et al., 1997). Likewise, those of Hispanic 
American origin and in those from South Asia and Arabia living western lifestyles 
are far more at risk than white Europeans. Variability in both diet and lifestyle are 
thought to be the two main factors responsible for denoting the percentage 
population of a cohort affected. For example, a much higher prevalence of glucose 
intolerance and Type 11 diabetes has been observed in the Pima Indians living in the 
United States as compared with those living in Mexico (Bloomgarden 1996, Bennett 
et al., 1976). This is thought a consequence of their sedentary lifestyle, coinciding 
with a high incidence of obesity as compared to their counterparts (Bloomgarden 
1996) 
There is no doubt that Type 11 diabetes is of increasing prevalence worldwide. The 
global increase is estimated to be 122% (from 135 million to 300 million people) 
between 1995 and 2025; 90% of these people will have Type 11 diabetes (King et al., 
1998). The developing world is predicted to suffer the most with an approximate 
170% increase in incidence rate, affecting mainly the 45-64 year old age bracket 
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(King et al., 1998). Whilst the disease is known to affect mainly older individuals, an 
increasing sedentary lifestyle in conjunction with a rise in the availability of so called 
fast food, is leading to a rise in the number of obese young adults in today's society. 
Consequently the identification of the disease in children and teenagers is far more 
frequent than in the past and since the number of obese young adults worldwide is on 
the rise, the resultant obesity epidemic looks set to cause a public health problem in 
years to come. 
1.3 Insulin 
1.3.1 Metabolic actions of insulin 
Insulin, produced by the ~ cells of the pancreas, is a major anabolic hormone whose 
action is essential for growth, development and homeostasis of glucose, fat and 
protein metabolism (Virkamaki et al., 1999, Le Roith 2001). Insulin stimulates the 
formation of metabolic storage compounds such as glycogen and triacyclglcyerols by 
facilitating the uptake of glucose into the cell via activation of a series of glucose 
transporters expressed in the cell membrane. Since cells are not permeable to 
glucose, a family of specialised glucose transporter (GLUT) proteins carry glucose 
into cells (Krusznynska, 2003). The principal stimulus for insulin secretion is a 
change in plasma glucose. In the liver, insulin promotes the metabolism of glucose 
via glycolysis and the Krebs cycle, whilst excess glucose is converted into the 
storage compound glycogen, thus insulin serves to regulate hepatic metabolism via 
control of the rate of catabolic reactions such as gluconeogenesis and ~ oxidation. 
Since the liver inactivates approximately 80% of insulin, the concentration of insulin 
in the systemic circulation is normally considerably lower than that found in the 
portal system. Even at these lower concentrations insulin can stimulate the synthesis 
of proteins in muscle cells through increased amino acid uptake and ribosomal 
protein synthesis. Of all the storage compounds, fat represents the most efficient 
means of storing energy, providing 9kcals per gram of stored substrate. Insulin 
promotes the formation of triglycerides in adipocytes through inhibition of 
intracellular lipolysis, hydrolysis oftriglycerides from circulating lipoproteins and by 
increasing glucose transport into fat cells. The latter enables increased availability of 
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a-glycerol phosphate, used in the esterification of free fatty aids into triglycerides 
(Krusznynska, 2003). 
1.3.2 Insulin-structure, secretion and mode of action 
Human insulin is a peptide honnone produced by the f3 cells of the pancreatic islets. 
Structurally it is comprised of 51 amino acids and is structurally homologous to 
insulin like growth factors 1 and 2 and also to the ovarian honnone, relaxin (Kumar 
et al., 2002). The gene for insulin codes for pre-proinsulin and is located on 
chromosome 11 (Kumar et al., 2002). Pre-proinsulin is comprised of a signal 
sequence at the N-tenninus (approximately 23 amino acids) that is cleaved following 
trafficking to the endoplasmic reticulum giving rise to proinsulin which is composed 
of an A chain, a joining C-peptide and a B chain. The C peptide is essential to the 
fonnation of disulfide bonds which fonn between cysteine residues allowing the A 
and B chains to adopt an appropriate confonnation which will ensure efficient 
cleavage in the golgi apparatus. In the trans-golgi apparatus, pro-insulin is packaged 
into secretory granules where proteases begin to slowly cleave the proinsulin 
molecule at two spots resulting in release ofthe C-peptide. Cleavage of the C-peptide 
results in conversion of proinsulin into mature insulin comprised of 51 amino acids, 
21 on the A chain and 30 on the B chain. The manufacture and release of insulin is 
illustrated in Figure 1.1 (Kumar et al., 2002). 
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Figure 1.1 Insulin synthesis and secretion: The ribosomes manufacture pre-
proinsulin from insulin mRNA. Cleavage of this pre region at the ER leaves pro-
insulin at the golgi apparatus. At the golgi, proinsulin is parcelled into secretory 
granules. These mature and pass towards the cell membrane where they are stored 
before release. The C peptide splits off from proinsulin in the secretory process, 
leaving insulin as a complex of two linked peptide chains. A small amount of insulin 
is secreted by the p cell directly by the constitutive pathway which bypasses 
secretory granules (Kumar et al. , 2002). 
Whilst there is still a degree of controversy as to whether C peptide exerts any 
functional biological role within the system, the fact that it is secreted in a 1: 1 molar 
ratio with insulin makes it a useful marker for insulin secretion. When insulin is 
secreted, it enters the portal circulation and is carried to the liver where most of it is 
removed. However, C-peptide is not metabolised by the liver and thus whilst the 
concentration of insulin in systemic blood does not quantitatively mimic the 
secretion of insulin, measurements of C-peptide do. 
Insulin is secreted in pulses every ten minutes or so In response to a variety of 
secretagogues. Whilst glucose is the best secretagogue, some amino acids and small 
ketoacids can also stimulate insulin secretion. The stages involved in secretion of 
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insulin have been proposed as follows and is illustrated in Figure 1.2 (Kumar et al., 
2002) 
1. In humans, glucose enters the ~-cel1 by the glucose transporter GLUT2. 
2. Glucose is metabolised by glycolysis consequently raising [ATP]i by 
phsophorylating ADP. 
3. The increased [ATPV[ADP]i ratio closes the ATP-sensitive K+ channel 
(K+ A TP) and results in depolarisation of the ~ cell (Le the membrane 
potential is less negative). 
4. This depolarisation results in an influx of calcium ions via calcium channels 
in the cell membrane through voltage-dependent Ca2+ channels. 
5. The rise in calcium leads to the fusion of insulin containing granules with the 
cell membrane and exocytosis of the granule contents, ultimately leading to 
insulin release. 
Secretion occurs in two main phases; the first phase represents the release of insulin 
stored in secretory granules, whilst the second phase, which is a longer sustained 
phase, may last up to several hours and is consequently reliant upon de novo 
synthesis of the hormone. 
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Figure 1.2 Local forces regulating insulin secretion from beta cells. Glucose 
enters the beta cell via the GLUT 2 transporter, which is closely associated with the 
glycolytic enzyme glucokinase. Metabolism of glucose within the beta cell generates 
ATP. ATP closes potassium channels in the cell membrane. If a sulfonylurea, binds 
to its receptor then this will close the K+ channel and depolarise the membrane 
allowing calcium ions to enter via calcium channels in the cell membrane. The rise in 
intracellular calcium leads to fusion of the insulin containing granules with the cell 
membrane and exocytosis of the insulin rich granules contents (Kumar et al. , 2002) 
Insulin mediates its effects through a heterodimeric receptor expressed in the cell 
membrane. This receptor is a tetramer with two a subunits, which comprise the 
insulin binding sites and two p subunits which traverse the cell membrane. When 
insulin binds to the a subunits, it induces a conformation change in the beta subunits 
stimulating the intrinsic tyrosine kinase activity. This results in phosphorylation of a 
number of target proteins including insulin receptor substrate (IRS) proteins which 
serve as docking sites for downstream effector molecules. This triggers two major 
signalling kinase cascades, the phosphoinositide 3-kinase (pI3-K) and the mitogen 
activated protein (MAP) kinase pathways. Together, these two signalling pathways 
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mediate the metabolic and growth promoting effects of insulin (Virkamaki et al., 
1999, LeRoith et al., 2001) 
1.3.3 Insulin resistance 
Insulin resistance occurs when cells fail to respond to ordinary levels of circulating 
insulin (Kahn et al., 2000, Matthaei et al., 2000). At the molecular level, this 
resistance can occur anywhere in the insulin signalling pathway from the receptor to 
alterations in downstream signalling events. Unknown genetic abnormalities can 
therefore attenuate insulin signalling within the cell producing resistance. Initially, 
insulin resistance is compensated for by the adaptive capacity of the p cells to 
increase insulin secretion, preventing any serious disturbances to glucose 
homeostasis. The ability of p cells to adapt to insulin resistance depends on various 
genetic factors that determine the total p cell mass, rates of replication, apoptosis of 
the cells and the activity of key biochemical components of these cells (Bonner-Weir 
2001, Chandra et al., 2001, Porte et al., 2001). Eventually, whether it is through 
increased insulin resistance or p cell bum out, the p cell is unable to compensate for 
the level of resistance and p cell failure can occur. 
1.4 Anatomy of the mammalian kidney 
Human adults produce on average a litre of urine (PH -6) each day. Urine contains 
water and other by products of metabolism, such as urea as well as NaCI, KC1, 
phosphates and other substances present in excess of the body's requirements. The 
role of the kidney is to maintain, through elimination of these waste products, a 
homeostatic environment and therefore has 3 major functions: 
1. Excretion, or the removal of waste products from body fluids 
2. Homeostatic regulation of the volume and solute concentration of blood 
The gross anatomy of the mammalian kidney is shown in Figure 1.3. Each individual 
has two kidneys one located each side against the dorsal inner surface of the lower 
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back. Despite their small size ( I S0g), the kidneys receive a remarkably large blood 
flow, equivalent to about 20%-25% of the total cardiac output (Kumar et al. , 2002) 
The kidney itself has two layers; an outer cortex and an inner medulla. The outer 
layer, the cortex is covered by a tough capsule of connective ti ssue, whilst the inner 
layer, the medulla consists of 6-1 8 distinct triangular structures called renal 
pyramids. The tips of these renal pyramids are referred to as papilla and project into 
the renal sinus. Adjacent pyramids are separated by bands of cortical tissue called 
renal co lumns which ex tend into the medulla. Collectively the renal pyramid, the 
overlying area of renal cortex and adjacent ti ssues of the renal columns are referred 
to as renal lobes. Urine production occurs in the renal lobes in microscopic structures 
called nephrons. Urine flows from these nephrons into the renal pelvis. The renal 
pelvis gives rise to the ureters which empty into the urinary bladder. Urine leaves the 
bladder via the urethra which leads to the end of the penis in males and into the vulva 
in females (Kumar et al. , 2002) . 
Minor calyx 
Ma,orcalyx 
Figure 1.3 Gross anatomy of the mammalian kidney (Guyton et al. , 2005). 
1.4.1 The nephron is the functional unit of the kidney 
The functional unit of the mammalian kidney is the nephron (Figure l.4A), an 
epithelial tube which may be, SOmm in length that is closed at the beginning but 
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open at its distal end. Each kidney contains roughly 1.25 million nephrons with a 
combined length of about 145 km (Kumar et al., 2002). The beginning of the 
nephron starts with the renal corpuscle, a spherical structure enclosing the bowmans 
capsule, a cup shaped chamber approximately 200~m in diameter with a capillary 
network known as the glomerulus. The lumen of the capsule is continuous with the 
narrow lumen that extends through the renal tubule. Blood arrives at the bowmans 
capsule by way of an afferent arteriole and subsequently leaves via the efferent 
arteriole. From here blood flows into a network of capillaries that surround the renal 
tubule. These capillaries, in turn drain into small venules that return the blood to the 
venous system. 
The glomerulus is the structure responsible for the first step in urine formation. 
Blood pressure forces water and dissolved solutes out of the glomerular capillaries 
and into the capsular space that is continuous with the lumen of the renal tubule. 
Filtration produces a protein-free solution referred to as the filtrate that resembles 
blood plasma. 
From the renal corpuscle, filtrate enters the renal tubule, which is responsible for 
three crucial functions. 
1. Reabsorption of the useful substrates that the body can utilise further 
2. Reabsorption of water 
3. Secretion of any waste products into the tubular lumen which failed to 
successfully filter through at the glomerulus 
The nephron can be divided into three main regions (see Figure I.4A), the proximal 
nephron, the Loop of Henle and the distal nephron. The proximal and distal nephron 
are convoluted tubules which lie in the kidney cortex, whilst the U shaped tube 
which separates these two tubes, commonly known as the Loop of Henle lies into the 
medulla. (Figure1.4B) 
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Figure 1 .4 Structure of the nephron (A) Main parts of the nephron (B) Sites of 
reabsorption or addition of substances into tubular fluid. (Kumar et al., 2002) 
1.4.1.1 The Proximal Convoluted Tubule 
The Proximal Tubule is initially convoluted (PCT) and then straightens out as it leads 
down to the Loop of Henle. The cells lining the proximal tubule are tall, cuboidal 
epithelium covered in apical microvilli. In the proximal tubule many substances are 
reabsorbed including sodium (70%), potassium, calcium, phosphate glucose, amino 
acids and water. Solutes are initially reabsorbed into the peritubular fluid, the 
interstitial fluid which surrounds the renal tubule. The proximal tubule is highly 
permeable to water. Therefore as solutes are reabsorbed water will follow by 
osmosis, thus whilst the volume of the filtrate is reduced in the proximal convoluted 
tubule, the filtrate is not concentrated. The primary function of the PCT is 
reabsorption however cells can also secrete substances into the lumen that have 
bypassed filtration. 
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1.4.1.2 Loop of Henle 
Approximately 60-70% of the volume of the filtrate produced at the glomerulus has 
been reabsorbed before the tubular fluid reaches the Loop of Henle. Here roughly 
half of the water as well as two thirds of the remaining sodium and chloride ions are 
reabsorbed into tubular fluid. 
The Loop of Henle can be divided into a descending limb and ascending limb. Each 
segment has very different permeability characteristics and together they work to 
increase medulla osmolarity and decrease the osmolarity of the filtrate. The thin 
descending limb is permeable to water but relatively impermeable to solutes. The 
thick ascending limb which is relatively impermeable to both water and solutes 
contains active transport mechanisms that pump sodium and chloride ions from the 
tubular fluid into the peritubular fluid of the medulla. The exchange that occurs 
between these segments is called countercurrent multiplication. Countercurrent refers 
to the fact that the exchange occurs between fluids moving in opposite directions; 
Fluid in the descending limb travels towards the renal pelvis whilst that in the 
ascending limb travels towards the renal cortex. Multiplication refers to the fact that 
the effect of the exchange increases as movement of the fluid continues. 
Countercurrent multiplication is a simple positive feedback loop and operates as 
follows 
• Sodium and chloride are pumped out of the thick ascending limb and into the 
peritubular fluid. 
• This pumping action elevates the osmotic concentration in the peritubular 
fluid around the thin descending limb. 
• The result is an osmotic flow of water out of the thin descending limb into the 
peritubular fluid increasing the solute concentration in the thin descending 
limb. 
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• The arrival of a highly concentrated solution in the thick ascending limb 
accelerates the transport of sodium and chloride ions into the peritubular fluid 
of the medulla 
Active transport at the apical surface of the ascending limb moves sodium, potassium 
and chloride ions out of the tubular fluid via a Na+/K+/2Cr co-transporter. With each 
cycle of the pump, a sodium ion, potassium ion and two chloride ions are moved into 
the tubular cell. Potassium and chloride ions are pumped into the peritubular fluid by 
cotransport carriers. However potassium ions are removed from the peritubular fluid 
as the sodium-potassium exchange pump pumps sodium ions out of the tubular cell. 
The potassium ions then diffuse back into the lumen of the tubule through potassium 
leak channels. The net result is that Na+ and cr enter the peritubular fluid of the 
renal medulla. This removal of N a + and cr ions from the tubular fluid in the 
ascending limb elevates the osmotic concentration of the peritubular fluid around the 
thin descending limb and subsequently draws water out of the thin descending limb 
by the process of osmosis. Solutes remain in the tubular fluid since the thin 
descending limb is impermeable to solutes, thus as the tubular fluid reaches the turn 
of the Loop of Henle, it has a higher osmotic concentration than it did as the start. 
(Figure 1.5) 
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Figure 1.5: Counter-current multiplication and concentration of urine in the 
Loop of Henle. Active transport of NaCl along the ascending thick limb results in 
the movement of water from the descending limb (Martini F et al. , 2004) 
Almost two thirds of the sodium and chloride ions that enter the thick ascending limb 
are pumped out of the tubular fluid. Since the thick ascending limb is not permeable 
to water; osmosis does not occur and thus the solute concentration in the tubular fluid 
is reduced. By the time the tubular fluid reaches the Distal Convoluted Tubule it has 
an osmotic concentration of only about 100mOsmJl, one third of the concentration of 
the peritubular fluid of the renal cortex. The rate of ion transport in the thick 
ascending limb is proportional to ion concentration in tubular fluid. As a result, more 
sodium and chloride ions are pumped into the medulla at the start of the thick 
ascending limb, where NaCl concentrations are highest than near the cortex. This 
determines the concentration gradient within the medulla. Sodium and chloride ions 
account for approximately two thirds of this gradient, the rest results from the 
presence of urea. Since the thick ascending limbs of the Loop of Henle, the DCT and 
the collecting ducts are impermeable to urea, therefore water reabsorption results in 
an increase in urea concentration. Urea reabsorption occurs in the papillary ducts 
where the epithelium is permeable. 
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1.4.1.3 The Distal Convoluted Tubule 
The Distal Convoluted Tubule (DCT) is the third segment of the renal tubule and is 
an important site for three processes 
1. The active secretion of ions, acids and other materials 
2. The selective reabsorption of sodium ions and calcium ions from tubular 
fluid. 
3. The selective reabsorption of water, which assists in concentrating the tubular 
fluid 
The DCT reabsorbs a further 5% of filtered sodium establishing a negative charge in 
the lumen of this portion of the nephron consequently sodium reabsorption is 
accompanied by the movement of negatively charged chloride ions. 
In the DCT, a group of specialised renin-secreting cells form a region called the 
macula densa. These cells are closely associated with smooth muscle fibres in the 
wall of the afferent arteriole. The fibres are referred to as juxtaglomerular cells and 
are situated on the afferent glomerular arteriole as it enters the glomerulus. Renin, 
converts angiotensinogen in the blood to angiotensin 1 and is released in response to a 
drop in afferent arteriole pressure, a fall in tubular flow rate or a fall in sodium and 
chloride in the distal tubule via the macula densa. angiotensin 1 is converted by 
angiotensin converting enzyme (ACE) into Angiotensin 11. Renin therefore promotes 
production of angiontensin 11 which acts via All receptors to promote 
vasoconstriction of afferent and efferent arterioles. The dominant effect is on efferent 
arteriolar constriction so that glomerular filtration rate is increased. 
1.4.1.4 The collecting system 
As the hypotonic urine passes down the collecting ducts, both water and sodium are 
reabsorbed. Around 2-5% of filtered sodium is reabsorbed in the collecting ducts. 
Two characteristic cell types are involved in this process 
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Principal cells-These are involved in sodium reabsorption via the apically expressed 
epithelial sodium channel (ENaC) and the basolateral Na+/K+ ATPase (For further 
details see section 1.9). 
Intercalated cells-These have no Na+/K+ ATPase but do have an H+ ATPase 
responsible for establishing a hydrogen gradient. Energetic drive of the pump is 
derived from this H+ gradient. As H+ ions are removed from the cell, the net result is 
the secretion of bicarbonate coupled to the reabsorption of chloride. Intercalated cells 
are also involved in the reabsorption of potassium via an apical H+/K+ ATPase. 
Water permeability is controlled in the collecting ducts by antidiuretic hormone 
(ADH) or vasopressin. Secreted by the pituitary in response to volume depletion, 
angiotensin 11, pain, trauma and temperature, ADH binds to its corresponding V2 
receptors, stimulating adenyl cyclase and raising intracellular cAMP levels (Knepper 
et al., 1993). This causes the fusion of intracellular vesicles containing the water 
channel aquaporin 2 (AQP2) with the apical cell membrane and the subsequent 
reabsorption of water (Brown, 2003) down an osmotic gradient established by the 
counter current multiplication of the Loop of Henle. If the permeability of the 
collecting ducts is low, there is no water reabsorption; yet sodium chloride is 
continually reabsorbed further diluting the urine. Contrary to this, if the permeability 
of the collecting ducts is high then water moves out of the hypotonic tubular fluid 
into the surrounding hypertonic interstitium. In the cortical collecting duct, tubular 
fluid equilibrates with the cortical interstitium which is at plasma osmolarity. In the 
deeper medullary collecting duct, tubular fluid then equilibrates with the high 
osmolality of the medullary interstitium producing concentrated urine. 
1.5 Diabetic nephropathy 
Of the complications associated with Type 11 diabetes, diabetic nephropathy is one of 
the most extensively studied conditions known to arise as a consequence of this 
hyperglycaemic state and is classically defined as: 
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"a progressive increase in urine albumin excretion, accompanied by rising blood 
pressure and a relentless decline in glomerular filtration, culminating eventually in 
end stage renal failure" (Grenfell 1997). 
The condition refers to both structural and functional alterations that occur in the 
kidney of the diabetic patient (Reeves et al., 2000). Whilst structural changes include 
renal hypertrophy, thickness of the glomerular basement membrane, and increased 
extracellular matrix accumulation in the glomeruli, functional disturbances include 
an increase in glomerular filtration rate, glomerular hypertension, proteinuria, 
systemic hypertension and finally renal failure. (Mason et al., 2003) 
The main pathological features of the diabetic kidney occur both in the glomerulus 
and in the tubule interstitium. In a normal subject, the glomerulus consists of a tuft of 
approximately 20-30 capillary loops, all of which arise from an afferent arteriole and 
subsequently drain into an efferent arteriole (Tisher 1981). These tufts are enclosed 
within the bowmans capsule. The mesangium and mesangial cells are composed of 
both cellular and matrix components involved in both production and degradation of 
extracellular matrix proteins, including Type I and Type IV collagen and fibronectin, 
providing structural support for the glomerulus (Kumar et al., 2002). The capillaries 
within the glomerulus are surrounded by a basement membrane. Resting against this 
membrane, are a class of epithelial cells called Podocytes which extend into primary 
and secondary cytoplasmic processes branching into long projections called foot 
processes (Figure 1.6). These foot processes attach to the urinary side of the 
glomerular basement membrane where they interdigitate with adjacent cells forming 
filtration slits of -2.5-5 nm. Across these slits, a highly organised network; of several 
glycoproteins form 'slit pores' responsible for filtration of water, solutes and 
macromolecules (Gnudi et al., 2003). 
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Together the fenestrated endothelium and the podocytes fonn the basement 
membrane. In patients with diabetes both kidney and glomerular volume are 
increased (Mogensen et al. , 1979), the latter of which continues to enlarge with the 
disease (Osterby et al. , 1987). Glomerular enlargement is initially due to an increase 
in capillary surface area and subsequently to adaptive changes in the surviving 
glomeruli upon both thickening of the basement membrane and mesangial expansion 
(Mauer et al. , 1984) 
[n diabetes, mesangial expansion occurs when cells of the mesangium exhibit a 
reduction in their ability to successfully degrade matrix proteins. Mesangial 
expansion often manifests itself in the fonn of a diffuse lesion that develops into a 
more structured nodular appearance often occupying the central mesangial area 
(Morley et al., 1988). This expansion occurs at the expense of the glomerular 
capillary lumen and filtration urface area. This reduction is glomerular filtation rate 
(GFR) correlates closely with the decline in renal function and the development of 
proteinuria (Mauer et al. , 1984). 
18 
It is widely accepted that the increased unne albumin excretion in diabetic 
nephropathy is mostly glomerular in origin. Loss of these glomerular epithelial cells 
has been reported to coincide with both development and progression of proteinuria 
in diabetic patients (Meyer et al., 1999). Albumin escapes through the glomerular 
filtration barrier. In the early stages of renal disease, when microalbuminuria is 
present, the clearance of albumin, a polyanion of molecular weight 69kDa and 
immunoglobulin G (lgG), a larger (lSOkDa) but neutral molecule are increased. 
Increased intraglomerular pressure, loss of negatively charged glycosaminoglycans 
in the basement membrane and later in the process increased basement membrane 
pore size all contribute to albuminuria. (Figure 1.7) 
The podocyte also has a role in increasing proteinuria and glomerulosclerosis. These 
foot processes are the final barrier to protein loss across the glomerulus into the 
urinary space. Like the basement membrane, podocytes are also covered in 
negatively charged proteins that repel anionic proteins such as albumin. This is 
essential as it prevents proteinuria through the aid of proteins such as nephrin which 
prevent escape of protein into bowmans capsule. Podocyte morphology is altered in 
diabetes where foot processes broaden and the effective pore size increases. 
Eventually the filtration barrier loses its selectivity and proteinuria ensues. With time 
damage results in complete loss of the podocyte (White et al., 2002). Failure of these 
podocytes to regerenate means that this loss cannot be compensated for. 
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Figure 1.7 The evolution of proteinuria in diabetes. Filtration of plasma proteins 
such as albumin and the larger electrically neutral immunoglobulin (IgG) is normally 
restricted by the resting negative charge on the glomerular basement membrane 
(OBM) and by the size of the filtration pores. Increased glomerular capillary pressure 
and the loss of negative charge increase filtration of proteins including albumin in the 
early stage of microalbuminuria. With further loss of negative charge and 
enlargement of filtration pores in advanced nephropathy, albumin loss increases 
greatly and IgO is readily filtered (Onudi et al., 2003) 
1.6 The socioeconomic burden of diabetic nephropathy 
Worldwide, diabetic nephropathy is now the single commonest cause of entry into 
the renal replacement therapy programme (US Renal Data System) and has become 
the leading cause of end-stage renal disease (ESRD) in the US and Europe. This is 
due to the fact that: 
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i. Diabetes, particularly Type 11 is increasing in prevalence 
11. Diabetes patients now live longer and 
111. Patients with diabetic ESRD are now being accepted for treatment in ESRD 
programmes where formerly they had been excluded. 
The incidence of ESRD caused by diabetes was 148 per million populations in the 
United States in 2001. Whilst about 20-30% of patients with type 1 or type 11 
diabetes develop evidence of nephropathy, in Type 11 diabetics a considerably 
smaller fraction of these progress to ESRD (US Renal Data System). However, since 
Type 11 diabetes is of increasing prevalence, such patients constitute over half of 
those on dialysis. 
Both racial and ethnic variability appear to be important determinants of those 
entering renal replacement therapy (RRT) since Native Americans, Hispanics and 
African-Americans have a much higher risk of developing ESRD than non-Hispanic 
Whites with Type 11 diabetes, thus the higher the proportion of individuals from 
ethnic minorities in one identified population, the higher the incidence of those 
entering RRT (American Diabetes Association., 2004). It is of no surprise therefore 
that the percentage entrance into the RRT varies widely geographically; from 54% in 
Brunei to 9.7% in Bulgaria (US Renal Data System) 
1. 7 Cell biology of diabetic kidney disease 
Hyperglycaemia is one of the predominant factors in the development of Diabetic 
nephropathy. There is strong evidence that poor blood glucose control contributes 
towards the development of albuminuria, however and in those diabetic patients who 
undergo intensive therapy, the risk of transition from normo to microalbuminuria is 
only reduced by approximately 35% (Krolewski et al., 1995). Some of the 
mechanisms that link hyperglycaemia to the functional/structural abnormalities of 
diabetic kidney disease have been elucidated. 
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A number of cellular events occur in the presence of high glucose that include 
increased flux of polyols and hexosamines, formation of reactive oxygen species 
(ROS), activation of PKC, transforming growth factor (TGF-Pl), Smad-mitogen -
activated protein kinase (MAPK) and G-protein signalling and altered expression of 
cyclin kinases, their inhibitors and of matrix proteins, matrix degrading enzymes and 
metallo proteinases (Gnudi et al., 2003). These events are all thought to be 
interconnected and generally resulting in increased deposition of extracellular matrix 
(ECM), a hallmark of Diabetic nephropathy which contributes towards the 
development of renal disease (Mason et al., 2003). 
Sustained hyperglycaemia also leads to non-enzyrnatic protein glycation. This 
involves the covalent bonding of glucose to proteins in which a lysine amino 
terminal group is exposed. These glycated products undergo dehydration, oxidation 
and rearrangement to form toxic advanced glycation end products (AGEs) 
(Brownlee, 1995). AGEs can be either intracellular or extracellular depending upon 
how they are formed. Those acting intracellularly can activate PKC, MAPK and 
transcription factors eg NF-KB, whilst extracellular AGEs act via a receptor to 
modulate expression of various cytokines and ECM proteins. This interaction has 
been shown to induce the synthesis and release of various cytokines, including TGF-
p I and IGF, various ECM proteins and Type I and IV collagens (Sakurai et aI2003). 
In diabetic animals, AGE accumulation in the kidney is paralleled by the 
development of albuminuria, mesangial expansion, and glomerular basement 
thickening. These developments were found to be attenuated upon administration of 
Aminoguanidine (AGN), an AGE inhibitor (Edelstein et al., 1992). 
Kidney cells, as with cells at other sites of diabetic vascular complications, do not 
have an absolute requirement of insulin for glucose uptake, thus the intracellular 
glucose level more directly reflects its plasma concentration. Glucose entry into renal 
cells is facilitated by GLUTl and GLUT4 (glucose transporters) as well as by both 
sodium co-transporters such as Sodium Glucose Transporter 1 (SGLTl) and Sodium 
Glucose Transporter 2 (SGLT2), which allow glucose into the cell for subsequent 
metabolism. GLUT 1 has been linked to the pathobiology of diabetic complications 
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following observations of excessive production of those proteins involved in 
enhanced ECM development under normal glucose ambience. Overexpression of 
GLUT 1 at a normal glucose concentration has been demonstrated to induce those 
phenotypic changes associated under conditions of hyperglycaemia (Heilig et al .• 
1995). The administration of GLUT 1 antisense was found to diminish the 
production of fibronectin in mesangial cells, suggetsing that the regulation of these 
glucose transporters is critical since they appear to play a role in both extracellular 
and intracellular events (Heilig et al .. 2001) 
Glucose metabolism feeds a number of related down-stream cascades (Figure 1.8) 
(Nelons et al .. 2000) 
• Firstly glucose is phosphorylated by hexokinase and after several steps 
fructose 6-phosphate and glyceraldehyde 3 phosphate are produced leading to 
adenosine triphosphate (ATP), generating reactions with pyruvate and lactate 
as end products 
• Secondly the glycerol phosphate is a precursor of Diacylglycerol (DAG). 
DAG is a powerful signalling molecule that modulates intracellular signalling 
events relevant to the pathogenesis of diabetic nephropathy (LeRoith et al .• 
2004, Brownlee 2000) and stimulates activation of PKC. PKC has too 
emerged as a potential regulator of all aspects of the development and 
progression of diabetic nephropathy 
• In conditions of high glucose, excessive sugar is shuttled into the hexosamine 
pathway in which fructose 6-phosphate is converted to glucose amine 6-
phopshate by a rate limiting enzyme, glutamine fructose-6-phosphate-
aminotransferase (GF AT). This leads to the production of UDP-N-
acteylglucosamine, a precursor of proteoglycans, lycoproteins and glycolipids 
(Schleicher et al.. 2000) Inhibition of GF AT has been shown to inhibit 
promoter activities of certain molecules relevant to Diabetic nephropathy eg 
TGF-p I and plasminogen activator protein (PAI)-l by affecting 
phosphorylation of a number of transcription factors eg SP 1 (Irvine et al .• 
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2005). Other tran cription factors that bind to promoters of glucose 
responsive genes and other nuclear or cellular proteins are also believed to be 
affected by high glucose. 
• As in the hexosamine pathway, intracell ular glucose can be diverted into the 
polyol pathway. In th is pathway, glucose is reduced to sorbito l, catalysed by 
an NADPH dependent enzyme aldose reductase. Sorbitol is then oxidised to 
fructose utilising NAD+ as a cofactor (Chung et al. , 2003). This results in an 
increase in the ratio of reduced nicotinamide adenine dinucleotide (NAD) and 
associated metabolic changes including osmotic stress and an imbalance in 
the cellular redox. Aldose reductase inh ibitors fail to prevent cellular and 
matrix changes in the kidney, suggesting that the polyol pathway may not be 
solely responsible for renal complications in diabetes mellitus (McAuli ffe et 
al. , 1998) 
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Figure 1.8: The metabolism of glucose in a cell and its possible involvement in 
the generation ofTGF-j31. 
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1.8 Molecular mediators of Diabetic nephropathy 
At the cellular level a number of key signalling molecules converge to bring about 
the pathogenesis associated with Diabetic nephropathy. 
1.8.1 Transforming growth factor-J31 
TGF-J3I is the founding member of the TGF-J3 superfamily that can be sub divided 
into 4 major families 
The Mullerian inhibitory substance (MIS) family. 
The inhibinlactivin family 
The bone morphogenetic protein (BMP) family and the 
TGF-J3 family 
TGF-J3I is a ubiquitous cytokine that has a broad spectrum of biological functions 
and actions in a variety of cell types (Arteaga et al., 1996, Platten et al., 200 I, 
Schuster et al., 2002). It exists in three isoforms 131, 132 and 133, of which TGF-J3I is 
the most highly expressed in the kidney. The extracellular concentration of active 
TGF-J31 is primarily regulated by the conversion oflatent TGF-pI to active TGF-pI. 
The TGF-J3I gene encodes a 390 amino acid precursor that contains a signal peptide, 
the active TGF-J3I molecule and a latency associated peptide (Hyytiainen et al., 
2004). Before secretion, TGF -131 non-covalently associates with the latency 
associated peptide (LAP) (Gentry et al., 1987) to produce an inactive, latent TGF-J31 
complex. TGFJ31 can be released from the latent complex and activated by various 
factors. Once activated TGFJ31 is able to bind to its receptor, initiating an 
intracellular cascade. 
Both glomerular and proximal tubule cells express all three isoforms of the TGF -131 
receptor (Border et al., 1994). Following binding TGF-J31 activates a family of 
transcription factors known as Smads (Massague 2000), found in vertebrates, insects 
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and nematodes (Heldin et al., 1997) Smad proteins consist of receptor regulated 
Smads, a common pathway Smad and inhibitory Smads. 
• Receptor regulated (R) Smads are phosphorylated by TGF-p 1 Type I receptor 
and include Smad 2 and Smad 3, 5 and 8 (Massague 2000). 
• Smad 4 is a common pathway Smad that is not phosphorylated by the TGF-
PI Type I receptor (Massague 2000, Liu et al., 1997). 
• Inhibitory Smads include Smad 6 and Smad 7 which downregulate TGF-p 1 
signalling (Massague 2000). 
• The Co-Smads form complexes with the R Smads. Although the Co-Smads 
are not required for the nuclear accumulation of R-Smad containing 
complexes, they are necessary for the formation of functional transcriptional 
complexes (Liu et al., 1997) 
TGF-p 1 initiates its cellular response by binding to its distinct receptor, TGF-p 
receptor 11 (TPRII) which activates the TPRI kinase prior to phosphorylation of the 
receptor-regulated Smads (R-Smads). Activated R-Smads form oligomeric 
complexes with the common Smad (Co-Smad). These oligomeric complexes then 
translocate into the nucleus. In the nucleus, they may regulate the transcription of 
target genes by functioning as transcriptional activators and binding to DNA directly 
(Dennler et al., 1998) or they may form associations with nuclear transcription 
factors such as AP-l. In many cell lines TGF -P 1 is capable of positively regulating 
its own expression (Van Ibberghen-Schilling et al., 1988,) Autoinduction of TGF-p 1 
transcription appears to be mediated through binding of an AP-l complex to the 
TGF-p 1 promoter. This autoinduction may be responsible for the pathologic 
induction ofTGF-p 1 that is associated with fibrosis of the kidney. 
Abnormalities in TGF-pl have been discovered in a wide variety of disorders, 
including auto immune diseases, malignancies and chronic renal disease (Roberts et 
al., 1998). Increased receptor expression has been described in experimental renal 
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disease models including membranous nephropathy, obstructive nephropathy and 
diabetic nephropathy (Chen S et al., 2003) 
The prosclerotic properties of TGF-p 1 has suggested a role for TGF-p 1 in diabetic 
glomerulopathy. TGF-pl has emerged as having a key role in the development of 
renal hypertophy and accumulation of extracellular matrix in diabetes (Ziyadeh et al 
1993) Renal fibrosis, characterised by increased accumulation of extracellular matrix 
(ECM) within renal tissue, represents the final common pathway for loss of renal 
function associated with primary disease states including diabetic nephropathy 
(Border et al., 1995). Extensive studies have demonstrated that in both glomerular 
mesangial cells and tubular cells, the response to increased levels of TGF-p 1 is an 
increase in synthesis of fibronectin, laminin and collagen (Ziyadeh et al., 1993). In 
addition, TGF-p 1 also inhibits the synthesis of metalloproteinases and activates the 
tissue inhibitor of metalloproteinases (Ma et al., 1999). This results in a reduction in 
extracellular matrix degradation and further contributes to matrix accumulation. 
In both human and experimental diabetes, TGF-p 1 gene expression and protein 
secretion are increased in both the glomeruli and tubuli (Yamamoto et al., 1993). The 
increased levels ofTGF-p 1 observed in hyperglycaemia arise from the activation of 
1) UDP-N-Acteylglucosmine: Once transported into the cell, glucose is then 
shuttled into the glycolytic pathway for subsequent metabolism and the 
generation of ATP. However, under conditions of hyperglycaemia a vast 
amount of glucose is fed into the hexosamine pathway. Inhibition of this 
pathway has been linked to altered promoter activities of various molecules 
relevant to Diabetic nephropathy eg TGF -p 1, through alteration to the 
phosphorylation status of transcription factors involved in binding to the 
TGF-p 1 promoter (Kanwar YS et al.,2005) 
2) PKC: Glucose is known to increase the de-novo synthesis of Diacylglycerol 
(Schena FP, et ai., 2005). Both DAG, and raised intracellular calcium [Ca2+]j 
will activate the protein kinase PKC. PKC can activate the MAPK pathway. 
This will result in activation of the extracellular regulated kinase (ERK1I2) 
27 
which is able to induce phosphorylation of AP-l, a transcription factor 
complex composed of c-Jun and c-Fos. APl is thought to bind to the TGF-pl 
promoter ultimately stimulating gene transcription 
In addition, mechanical stretch, AGEs, lipids, angiotensin-2 and reactive oxygen 
species (ROS) have also been linked to the stimulation of TGF-p 1 expression in 
renal cells (Ziyadeh et al., 1994., Gruden et al., 1999, Rocco et al., 1992, Rumble et 
al., 1997, Wolf et al., 1995). Whilst glucose induced TGF-p 1 is not considered the 
sole mediator in eliciting these deleterious effects associated with diabetic 
nephropathy, the administration of the TGF-p 1 neutralising antibody decorin, a 
proteoglycan capable of binding and inactivating TGF-p 1 (Border et al., 1992) was 
found to effectively reverse the symptoms of diabetic nephropathy, indicating other 
mediators play a relatively small role compared to TGF -P 1 (Ziyadeh et al., 2000). 
1.8.2 Protein kinase C 
PKC, a family of serine/threonine kinases has at least eleven isoforms, many of 
which are upregulated in glomerular cells of hyperglycaemic rats (Whiteside et al., 
2002). PKC can be categorised into classical PKC, novel PKC, and atypical PKC on 
the basis of their common structural features. 
• The classical PKC enzymes are comprised of two cysteine rich zinc finger 
like motifs (Cl region), which are essential for interaction with phorbol ester 
and diacylglycerol (DAG), and a Ca2+ binding domain (C2 region) in their 
regulatory region. 
• The novel PKC enzymes do not require Ca2+ since the C2 region is absent. 
The novel PKC enzymes are activated by phosphatidylserine and DG or 
phorbol esters. 
• The atypical PKC enzymes, which lack the C2 region and one of the cysteine 
rich finger-like motifs in the Cl region are not activated by Ca2+, DG phorbol 
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esters, but their activation depends on phosphatidylserine and eis-unsaturated 
fatty acids. 
PKC activation regulates a number of cellular functions, including vascular 
permeability, contractility, cellular proliferation, basement membrane synthesis and 
signal transduction mechanisms (Koya et aI., 1998). PKC has emerged as a potential 
regulator of all aspects of the development and progression of diabetic nephropathy, 
with both DAG levels and subsequently PKC activation increased in a variety of 
tissues, including kidney glomeruli (Craven et al., 1989). 
PKC is a crucial downstream mediator of TGF-pI and is thought to play a role in 
modulating TGF-p I expression via regulation of transcription factors c-fos and c-jun, 
which form the activator protein (AP-l) transcription complex, which binds to and 
induces genes with AP-I binding consensus sequences in their promoter regions 
(Ingram et al., 1997). Genes encoding for TGF-p 1, including fibronectin and 
laminin, all contain an AP-I binding site in their promoter (Kim et al., 1990). 
Multiple cellular and functional abnormalities within the kidney have been attributed 
to the activation of PKC, since inhibition with various inhibitors has prevented the 
increase in ECM deposition, TGF-p 1 upregulation and the development of 
albuminuria (Koya et al., 2000). 
1.8.3 P38 MAPK 
Mitogen activated protein kinases (MAPKs) including the extracellular signal-related 
protein kinase 112 ERK, stress activated c-Jun N-amino terminal kinase (JNK) and 
p38 MAPK play a key role in the intracellular signal transduction cascade to 
integrate the transcription of genes for a variety of cellular responses (Cuschieri et 
al., 2005). Activation of these serine/threonine kinases by phosphorylation, can lead 
to their translocation to the nucleus where they can then phosphorylate and activate 
transcription factors e.g. AP-l. 
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The classic MAPKs, ERK-I and -2 are activated through Ras dependent transduction 
pathways and mediate cellular proliferation and differentiation by stimulating 
transcription factors that induce the expression of c-fos and other growth responsive 
genes (Bilato, 1995). In contrast, JNK and p38 MAPK lead to alterations in cell 
growth and other cellular dysfunctions and are strongly activated by ultraviolet light 
(han et al., 1994), oxidants (Liu et al., 1995), osmotic stress (Shapiro et al., 1992), 
TNF-a (Beyaert et al., 1996) to name but a few. 
High glucose stimulates ERK and p38 MAPK in mesangial cells of diabetic animals 
(Haneda et al., 1997, Igarashi, 1999). The PKC dependent increase in ERK activates 
TGF-pI production via AP-I (Haneda M et al., 1997). TGF-pl then augments p38 
MAPK activation. Inhibition of MAPK prevents TGF-p 1 induced fibronectin 
production and associated changes in N a + reabsorption. This ability of TGF -p I to 
mediate its effects via p38 MAPK stems from a degree of cross-talk between MAPK 
and Smad pathways. TGF-p 1 can directly activate ERK, p38 and JNK signalling 
pathways (Yue et al., 1999), a result of a novel Mitogen Activated Protein kinase 
kinase kinase (MAPKKK) termed TGF-p activating kinase (TAKl) which 
participates in signal transduction of TGF-p 1 enabling the activation of both the p38 
and JNK pathway (Wang et al., 1997). c-Fos and c-Jun regulated by ERK and JNK 
can bind directly to Smad 3, while the Smad 3-Smad 4 heterodimer can bind to the 
AP 1 binding site of various promoters of the TGF-J31 target genes. This would 
suggest therefore that TGF-p 1 signalling is central to the pathobiology of diabetic 
nephropathy. 
1.9 The Epithelial Sodium Channel (ENaC) 
1.9.1 DEG/ENaC ion channel family 
The reabsorption ofNa+ into the bloodstream is of critical importance in maintaining 
blood volume homeostasis and is therefore central to blood pressure control and the 
prevention of secondary hypertension. At the molecular level, Na + is reabsorbed 
along the whole length of the nephron by a number ofapically expressed transporters 
(Eaton et al., 1995, Gamba et al., 1999). Whilst it only accounts for a relatively small 
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proportion of the sodium reabsorbed «5%), the concentration of both hormone 
receptors and other regulatory molecules that control Na + reabsporption in the distal 
nephron suggests that fine control of N a + reabsorption is most likely to be mediated 
in the distal nephron and the collecting duct. Key in this process is the epithelial 
sodium channel (ENaC), an apically expressed amiloride sensitive channel that 
moves Na+ across absorptive epithelial in a wide variety of tissues including renal 
tubules, distal colon, skin and the lungs (Garty et al., 1997). 
The ENaC is a member of the ENaC/degenerin gene family which was first 
discovered at the beginning of the 1990s (Alvarez de la Rosa et al., 2000). The name 
degenerin (DEG) is derived from the phenotype associated with mutation of the deg-
1 gene and other related genes that result in selective degeneration of sensory 
neurons involved in touch sensation (Mano et al., 1999). In parallel to those studies 
in C.elegans which resulted in the identification of the DEG gene family, cloning 
studies in Xenopus laevis oocytes led to the isolation and sequencing of a cDNA 
encoding the a. subunit of the ENaC (Cannessa et al., 1993, Lingueglia et al., 1993). 
Both ENaC and degenerins were found to have substantial sequence homology. 
Identification of additional members formed a new subfamiliy of ion channels 
(Figure 1.9), all of which have wide tissue distribution and have been shown to 
function as receptors for taste, touch and acidic pH. Their role within the cell dictates 
their level of activity; with some constitutively active and others e.g. C.elegans 
degenerins requiring activating stimuli in the form of mechanical stimulation 
(Kellenberger et al., 2002). Expressed only in animals with specialised organ 
functions for reproduction, digestion and coordination, the channels in vertebrates 
are subdivided into three main categories: ENaC, acid sensing ion channel (ASICS) 
and brain-liver-intestine sodium channel (BLINaC/human intestine sodium channel 
(hINaC). Aside from its role in Na+ absorption, ENaC is expressed in both taste cells 
of the tongue and non epithelial cells including specialised sensory neurones 
(Kellenberger et al., 2002). This latter observation has led to the supposition that 
ENaC like Degenerins may also be responsive to mechanical stimuli. 
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Figure 1.9: Phylogenetic tree of the epithelial sodium channel (ENaC)/degenerin 
(DE G) family showing the organisation into subfamilies of related sequences. 
The channels from vertebrates are divided into three groups: ENaC, acid sensing ion 
channels (ASICs) and brain liver intestine sodium channel (BLINaC)/human 
intestine sodium channel (hiNAC). ENaC/DEG proteins of invertebrates can be 
divided into four groups: 1) the degenerins from Caenorrhabditis elegan ; 2) the 
Drosophila channels RPKldGNaC 1 and PPKldmdNaCI; 3) FMRFamide-gated 
sodium channel (FaNaC), which is expressed in molluscs; and 4) FLR-l, which is the 
only characterised member of a group of Celegans ENaC/DEG family members that 
are different from the degenerins (Kellenberger et al. , 2002). 
1.9.2 ENaC at the molecular level 
The ENaC is composed of three partly homologous subunits (a, p and y) (Canessa et 
al., 1993, Canessa et al. , 1994) inserted into the membrane with a proposed 
stoichiometry of one of two subunit compositions, a tetrameric structure comprising 
2a: 1 p: I y (Figure 1.10) Dijkink et al. , 2002, Firsov et al. , 1998, Kosari et al. , 1998) 
or an eight to nine subunit structure (Snyder PM et al. , 199~), the latter of which has 
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been reported to assemble prior to transport of the ENaC from the Golgi complex to 
the plasma membrane. To date however, the exact stoichiometry of the ENaC 
subunits when inserted into the plasma membrane remains to be resolved, with 
reports of both tetrameric and eight subunits structures reported in various cell types 
(Firsov 0 et al. , 1998, Staruschenko A et al. , 2005). This ability to assemble with 
different stoichiometries, in conjunction with variability in messenger RNA 
expression across tissue type raises the possibility that different stoichiometries may 
exert functional differences. 
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Figure 1.10: Model of the tetrameric assembly of an ENaC channel. The model 
shows the tetrameric assembly ofENaC sub units around the central pore and is based 
on functional analyses that demonstrate the three subunits to be inserted into the 
membrane as a tetramer. 
The a subunit was first cloned by virtue of its ability to potentiate amiloride-
sensitive Na+ currents in Xenopus oocytes (Cannessa et al., 1993, Lingueglia et al. , 
1993), whi lst neither expression of the p or y subunit alone or in combination is 
sufficient to generate a Na+ current. However, when co-expressed with the a subunit, 
expression of all three subunits potentiates the Na + current suggesting that whi lst all 
three subunits are required for formation of a fully functional channel a subunit 
expression is a pre-requisite for Na + conductance (Canessa et al., 1993). 
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Structurally, the ENaC subunits have two membrane spanning segments and a large 
glycosylated extracellular domain that contains both numerous potential N-linked 
glycosylation sites and two short NH2 and COOH termini (Renard et al., 1994, 
Canessa et al., 1994). The C-terrn inal contains two proline rich regions the second of 
which is highly conserved and is referred to as the PY motif (xxPPxY) where x is 
any amino ac id, P is proline and Y is tyrosine (Staub et al., 1996, Schild et al., 1996) 
(Figure 1.11). Tyrosine residues present in the proline-rich motifs of ~ and y subunits 
of ENaC are important in the regulation of ENaC activity, since recognition of the 
motif by endocytic machinery (Rotin 0 et al. , 2000) and its ability to form protein-
to-protein interactions provides a possible link between tyrosine rich motifs and 
subsequent retrieval of the sodium channel from the membrane. The importance of 
these proline rich motifs in targeting the ENaC for degradation via a ubiquitin 
pathway is supported in those patients diagnosed with Liddle's syndrome, a 
hypertensive disorder in which a reduction in the rate of ENaC degradation leads to 
an increase in the number of functional complexes able to assemble at the apical 
membrane. In turn Na + reabsorption is increased and blood pressure rises (Shimkets 
et al. , 1994, Hansson et al., 1995, Hansson et al. , 1995, Schild et al. , 1996, Firsov et 
al., 1996). The extracellular domain represents more than half of the mass of the 
ENaC subunits and contains two conserved cysteine rich domains (CRD) 11 and Ill, 
reported to be involved in maintenance of the tertiary structure through disulfide 
bond formation. 
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Figure 1.11: Membrane topology of the ENaC subunits. Each subunit has two 
membrane spanning segments, a large glycosylated extracellular domain comprising 
two cysteine rich domains (CROII and Ill) and cytoplasmic Nand C termini. The C 
termini, contains a proline rich motif, thought critical in enabling efficient regulation 
ofENaC activity (adapted from Snyder, 2002a). 
1.9.3 ENaC in epithelial Na+ transport 
Regulation of ENaC mediated Na + transport is critical for a variety of processes. In 
the collecting duct of the kidney, ENaC is an integral component of the pathway for 
Na + reabsorption, serving to maintain salt homeostasis preventing increased blood 
pressure known to potentiate circulatory and renal system failure. 
Located in epithelial cells of the connecting tubule (eNT), cortical collecting duct 
(CCO) and outer medullary (OMCO) collecting duct, (Duc et al .• 1994, Masilamani 
et al .• 1999, Schmitt et al .• 1999), ENaCs control fine regulation ofNa+ reabsorption. 
In hyponatraemia the natural response is to increase the rate of Na + reabsorption 
preventing further volume depletion. Contrary to this, in hypematraemia Na+ 
transport is decreased. 
The transepithelial transport and reabsorption of Na+ across an epithelial cell 
membrane is mediated via a two step transport process which is reliant upon the 
large electrochemical gradient for Na + that exists across the apical membrane. This 
eIectrochemical gradient provides the driving force for entry of Na+ into the cell 
through the pore of the ENaC. The Na+ transport process is completed by the Na+/K+ 
ATPase pump located in the basolateral membrane. This ATP driven pump couples 
the extrusion of three N a + and the uptake of two K+ ions to the intracellular 
hydrolysis of one molecule of ATP, allowing for the reabsorption of Na+ whilst 
maintaining throughout, a low [Na+]i and high [K+]i relative to our ECF (Taniguchi et 
al., 2001) (Figure 1.12). 
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Figure 1.12: ENaC forms the pathway for epithelial Na + absorption. A model of 
renal epithelial cells. ENaC is expressed at the apical membrane, where it forms the 
pathway for Na+ in the lumen to enter the cell. At the basolateral membrane, the 
extrusion of 3Na+ ions out of the cell by the Na+/K+ ATPase is accompanied by the 
influx of 2K+ ions into the cell, maintaining both low [Nali and high [K+]i 
concentration. 
1.9.4 Hormonal regulation of ENaC 
The regulation of ENaC is complex and depends upon a variety of hormonal signals. 
Whilst many of the mechanisms involved in ENaC regulation remain to be 
elucidated, a number of secondry messengers (cAMP), regulatory proteins (0 
proteins; kinases; proteases) and intra-and extracellular ions (Na +, Ca2+) have been 
associated with the regulation of this Na+ channel (Oarty et al., 2001, Kellenberger et 
al. , 2002) 
Na+ transport via ENaC is regulated principally by two hormonal pathways: 
1.9.4.1 Aldosterone 
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Tight regulation of the ENaC is critical in maintaining homeostatic [Na+]j levels and 
is primarily mediated by the mineralocorticoid aldosterone, the principal hormone 
controlling salt and water balance in vertebrates. Increases in plasma aldosterone 
stimulate Na+ reabsorption in the kidney collecting duct and distal colon, in part by 
increasing the rate of Na + entry through ENaC (Garty et al., 1997). When 
aldosterone levels are low, ENaC is reportedly confined to an intracellular location in 
a vesicular pool (Snyder et al., 2005). Aldosterone infusion or N a + restriction induces 
a dramatic redistribution of the ENaC to the apical surface (MasiIamani et aI., 1999,), 
thereby enabling the channel to uptake Na+. Therefore aldosterone acts by increasing 
the number of active ENaC channels at the cell surface, a process thought to be 
dependent on both transcription and translation (Alvarez de la Rosa et al., 2002, 
Loffing et al., 2001). 
The effects of aldosterone are divided into three main phases: a lag period of 20-60 
minutes, followed by an early phase over approximately 1-3 hours in which 
aldosterone induced regulatory proteins are able to act on pre-exisiting Na + transport 
machinery and a late phase initiated over a 6 -24 hour time period following 
hormone addition, during which a further increase in transport activity correlates 
with increased channel number and other elements of the transport machinery 
(Naray-Fejes-Toth et al., 2004). 
The increase in Na+ reabsorption observed in the early phase of aldosterone action 
occurs prior to any significant increase in ENaC mRNA transcripts (Garty et al., 
1997). It has been proposed that aldosterone may induce the transcription of proteins 
which are able to directly modulate ENaC trafficking function. To date, two such 
gene products have been identified, K-Ras2 and serum and glucocorticoid inducible 
kinase (SGK1), both show increased message in response to increased aldosterone 
and increase aldosterone induced Na+ current when overexpressed (Rotin D et al., 
2000). A role for K-Ras2 in mammalian epithelia however is yet to be established. 
1.9.4.2 Vasopressin 
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Released by the pituitary in response to a decrease in ECF, vasopressin has been 
reported to stimulate N a + reabsorption in skin and urinary bladder epithelia of 
amphibians, in rat cortical collecting duct and in many in vitro and cultured epithelia 
possessing transport characteristics similar to the mammalian collecting duct (Tomita 
et al., 1985, Reif et al., 1986, Garty et al., 1988, Schafer et al., 1992, Schafer 1994, 
Garty et al., 1997). However, whilst the channel responsible for this N a + 
reabsorption is ENaC, not all ENaC expressing epithelia respond to vasopressin 
driven Na+ transport. Two mechanisms have been proposed explaining how 
vasopressin may mediate increased Na+ reabsorption via ENaC. Firstly vasopressin is 
thought to increase the open probability and conductance of the channel (Prat et al., 
1993) or increase the number of channels in the membrane via a mechanism 
analogous to that observed upon vasopressin-stimulated insertion of AQP2 
(Butterworth., 2001, Morris et al., 2002). The binding of vasopressin to the V 2 
receptor activates a G protein which leads to the downstream activation of adenylyl 
cyclase. This generates a rise in intracellular cyclic adenosine monophosphate levels 
(cAMP) which can activate protein kinase A (PKA), a protein kinase known for its 
ability to phosphorylate a number of downstream proteins which mediate the 
trafficking and fusion of intracellular vesicles containing AQP2. An increase in 
intracellular cAMP increases membrane trafficking of all three subunits, of which the 
a suhunit has been reported to co-localise with the AQP2 channel (Harger et al., 
2001). Since neither one of these mechanisms is dependent on de novo protein 
synthesis, the increase in Na + transport in response to vasopressin is far greater than 
that observed following a rise in aldosterone. 
1.9.5 Regulation of ENaC activity by Nedd4-2 
Whilst aldosterone and vasopressin have been demonstrated as positive regulators of 
ENaC availability at the apical membrane, ubiquitination, a post-translational 
modification involving the covalent linkage of 76 amino acid long ubiquitin 
polypeptides on target proteins has been suggested to play a role in the regulation of 
ENaC through directing proteasomal mediated degradation of the channel thus 
preventing insertion into the apical membrane. Ubiquitination requires the sequential 
action of several enzymes. Firstly ubiquitin becomes activated in an ATP dependent 
manner by forming a thioester with a cysteine on the ubiquitin activating (or El) 
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enzyme. It is then transferred on the cysteine of a ubiquitin conjugating (or E2) 
enzyme which will interact with a ubiquitin protein ligase (or E3 enzyme). These 
ubiquitin-protein ligases are thought to provide specificity by recognising and 
binding to specific target proteins, while attaching ubiquitin via an isopeptide bond 
between its COOH terminus and the s-amino group of a lysine residue (Hershko et 
al., 1998). Ubiquitination can be of two different types, mono and polyubiquitination 
(also referred to as multi). Whilst monoubiquitinated proteins are degraded in the 
lysosomes, polyubiquitinated proteins are recognised by and subsequently degraded 
by the 26s proteasome. The ubiquitin ligase neural precursor cell-expressed 
developmently downregulated protein (Nedd4-2) is an ENaC specific ubiquitin ligase 
that contains three or four WW domains (serving protein-protein interactions) that 
interact with the ENaC subunit PPxY domain (Staub et al., 1996) and a calcium/lipid 
domain (CaLB/C2). Such ubiquitination would cause a decrease in ENaC at the cell 
surface. ENaC ubiquitination is followed by proteasomal degradation, interference of 
which negates the degradation of ubiquitinated proteins and ultimately depletes the 
available pool of free ubiquitin thus halting the ubiquitination reaction, allowing for 
accumulation of ENaC at the cell surface (Staub et al., 1997). 
1.9.6 Clinical conditions associated with aberrant ENaC mediated Na + 
reabsorption 
Conditions linked to malfunction or mutations of the ENaC suggest it as a candidate 
gene for the control of blood pressure. Defects in the regulation of Na + transport 
underlie all of the known inherited forms of hypertension (Lifton et al., 2002). 
Clinical disorders of the kidney due to malfunction of the ENaC complex are well 
described (Scheiman et al., 1999) and include Liddle's syndrome, an autosomal 
dominant form of arterial hypertension characterised by severe hypertension, salt 
sensitivity, hypokalaemia, and low aldosterone and renin levels. Shimkets et al., 
(1994) discovered that the genetic defect in the original Liddle's syndrome was a 
mutation in B-ENaC. Truncation of the B-ENaC gene resulted in a complete absence 
of carboxy terminus synthesis, expression of which is essential for recognition via 
endocytic machinery and subsequent channel retrieval from the apical membrane 
surface. Further truncations of both the ~-ENaC and y-ENaC C termini have 
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subsequently been reported. Thus, mutations of the cytoplasmic C-termini of the p 
and y subunits in patients presenting with Liddle's syndrome inhibits degradation of 
the channel via the ubiquitin pathway (Staub et al., 1996), consequently resulting in 
increased functional complexes at the apical membrane and increased Na+ 
reabsorption. In contrast, loss of function mutations results In 
pseudohypoaldosteronism Type I (PHA-l), a condition associated with salt wasting, 
hyperkalaemia and metabolic acidosis that presents soon after birth (Grunder et al., 
1997, Chang et al., 1996). Mutations in ENaC that have been identified in those 
patients with PHA-I are recessive and produce physical disruption of the affected 
subunit causing loss of one or both membrane spanning domains. The end result is a 
defective ENaC which renders the individual unable to retain sodium and 
consequently leads to hypotension (Grunder et al., 1997, Chang et al., 1996). 
1.10 The Serum and Glucocorticoid inducible kinase. 
One of the key regulators involved in the Na+ reabsorption in the nephron is the 
serum and glucocorticoid induced kinase (SGKI), an aldosterone regulated gene, 
which mediates Na+ reabsorption via its actions on the ENaC. SGKI is expressed in 
a variety of tissues including the kidney, eye, liver, heart, pancreas, skeletal muscle, 
and brain (Waldegger et al., 1997) and is tightly regulated by numerous signalling 
cascades through control of its expression levels, intrinsic kinase activity and 
subcellular localisation. Thus SGKl integrates into numerous pathways adapting to 
different roles within the cell, dependent upon the nature of the stimuli (Firestone et 
al., 2003). 
SGKI was originally cloned as a glucocorticoid responsive gene from rat Con8 
mammary tumour cells and was termed SGKl to reflect its regulation at the 
transcriptional level by serum and glucocorticoids, with both glucocorticoids and 
serum capable of inducing SGKI in both mammary epithelial cells and fibroblasts 
within 30 minutes (Webster et al., 1993a, Webster et al., 1993b). 
The effects of aldosterone on SGKl have been well documented in both in vitro and 
in vivo systems, including Xenopus A6 cells (Zecevic et al., 2004), Primary rabbit 
CCD cells (Naray-Fejes Toth et al., 1999), mouse Ml cells (Helms et al., 2003) and 
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mouse and rat kidneys (Loffing et al., 2001). This induction of SGKI coincides with 
enhanced phosphorylation of an ubiquitin ligase involved in SGKI degradation (see 
section 1.10.3), increased Na + reabsorption and decreased Na + secretion. The 
importance of aldosterone induced SGKI is demonstrated under conditions of dietary 
Na+ restriction where circulating levels of aldosterone increase, maintaining Na+ 
homeostasis and ultimately preventing a fall in blood volume and therefore pressure 
(Farjah et al., 2003). 
The functional significance of SGKI in regulation of transepithelial Na + transport is 
seen in a series of knockout experiments in Xenopus laevis in both A6 cells and M I 
CCD cells. Transfection of these cells with SGKI leads to an increase in 
transepithelial Na+ transport whilst transfection of a dominant negative "kinase dead" 
SGKI mutant or si RNA abolishes both dexamethasone and insulin dependent 
regulation of transepithelial Na + transport (Helms et al., 2003, Alvarez de la Rosa et 
al., 1999). 
Interestingly, SGKI knockout (KO) mice (SGKI -/-) on a standard diet exhibit Na+ 
reabsorption comparable to that of their wild-type littermates although circulating 
plasma aldosterone levels are significantly elevated. However, in SGKI KO mice on 
a Na+ restricted diet, activated compensatory mechanisms are no longer able to 
maintain Na+ homeostasis. These data suggest that aldosterone dependent control of 
ENaC function does not rely solely on induction and activation of SGKI, a 
hypothesis further supported by reports of Nedd4-2 phosphorylation in mouse 
cortical collecting duct cells in the absence of any aldosterone and detectable SGKI 
protein expression (Flores et al., 2005). 
1.10.1 SGKl is a serine/threonine kinase 
The SGKI gene is located on chromosome 6q23 and contains several consensus 
sequences for transcription factors (Firestone et al., 2003) and a functional 
glucocorticoid response element (GRE) located approximately 1000bp from the 
transcription start site that is highly homologous to the consensus GRE (ltani et al., 
2002). Additional regulatory transcription sites have also been identified and these 
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include p53 binding sites, a cAMP responsive element binding (CREB) protein site 
and a Spl responsive element (Firestone et al., 2003, Lang et al., 2001) 
SGKI has characteristic motifs of a serine/threonine kinase and is part of the family 
of AGC kinases. These include PKA, protein kinase G (PKG), PKC and protein 
kinase B/ Aktlrac. Its catalytic domains shares 54% homology with those of 
AktlPKB/ and rac kinases and 45% with that of PKA. Kinase activity of SGKl has 
been demonstrated in vitro (Park et al., 1999). 
SGKI is regulated by a variety of both hormonal and non hormonal stimuli and is 
involved in controlling a wide variety of cellular processes including apoptosis, ion 
transport and cellular differentiation, In contrast to most protein kinases an unusual 
property of SGKI is its acute transcriptional control by different signal transduction 
pathways. In addition to serum and glucocorticoids, levels of expression have been 
shown to be acutely (30 minutes) regulated by aldosterone (Chen et al., Naray-Fejes 
Toth), cell shrinkage (Waldegger S et al., 1997), TGF-~I.!Waldegger s et al., 1999, 
Lang et al., 2000), follicle stimulating hormone (FSH) (Alliston et al., 1997), 
osmotic stress and DNA damage (You et al., 2004), p53 (Firestone et al., 2003). This 
list is not exhaustive and many of these stimuli are highly cell specific (Table I). 
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Stimuli Cell or tissue type 
Serum Ubiquitous 
Glucocorticoids Ubiquitous 
Aldosterone Distal nephron 
Cell shrinkage HepG2, MDCK, neuroblastoma 
Cell swelling A6 cells 
TGF-pI U937, HepG2, intestine, fibroblasts, 
endothelial cells 
Chronic viral hepatitis Liver 
Ischemic injury of brain Brain 
Neuronal excitotoxicity Brain, glial cells 
Memory consolidation Brain, hippocampus 
DNA damage Fibroblasts 
I a,25-dihydroxyvitamin D3 Squamous cell carcinoma 
Psychophysiological stress Brain, heart, Kidney 
Iron Intestine 
Glucose Endothelial cells 
Endothelin-I Endothelial cells 
GM-CSF Granulocytes 
FGF Mouse fibroblast cells 
PDGF Mouse fibroblast cells 
Phorbolesters Mouse fibroblast cells Rat ovarian 
granulosa cells 
FSH Rat ovarian granulosa cells 
Sorbitol mammary epithelial cells 
UV raidation mammary epithelial cells 
Heat shock mammary epithelial cells 
Oxidative stress mammary epithelial cells 
PPARy Distal nephron 
Protein kinase 53 (p53) Mammary epithelial cells 
Table 1.1 Stimuli that cause induction of SGKI expression (reviewed in Loffing et 
al., 2006) 
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1.10.2 Regulation ofSGKl by phosphorylation 
Many AGC kinases possess phosphorylation sites in both their catalytic domain and 
C-terminal region. The motif in the catalytic domain is situated on the so called 
activation loop (A-loop) and was first identified in PKBI Akt, a kinase shown to be a 
target of phosphatidylinositol-3,4,5-triphosphate (PIP3 )-dependent kinase I (PDK-I). 
PDK-l is regulated by an upstream PI3K-dependent kinase (Kobayashi T et al., 
1999). Like PKB, SGKl has also been shown to possess PDKI-phosphorylation 
sites. PDKl phosphorylation of SGKI occurs on Thr256 in the A-loop of the 
catalytic domain and Ser422 in a C terminal region termed the hydrophobic motif 
(H-motif) (Lofting et al., 2006). However, unlike PKB, SGKI does not possess 
Pleckstrin homology domains. In PKB and PDK-I, these PH domains allow for 
interaction with phosphoinositides and recruit both PKB and PDKI to the membrane 
subsequently allowing for PDKl mediated phosphorylation of PKB (Biondi et al., 
2001). Activation is very fast and occurs approximately two minutes after 
stimulation with either insulin or insulin-like growth factor. An absence of PH 
domains in SGKI led to the discovery of an unknown PI3-K dependent kinase which 
phosphorylates Ser422 and has subsequently been denoted PDK-2 (Park et al., 
1999). This phosphorylation transforms SGKI into a substrate for PDK-I which is 
able to bind via its PDK-l interacting fragment (PIF)-binding pocket to the H-motif 
of SGKI. This association promotes phosphorylation of Thr256 in the A-loop and 
renders SGKI active. Activation of SGKI and PKB is clearly very different since 
activation of SGKI is not reliant on phosphoinositides or the PH domain in PDKI. 
SGKI has also been shown to contain consensus sites for phosphorylation by other 
intracellular signalling molecules, including cAMP dependent PKA (Perotti et al., 
2001). Activation of SGKl by PKA could mediate the vasopressin driven increases 
in Na + reabsorption previously discussed in section 1.11.4 (Reif MC et al., 1986). 
The exact mechanism behind this phosphorylation however requires further 
clarification. Other kinases capable of phosphorylating SGKl include MAP kinases 
(ERK5 or p38), and WNKI (with!lo lysine kinase 1). Whilst WNKl is believed to 
play a role in Na+ homeostasis, a direct phosphorylation remains to be confirmed (Xu 
et al., 2005). 
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1.10.3 Regulation of SGKl by ubiquitination 
SGKI protein has a half life of approximately 30 minutes (Webster et al., 1993). 
Degradation of SGKI is initiated upon ubiquitylation. Ubiquitinated SGKI becomes 
associated with a membrane associated fraction of the cell prior to degradation by the 
26s proteasome (Brickley et al., 2002). The first 60 amino acids of the N-terminaI 
region of SGKI regulate its stability and SGKI-mutants that lack the first 60 amino 
acids of the N-terminal region results in a near loss in ubiquitin modification and 
proteasomaI degradation (Brickley et al., 2002). Controversy still surrounds how this 
N terminal is able to regulate the rate at which SGKI is ubiquitinated it does 
however possess six lysines in its N terminus. Whilst lysines are known potential 
ubiquitylation sites, mutation of these residues to aspartates does not negate 
ubiquitinylation. In 2005, Snyder et al., showed that Nedd4-2, a substrate of SGKI, 
increases SGKl ubiquitination and degradation (Zhou et al., 2005). SGKl contains a 
PY motif, whilst Nedd4-2 comprises two consensus sites for phosphorylation by 
SGKI (Park et al., 1999). In Xenopus oocytes Debenoville et al., 2001. demonstrated 
SGKl induced phosphorylation of Nedd4-2 in a PY motif (P-P-X-Y where P is a 
proline, Y a tyrosine and X an amino acid) dependent manner. SGKI phosphorylates 
at primarily Ser444, but can phosphorylate at Ser 338 (Debonneville et al., 2001) of 
Nedd4-2 and ultimately induces the dissociation of the previously discussed Nedd4-
2/ENaC complex in the cell, leading to increased apical targeting of the ENaC and 
increased Na + reabsorption (Snyder et al., 2002)(see section 1.10.4 for further 
details). 
1.10.4 Role ofSGKl in Na+ reabsorption 
In the kidney, the majority of studies have focussed on the regulation of SGKI 
mRNA expression by aldosterone and glucocorticoids. Studies have shown that 
SGKl appears to be expressed in the glomeruli and distal tubules, the medulla and 
with the highest abundance on the renal papilla (Chen et al., 1999, Lang et al., 2000, 
Bhargava et al., 2001, Hou et al., 2002). However, a predominant role for SGKI in 
the kidney is in regulating and maintaining Na+ homeostasis in principal cells of the 
collecting duct, where both ENaC and Na+/K+ ATPase expression is tightly regulated 
by aldosterone and SGKI. The effects of SGKI on the Na+/K+ ATPase have been 
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shown to be independent of changes in protein expression or in abundance at the 
plasma membrane. This mode of regulation remains to be elucidated (Alvarez de la 
Rosa et al., 2006). 
Nedd4-2 is the negative regulator of ENaC cell surface expression (Kamynina et al., 
2002). In the absence ofSGKI, the physical association between Nedd4-2 and ENaC 
results in ubiquitinylation of ENaC subunits inducing channel retrieval and 
proteasomal degradation. Consequently, blood Na +, blood volume and thus blood 
pressure is reduced. Activation of ENaC by SGKI serves to increase both the 
number of channels at the plasma membrane (Debonneville et al., 2001) and increase 
activity ofthose already present in the membrane (Diakov et al., 2004). 
Activation of SGKl is PI3-K dependent (Blazer-Yost et al., 1999), phosphorylating 
at Ser 422 and Thr 256 via the two downstream kinases PDK2 and PDKl 
respectively. Following its activation, SGKl is able to bind to and inhibit Nedd4-2, 
an effect that appears to require a physical association between the PY motif of 
SGKl and the WW domain of Nedd4-2. Through its PY motif, SGKl 
phosphorylates the WW domain of Nedd4-2 itself (Debonneville et al., 2001) 
impairing formation of the ENaC-Nedd4-2 complex. Dissociation of the ENaC-
Nedd4-2 complex allows for increased apical ENaC surface expression and increased 
Na + reabsorption (Kamynina et al., 2002, Snyder et al., 2002). 
SGKl dependent inhibition of Nedd4-2 involves 14-3-3 proteins (Liang et aI., 2006). 
These proteins are found in all eukaryotes and regulate a wide range of biological 
processes. They interact directly with numerous target proteins altering their activity. 
This interaction is generally mediated by phosphorylation of specific binding sites 
(Toker et aI., 1990). SGKl increases the binding of 14-3-3 to Nedd4-2 in a 
phosphorylation dependent manner, an interaction proven to be crucial for Nedd4-2 
dependent ubiquitinylation ofENaC (Ichimura et al., 2005). 
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Figure 1.13: Regulation of epithelial Na + transport by SGK1: Aldosterone 
induces the expression of SGKl by binding to the mineralocorticoid receptor (MR) 
and translocating into the nucleus. SGKI is activated following phosphorylation on 
Ser422 by the first of two kinases. This unknown kinase, activated by a PI3-K 
dependent pathway (i.e insulin pathway) is referred to as 3-phosphoinositide-
dependent protein kinase (PDK)-2 or hydrophobic motif (H-motif) kinase. 
Phosphorylation of Ser422 by PDK-2 allows PDKI to subsequently bind at this 
residue, leading to phosphorylation at Thr256. Activation of SGKI can also occur 
via WNK. SGKI when activated is able to phosphorylate Nedd4-2 on Ser444 and 
Ser338. This phosphorylation allows binding of 14-3-3 on Ser444. This binding 
induces dissociation of the Nedd4-2/ENaC complex, enabling ENaC to translocate to 
the cell surface where it can then take part in Na + reabsorption (Adapted from 
Lofting et al. , 2005). 
1.10.5 Pathophysiological role of SGKl 
Whilst aldosterone is the main physiological regulator of epithelial Na+ transport 
within the collecting duct, a variety of other hormonal and non-hormonal factors 
regulate the activity SGKl which acts to integrate stimuli involved in regulating Na+ 
transport. Recent evidence has led to the supposition that SGK 1 may serve as a 
potential candidate in the development of diabetic secondary hypertension, because 
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SGKl is also activated by insulin (Kageyama et al., 1994) a process that might be of 
considerable relevance to the pathogenesis of hypertension associated with 
hyperinsulinaemia, hypertonicity (Waldegger et al., 1997), glucose, increased 
intracellular calcium and the transforming growth factor TGF-PJ (Lang et al., 2000) 
whose upregulation in Type 11 diabetes is thought to contribute towards those 
abnormalities which collectively manifest themselves as micro and macrovascular 
complications. 
SGKl has since been shown to be transcriptionally upregulated in both models and 
patients presenting with Diabetic nephropathy (Wang Q et al., 2005, Lang et al., 
2000, Kumar et al., 1999), a phenomenon that is thought to be mediated by the 
hyperglycaemia and high circulating insulin levels that precede the development of 
type 11 diabetes. Whilst the underlying mechanisms remain to be elucidated, further 
studies have identified a number of signalling molecules upstream of SGKl which 
have been shown to be up-regulated in NIDDM. These molecules that include TGF-
PI, PKC, DAG, [Ca2+]j (Lang et al., 2000) may trigger the induction and activation 
ofSGKl. 
1.10.6 SGKl is regulated by cell volume 
The loss of nephrons observed during the progression of renal disease is paralleled 
by a compensatory hypertrophy of the remaining nephrons of which is mediated via 
an increase in cell volume. Cell hypertrophy contributes to the onset and progression 
of diabetic nephropathy. Changes in sodium transport that either result in, or are the 
cause of hypertensive stresses, can instigate a number of downstream effector 
mechanisms that can influence both cell volume and integrity. Prolonged exposure of 
kidney epithelial cells to changes in osmolarity has thus led to a number of 
suggestions concerning the mechanisms involved in sensing changes in cell volume. 
In addition to it's identification as a glucocorticoid responsive gene, SGKl was also 
cloned in human liver cells as one of the principally volume-regulated protein 
kinases (Waldegger et al., 1997) since it is markedly increased following hypertonic 
cell shrinkage. It is one of the principal volume-regulated protein kinases involved 
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in Na+ transport in the kidney and contains a hyperosmotic stress regulated element 
of between 50 and 40bp that mediates the hyperosmotic induction of SGKI 
transcription in response to the organic osmolyte 0.3M sorbitol (Bell et al., 2000). 
Analysis of this promoter region identified a GC rich region that required binding of 
the transcription factor Spl. SpI interacts with other transcription factors and may 
function as a target or a member of a multiprotein complex involved in hyperosmotic 
stress regulation of the SGKI promoter. Activation of this pathway induces an 
increase in the production of an active SGKI that maintains its dependence on the 
PI3-K pathway for its phosphorylation and activity. 
The effect of hypertonic stress on SGKl transcription has been demonstrated to be 
dependent on p38 MAPK (Waldegger et al., 2000), with the phosphorylated form of 
p38 having been detected 1-2 hrs after hyperosmotic induction of SGKI. In further 
support of a role for p38 MAPK, application of pharmacological inhibitors of p38 
MAPK was found to significantly reduce the induction of SGKI expression in 
response to hypertonicity (Bell et al 2000). 
P38 MAPK is phosphorylated and activated by the dual specificity MKK3/6 kinases 
in response to various forms of stress including hyperosmotic stress (see Figure 
1.14). Transfection of cells with plasmids for either the wild type MKK3 kinase or 
the kinase dead form of MKK3 was found to either enhance or completely abolish 
the effect on SGKI protein levels respectively, thus indicating that the hyperosmotic 
stress stimulation ofSGKI promoter activity requires the MKK3 mediated activation 
of p38 MAPK. As treatment with p38 inhibitors did not completely abolish the 
response to hyper-osmolarity, there is the possibility that MKK3 may have one or 
more as yet unidentified targets in addition to the p38-a or p38-p MAPK isoforms 
that are known to play a role in the hyperosmotic response (Bell et aI2000) .. 
Glycosuria exposes the renal epithelia to increased hypertonicity as the urine flows 
through the nephron and results in cell shrinkage at the apical side of the membrane. 
SGKI may be involved in the hyperosmotic response to high glucose levels since 
p38 MAPK activity has been shown to be rapidly induced under hyperglycaemia 
(lgarashi et al., 1999). Continuous exposure to increased osmolality may thereby see 
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constitutive expression/activation of SGKl leading to the excessive and aberrant Na + 
reabsorption widely seen in diabetic nephropathy. 
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Figure 1.14 Regulation of SGK by hyperosmotic stress: The activation of SGKl 
transcription in response to osmotic stress can be inhibited by the overexpression of a 
dominant negative kinase-dead form of MKK3 and by the p38 MAPK 
pharmacological inhibitors (SB202190). P38 MAPK when active targets a GC rich 
hypersomotic region located at -55 to -46 base pairs in the SGKI promoter that 
includes the Spl transcription factor. Hyperosmostic stress leads to the production of 
a phosphorylated and enzymatically active SGKl (adapted from Bell et al. , 2000) 
1.10.7 TGF-pl and the progression of renal disease via its actions on SGKl 
Cell swelling will instigate a number of regulatory mechanisms aimed at restoring 
cell volume through a regulatory volume decrease (RVO). Any increase of cell 
volume mediated by SGKl induced Na+ entry, may further contribute to the 
progression of renal damage through impairment of matrix protein degradation. 
Vascular complications seen in diabetes are characterised by structural alterations of 
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extracellular matrix (ECM) components III glomeruli and large vessel walls 
(Y okoyama et al., 1996). 
The molecular and cellular events that occur during chronic renal failure also include 
the release of a number of different growth factors and cytokines. The 
multi functional cytokine Transforming growth factor TGF-pl has recently emerged 
as a. key pathophysiological component in the cascade of events that contributes to 
the pathogenesis and progression of diabetic nephropathy (Fine et al., 1985, Ling et 
al., 1995, Sharma K et al., 1996). Known to have powerful fibrogenic actions 
resulting from both stimulation of matrix synthesis and inhibition of matrix 
degradation, TGF-f3 1 has been implicated as the key mediator in the development of 
renal hypertrophy and increased matrix deposition (Chen et al., 2001). 
Previous studies have shown that under conditions of elevated levels of glucose 
TGF-f3 1 expression is markedly increased (Ziyadeh et al., 1998, Hoffman et al., 
1998). A sequence of events has been proposed in which hyperglycaemia enhances 
production of both TGF-pl and its receptors. Increased UDP-N-Acteylglucosamine 
(Kolm-Litty et al., 1998), Diacylglycerol and protein kinase C (Fumo et al., 1994, 
Kuya et al., 1997) levels have all been related to the increased rate of glucose 
metabolism associated with Type 11 diabetes. Collectively with the aid of 
downstream signalling molecules, they enhance binding of specific transcription 
factors e.g. AP-l, SP-l to the TGF-pl promoter, thereby initating TGF-pl 
transcription (Kim et al., 1990, Liberati et al., 1999) and raising TGF-p 1 levels 
within the cell. Whilst the downstream targets of TGF-p 1 mediating the 
pathophysiology of diabetic nephropathy remain largely elusive, the cell hypertrophy 
observed upon TGF-f3 I upregulation may be in part be mediated by SGKI. A 
downstream target of TGF-f3 1, SGKl has been shown to be transcriptionally up-
regulated by TGF-p 1 in various cell types (Lang et al., 2000). TGF-f3 1 also 
stimulates transcription, an effect reported to be mediated via p38 kinase (Bell et al., 
2000). TGF-f3 1 therefore utilises the same signalling pathway as for increased SGKl 
transcription in response to osmotic stress. This ability to activate SGKl via p38 
MAPK is a consequence of cross talk between the TGF-p 1 Smad signalling pathway 
and the MAPK signalling cascade. Studies in which SGKl expression has been 
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studied following application of TGF-pl have shown that SGKl expression is 
enhanced, however in the presence of a p38 MAPK inhibitor, expression is blunted, 
thus indicating that the activation of SGKl transcription via TGF-pl is mediated via 
the p38 MAPK signalling pathway (Waerntges S et al., 2002). Therefore TGF-pl is 
implicated as a signalling component whose enhanced expression may exacerbate the 
cell hypertrophy in association with enhanced SGK1. Increased expression of TGF-
PI . mediates the renal actions of high ambient glucose promoting cellular 
hypertrophy, whilst stimulating extracellular matrix biosynthesis, two hallmarks of 
diabetic renal disease. 
1.10.8 Other SGK isoforms 
Recently two other isofonns ofSGKI were identified, SGK2 and SGK3. Like SGKI, 
SGK3 appears to be expressed in all tissues, whilst expression of SGK2 is restricted 
to the kidney, liver, pancreas and brain (Friedrich et al., 2003). Both SGK2 and 
SGK3 share approximately 80% amino acid identity with SGKI in their catalytic 
domains, whilst the N tenninal exhibits most variability (Kobayashi et al., 1999). 
SGK2 and SGK3 have both been shown to possess the same phosphorylation 
consensus as SGKI (and PKB/Akt) (Kobayashi et al., 1999). However, functional 
differences between the isofonns exist and arise as a consequence of a number of 
different factors, including subcellular localisation and co factors. However, since 
they share a degree of amino acid identity in their kinase domains, the potential 
exists for cross-talk between their signalling pathways. This is even further 
exemplified by their ability to activate identical pathways. SGK2 has been shown to 
stimulate the activity of numerous ion channels including the Na+/K+ ATPase pump 
(Henke et al., 2002), ENaC (Friedrich et al., 2003) and the Kv1.3 channel (Gamper 
N et al., 2002 ), all of which are stimulated in the same cellular systems by SGKI 
and SGK3. 
SGK3 acts downstream of PI3-K; in parallel with PKB/AKT. It phosphorylates and 
inhibits Bad and FKHRLl, a proapoptotic protein and proapoptotic transcription 
factor respectively (Liu et al., 2000). As with SGK2, SGK3 has also been implicated 
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In the regulation of numerous transporters and channels, including the Na+/K+ 
ATPase (Henke et al., 2002), ENaC (Friedrich et al., 2003), and the epithelial Ca2+ 
channel TRPV5 (Embark HM et al., 2004). 
1.11 TRP channels 
The ability of living organisms to both sense and respond to alterations in their 
environment is critical to survival. Equipped with highly organised and developed 
sensory systems, we are able to detect alterations in light, taste, odour, sound and 
touch. Two of our five senses are based on mechanosensation and the ability to 
respond is reliant upon activation of mechanically gated ion channels coupled to our 
sensory system. These ion channels detect and subsequently transduce mechanically 
based stimuli into electrical signals. Whilst mechanosensors of both ear and hair cells 
permit hearing and balance (Hudspeth et al., 1985), mechanoreceptors localized in 
sensory cells of the skin respond to touch (Garcia-Anoveros 1997). Despite the 
widespread utilisation of mechanosensation by many different cell types, little is 
known about the molecular components of these sensors. 
With the availability of genetic screening, the recent identification of several 
vertebrate and invertebrate genes encoding a class of non selective cation channels 
has provided a number of clues as to the molecular make up of these receptors 
responsible for mechanotransduction. 
Identification of the first transient receptor potential (TRP) protein came from studies 
examining Drosophila phototransduction (Wong et al., 1989). Photoreceptor cells of 
Drosophila carrying trp gene mutations were found to exhibit sustained receptor 
potentials in response to continuous light exposure (Montell et al., 1985, Cosens 
1969), a consequence of calcium influx from the extracellular space. The trp gene 
was first cloned in 1989 and was subsequently shown to encode a calcium permeable 
cation channel (Wong et al., 1989). To date, many channels bearing sequence 
homology to the drosophila trp have since been cloned from flies, worms and 
mammals. Collectively these channels form the TRP superfamily. 
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The TRP superfamily is an emerging group of channel proteins each of which have 
designated roles in different organ systems (Benham et al., 2003, Clapham 2003). 
The commonly accepted nomenclature for TRP channels subdivides 28 channel 
subunit genes into 7 subfamilies: TRPP, TRPML, TRPA, TRPN, TRPC, TRPV and 
TRPM with evolutionary links from worms to mammals and sequence identity as 
low as 20%. With the exception of TRPN, each family contains at least one 
vertebrate representative (Clapham 2003, Montell et al., 2005). 
Whilst most ion channels are identified by their ligand function and ion selectivity, 
those members of the TRP superfamily are grouped based purely on homology alone 
since their functions are disparate and often unknown. Nonetheless, TRP channel 
activation is divided into three main categories. 
Receptor activation. G protein coupled receptors and receptor tyrosine kinases 
capable of phospholipase C (PLC) activation are able to modulate TRP channel 
activity in at least 3 ways (a) hydrolysis of phosphatidylinositol (4,5) bisphosphate 
(P1P2) (b) production of diacylglycerol (DAG) or (c) production of inositol (1,4,5) 
triphosphate OP3) with subsequent release of calcium from intracellular stores 
(Clapham et al., 1995). 
Ligand activation. Ligands that activate TRP channels can be broadly classified into 
small exogenous molecules e.g. capsaicin, endogenous lipids or products of lipid 
metabolism e.g. diacylglycerol, purine nucleotides and their metabolites e.g. 
adenosine diphosphoribose (ADP-ribose) and inorganic ions (Clapham et al., 1995). 
Direct activation. Direct stimuli capable of inducing TRP channel activation include 
mechanical stimuli, channel phosphorylation, a rise in temperature, a decrease in 
temperature and hypertonicity (Vriens et al., 2004). 
Ion channels within the TRP superfamily have diverse functions (table 2). The 
categorisation of these subfamilies based purely on amino acid sequence and 
structural similarity conveys no information regarding the function of channels 
within that subfamily. For example members of the TRPV subfamily are involved in 
both thermal sensing and calcium transport in epithelial tissues, whilst members of 
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the TRPM subfamily function as both mechanosensors and play a role In the 
regulation of cell growth control (reviewed in Ramsey et aI. , 2006) . 
TRP subfamily TRP Protein Function 
TRPC TRPC 1-7 PLC dependent Ca2+ influx in CNS and peripheral 
tissues including kidney, TRPCl can associate with 
TRPP2 (PDK2) 
TRPV 1 Thermal receptor; noxious rcceptor 
2 Thermal receptor 
3 Thermal receptor 
4 Thermal receptor; noxious receptor; 
mechanoreceptor, osmoreceptor 
5 Epithelia Cal+ transport 
6 Epithelia Caz+ transport 
TRPM 1 Cell growth control ( a tumour suppressor) 
2 Contains an ADP-ribose and NAD binding domain; 
may be important in sensing oxidative stress and 
linking apoptosis to cellular NAD metabolism 
3 Possible mechanosensor 
4 Activated by high intracellular ca; may be 
important in regulation of membrane potential by 
intracellular Ca2+ 
5 Taste sensor 
6 Epithelial Mgl+ transport 
7 Involved in cellular uptake of divalent cations in 
every cell. 
S Cold receptor, cell growth control 
IRPP I 5 Ph..I> I and Ph..D2 arc important in ciliar~ 
mcchanOscJlIIlltion; mutations of PI and P2 C~llISC 
pol) c~ stic kidnc) discasc 
TRPML 1 Sorting or transport of intracellular vesicles 
3 Mechanosensor 
TRPA 1 Cold receptor 
Table 1.2: F unctions of m a mma lia n TRP proteins (reviewed In Huang et al., 
2004) 
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1.11.1 Mammalian TRP channel structure 
All TRP channels are putative six transmembrane polypeptide subunits with three to 
five ankyrin-repeat domains at the intracellular amino-terminal domain. These 
ankyrin repeats of 33 residues are considered a requirement in establishing a 
structural bridge between the channel and the cytoskeleton. These six transmembrane 
polypeptides are likely to assemble as tetramers to form cation-permeable pores. The 
pore region lies between transmembrane segment 5 and 6. Across the superfamily 
amino acid sequence identity is only ~20%, however within each subfamily amino 
acid similarity is much higher extending along the whole length of the peptide 
(Owsianik et al., 2006). In addition all TRPs have multiple regulatory and protein 
interaction sites and multiple putative PKA and PKC phosphorylation sites. 
Extracellular 
U~ .~.I tl I~. ~.I 
Im IO~ Ut O~ 1nl IO~ I~U IU 
Intracellular 
c 
Figure 1.15: Membrane topology of TRP channels. The channel is characterised 
by six transmembrane segments (TMI-TM6), a pore loop segment (PL) between 
transmembrane segments 5 and 6, and from 3-5 ankyrin repeat domains in the N 
terminal segment (adapted from O'Neil et al., 2005). 
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1.11.2 The TRPV subfamily 
The founding members of the TRPV subfamily are OSM-9 in C. elegans and TRPVI 
in mammals. OSM-9 was first identified following a genetic screen in C. elegans for 
those mutants lacking the ability to avoid steep osmotic gradients (Colbert et al., 
1997). OSM-9 mutants display additional insensitivity to "nose" touch and to certain 
odorants, suggesting the OSM-9 gene is responsible for the combined sensing of 
chemical, osmotic and touch stimuli. TRPVl, also known as the capsaicin receptor or 
vanilloid receptor 1, is the most thoroughly studied channel among the TRPV 
channels and was first identified in sensory neurons (Caterina et al., 1997, Tominaga 
et al., 1998). The TRPV channels can be sub-grouped into four branches by sequence 
homology, two are vertebrate branches and two invertebrate. 
One branch includes four members of mammalian TRPVs, TRPVl -V2,-V3, and 
V4, all of which respond to temperatures higher than 42, 52, 31 and 27°C 
respectively. The second mammalian branch comprises the calcium selective 
channels TRPV5 and TRPV6, both of which are thought to play a role in calcium 
uptake in the kidney and intestine (Hoenderop et al., 2005). The last two branches of 
the TRPV subfamily include invertebrate TRP homologues. One invertebrate branch 
includes the mammalian TRPV4 homologue OSM-9 and Drosophila lA V (Gong et 
al., 2004), whilst the other branch contains four C. elegans OCRs and Drosophila 
NAN (Kim et al., 2003, Tobin et al., 2002). 
1.11.3 TRPV4 and cell volume regulation- a potential osmosensor? 
The exposure of cells to a hypotonic environment will cause cell swelling. This is 
rapidly accompanied by the loss of both K+ and cr ions paralleled by the passive 
loss of water. This process is known as a regulatory volume decrease (RVD) and 
enables cell volume recovery in response to cell swelling. In several cell types, an 
RVD has been shown to be solely dependent on calcium influx. In these systems, 
volume regulation can be inhibited by either removing calcium from the extracellular 
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medium, or applying calcium channel blockers (Montroze-Rafizadeh et al., 1991, 
Wong et al., 1990 Shen et al., 2001, Tinel et al., 2002). 
Prolonged exposure of kidney epithelial cells to changes in osmolality has led to a 
number of suggestions concerning the mechanisms involved in sensing these cell 
volume alterations. TRPV4 is rapidly activated under hypotonic conditions when 
expressed heterologously (Strotmann et al., 2000). Subsequently TRPV 4 activation 
has also been reported to be mediated by synthetic agonists including, the phorbol 
ester 4-a.-phorbol 12, 13-didecanoate (4a.-PDD) (Watanabe et al., 2002), 
temperatures greater than 27°C (Guler et al., 2002), acidic pH (Suzuki et al., 2003), 
mechanical stress (Gao et al., 2003) and endogenous ligands (Watanabe et al., 
2003b). Expressed in a wide variety of tissues including skin, lung epithelium and 
vascular endothelium (Wissenbach et al., 2000, Strotmann et al., 2000, Watanabe et 
al., 2002), TRPV4 is highly expressed in the mammalian kidney (Liedteke et al., 
2000). RVD in renal tubule cells following exposure to hypoosmotic stress has been 
shown to be Ca2+ dependent. The hypotonic activation ofTRPV4 with a concomitant 
rise in [Ca2+]j and the reduced osmotic sensitivity of TRPV4 knockout mice has 
implicated TRPV4 as a possible candidate as a cellular osmosensor in the nephron 
(Liedtke et al., 2000). 
1.11.4 Activation ofTRPV4 in response to hypotonicity 
Conflicting data has emerged suggesting two potential mechanisms through which 
hypotonicity may influence TRPV4 function. In 2003, Xu et al reported that when 
HEK293 cells are exposed to a hypotonic environment, TRPV4 is rapidly (minutes) 
phosphorylated by Lyn Kinase at tyrosine residue Y253 in the first ankyrin binding 
repeat of the NH2 terminal domain. The response is specific to osmotic stress and is 
abolished in Y253F mutants (Xu et al., 2003). Mutation of this site to any number of 
different residues blocked hypotonicity dependent calcium transients. However, 
these results are conflicting, since studies by the Nilius group failed to demonstrate 
any effect on the swelling induced activation of TRPV 4 in the Y253 mutant (Vriens 
et al., 2004). They proposed a mechanism consistent with previous findings that 
hypotonicity activates phospholipase A2 dependent arachidonic acid release 
(Basavappa et al., 1998), in which the activation of phoshpolipase A2 (PLA2) 
activates TRPV4 (Vriens et al., 2004) as follows: 
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I. Swelling induced activation of phospholipase A (PLA2) 
11. PLA2 dependent release of arachidonic acid (AA) from membrane 
phospholipids. 
Ill. AA acts through the cytochrome P450 enabling cytochrome P450 
mobilisation of AA to 5'6'-epoxyeicosatrienoic acid (5',6'EET) 
IV. Activation ofTRPV4 by the TRPV4 activating messenger 5'6' EET. 
Contrary to the results by Xu et al., 2003, this mechanism suggests that cell swelling 
activates TRPV4 by means of 5'6'EET and is not therefore, reliant on 
phosphorylation as a means of regulating channel activity. 
Finally, the NH2 ankyrin repeat domains of TRPV4 have also been suggested as 
fulfilling a role in TRPV 4 activation, albeit a structural link between the channel and 
the cytoskeleton. Studies in which TRPV 4 activation is delayed if these ankyrin 
repeats are lacking suggest a possible role for these domains in TRPV 4 gating 
(Liedtke et al., 2000). 
1.11.5 Modulation ofTRPV4 gating by calcium 
Post translational modification of TRP channels and other cellular signalling 
mechanisms are thought to represent a mode by which constitutively active TRP 
channels can be regulated. Many protein kinases, including PKA, PKC and PKG 
have all been demonstrated to modulate TRP channel activity and, as discussed, TRP 
channels have been shown to possess multiple phosphorylation sites. Intracellular 
calcium is an important regulator of TRPV4 channels. Most calcium permeable 
channels are inhibited by large increases in intracellular calcium, a protective 
mechanism that minimises detrimental rises in [Ca2+]i. However, at lower 
concentrations depending upon the concentration, calcium can potentiate channel 
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activity. Numerous reports have demonstrated that an increase in [Ca2+]j upon 
exposure to hypotonicity stimulates TRPV4 activity, a response which is abolished in 
the absence of extracellular calcium (Strotman et al., 2003, Watanabe et al., 2003a). 
This increase in TRPV 4 activity has since been shown to be mediated by an 
intracellular binding site, evidence of which includes the ability of Ca2+ release from 
intracellular stores to restore TRPV4 activity in the absence of extracellular calcium, 
and the loss of TRPV 4 currents following mutation of putative intracellular domains 
(Strotman et al., 2003). The intracellular site responsible for regulating TRPV4 has 
since been identified as a calmodulin binding domain in the C terminus that binds 
calmodulin in a calcium dependent manner. This interaction is thought to induce a 
conformational change in TRPV 4 thereby allowing increased channel activity 
(Strotmann R et al., 2003). 
The biphasic current observed upon TRPV4 mediated calcium entry would suggest 
that whilst small concentrations of calcium may potentiate TRPV 4 a hypothesis 
supported by the fact that the Ca2+ -CAM interaction is mediated by submicromolar 
concentrations of calcium, a large increase in intracellular calcium inhibits any 
further activation (Strotmann R et al., 2003). This dual regulation of TRPV4 by 
calcium will ultimately enable Ca2+ stimulus response whilst protecting from Ca2+ 
induced cellular damage. 
1.12 Gap junctions 
The ability of cells to co-ordinate their activities is a pre-requisite in maintaining the 
homeostatic environment within which they reside. The exposure of kidney epithelial 
cells to fluctuations in extracellular osmolarity necessitates not only mechanisms by 
which these cells are able to detect these osmotic changes, but mechanisms by which 
they are able to detect and subsequently convert these changes into transmittable 
signals. A widespread mechanism which ensures intercellular communication 
involves gap-junctions, plasma membrane channels which allow for the passive 
transfer of low molecular weight molecules such as Ca2+, amino acids, water and 
nucleotides between coupled cells (Goodenough DA et al., 1996). This exchange 
enables electrical and metabolic signals to spread widely among cell populations 
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including cells of the nephron, allowing surrounding cells to lock into a particular 
frequency of cellular activity. This ensures a simultaneous response across the 
epithelial layer in which efficient function and integrity of the overall nephron is 
maintained, enabling the maintenance of blood volume homeostasis. 
The use of fluorescent dyes injected into cells has becomes a popular technique to 
establish whether cells are functionally coupled by gap junctions. Determining the 
biochemical nature of the messenger transmitted across these gap junctions however 
proves more difficult since the diversity of connexins has led to variation in channel 
permeability of a number of different signalling molecules. Among those signalling 
molecules thought to move across gap junctions are calcium and inositol tri 
phosphate (lP3). 
Studies employing both calcium sensitive dyes and live cell imaging have confirmed 
that calcium itself, in response to a variety of stimuli, can propagate through gap 
junctions into neighbouring cells (Toyofuko et al., 1998). Cells can also 
communicate via a local paracrine mechanism that may involve the release of ATP 
into the extracellular milieu. Extracellular A TP triggers calcium signalling by 
interacting with purinergic receptors on the plasma membrane (Bidet et al., 2000). 
Since purinergic receptor mediated ATP release has been linked to both hemichannel 
activity and expression, it seems feasible that gap junctions not only communicate 
directly via the intercellular transfer of calcium, but also control calcium dependent 
cell signalling by regulating ATP release. Together the two pathways may coordinate 
with one another thereby enhancing both cell-to-cell communication and the overall 
performance of the cell. 
Numerous reports have suggested a role for IP3 as a gap junction secondary 
messenger (Sanderson et al., 1990, Boitano et al., 1992). IP3 is able to stimulate the 
release of calcium from intracellular stores upon binding to its specific receptors 
located on the endoplasmic reticulum (Szlufcik et al., 2006). Coupled to a calcium 
sensitive ion channel, receptor binding induces a conformational change which 
switches the ion channel into an open state. As a result calcium floods into the 
cytoplasm and intracellular calcium levels rise. The IP3 induced calcium waves 
previously reported to arise as a consequence of gap junction mediated cell-to-cell 
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communication, have been reported in various cell types including pacemaker cells 
(Boitano et al., 1992, Fry et al., 2001). In these cells, the spread of IP3 generates 
calcium waves allowing for increased synchronicity, thus enhancing coordination 
and allowing for amplification ofthe overall metabolic performance. 
1.12.1 Connexins, connexons and gap junctions 
To date, 21 human genes and 20 mouse genes for connexins have been identified 
(Sohl et al., 2003). Connexins are commonly designated with numerical suffixes 
referring to the molecular weight of the deduced sequence in kilodaltons (e.g. 
connexin 26 or Cx-26). Each connexin shows tissue or cell type specific expression, 
whilst most organs and cells express more than one type of connexin. Examples 
include Cx-32 and Cx-43 both of which are expressed in numerous cell types 
including cardiac tissue, the kidney and hepatocytes, whilst other connexins, for 
example Cx-40 and Cx-62, are expressed only in retinal tissue. Not only do 
connexins show widespread variability in their tissue expression they also exhibit 
different patterns of expression during development e.g. increasing Cx-43 expression 
is the inverse of the Cx-40 expression pattern (Oyamada et al., 2005). 
All connexins share common features, they comprise four transmembrane helices; 
essential for enabling oligomerisation into hexameric connexon hemichannels, two 
extracellular loops rigidly held together by disulfide linkages critical for both 
docking and assembly of gap junction channels (John et al., 1991) and three variable 
cytoplasmic domains: amino terminus, cytoplasmic loop and carboxy terminus 
(Kumar et al., 1996) (Figure 1.16 ). The highly conserved amino terminal tail 
incorporates a putative calmodulin binding motif (Torok et al., 1997) which is 
necessary for insertion of connexins into the membrane. High variation in amino acid 
sequences in the carboxy terminus ascribed functional differences (Martin et al., 
2000). The most intensively studied property of the carboxy tail is phosphorylation, a 
post-translational modification involving numerous protein kinases which through 
phosphorylation; control assembly, degradation and channel function. 
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Figure 1.16: The transmembrane topology of a connexin. The connexion 
polypeptide is folded in the plasma membrane in the approximate shape of an M. The 
Nand C termini project into the cytoplasm (IN) and the remaining segment traverses 
the membrane four times (1 -4) with two short extracellular (EC) loops (El and E2). 
The third membrane spanning region is rich in hydrophobic acids and is believed to 
line the interior of the channel. The four membrane spanning regions and the 
extracellular loops are highly conserved between different connexins whereas the 
cytoplasmic regions vary (adapted from Li et al. , 2000). 
Gap junctions consist of aggregates of transmembrane hemichannels or connexons. 
Each connexon is a six subunit structure formed when connexins oligomerise into a 
hexameric structure. The formation of gap j unction channels stems from the 
extracellular interaction of two connexons or hemichannels, aligned between 
neighbouring cells. The interaction of two connexons creates a 2nm diameter 
aqueous pore that spans the two apposed plasma membranes creating a narrow pore 
through which both ions and molecules can transverse (Goodenough et al. , 1996, 
Evans et al. , 2002). Whether gap junctions assemble and membrane insertion is 
random or involves junctions being inserted into the centre or edge of pre-existing 
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clusters of gap junction plaques is unknown. There does however appear to be a 
requirement for extracellular matrix proteins, cadherins (Fujimito et al., 1997) 
integrins and laminins (Lampe et al., 1998) in facilitating their adhesion once 
inserted into the membrane. 
Gap junction channels although typically fonned between cells of the same type 
(homo cellular gap junctions), have been reported to fonn between different cell types 
(heterocellular gap junctions) (Sandow et al., 2003, 10hnson et al., 1973) (Figure 
1.17). The channels themselves can adopt one of a variety of fonnations dependent 
upon the nature of the connexin involved and consequently are designated homotypic 
or heterotypic in nature. Two connexons each consisting of identical connexins can 
fonn a homotypic gap junction channel (Bittman et al., 2002), in this case, the 
connexons are themselves referred to as homomeric. If the opposing connexons are 
not identical to each other yet homologous within themselves, the channel is tenned 
heterotypic, whilst the connexins homomeric. Lastly, if the channel is heterotypic 
and each connexon is comprised of different connexin proteins, the connexon is 
referred to as heteromeric (Elenes et al., 2001). Whilst both homomeric connexons 
and heteromeric connexons exist in vitro and in vivo (Valiunas et al., 2001, Ahmad S 
et al., 1999, Martinez et al., 2002), it is the constituents of a gap junction channel ie 
the connexins involved and the fonnation that they adopt, which dictate both 
selectivity and penneability of the channel (Goldberg et al., 1999). 
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Figure 1.17: Possible arrangements of connexins in a gap junction channel unit. 
Gap junctions are comprised of opposing connexons. These connexons can adopt one 
of two comformations, homotypic or heterotypic, dependent upon the nature of the 
connexons involved in their formation. Since most cells express more than one 
connexin isoform, the hexameric connexon hemichannels can be homomeric or 
heteromeric depending upon the homology of the connexins involved in formation of 
the hexanleric structure (Adapted from Evans et al. , 2002) 
1.12.2 Gating mechanisms of connexin based hemichannels 
Whilst functional gap junctions exist in an open tate conformation, the ability to 
switch between an open or closed state is dependent upon a number of modulatory 
factors and is a necessity in pathophysiological conditions in which the ionic 
composition of the cell may alter. This ability to switch between an open and closed 
conformation uncouples neighbouring cells from one another, thereby serving as a 
protective mechanism through inhibition of a signal which may serve to cause 
overall tissue damage. The formation and degradation of gap junctions is a dynamic 
process, with reports of half lives of less than 2-5 hours in cultured cells and tissues 
(Evans et al., 2002). The rapid synthesis and turnover of connexins is an indicator 
that gap junction number, composition and function are subject to tight regulation 
and are rapidly remodelled. Deficient or improper gap junction function has been 
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associated with a variety of diseases, including fonns of neuropathy, cataracts, skin 
disease, heart disease, and hypertension (Pal et al., 2000, Kelsell et al., 2001, 
Dasgupta et al., 2001, Haefliger J-A et al., 2001), regulation therefore is critical. 
In most hemichannels studied to date, opening is enhanced at positive membrane 
potentials or when extracellular calcium is below ImM (Stout C et al., 2003, Verselis 
VK et al., 2000). The open probability of gap junctions therefore is reported to 
decrease in conditions in which calcium concentrations may become dangerously 
high. In the kidney, changes in cell volume have been reported to be accompanied by 
a rise in intracellular calcium (Montrose-Rafizdeh et al., 1991). This increase in 
calcium has been shown, in both kidney and numerous other cell types, to evoke 
instigation of cell volume recovery mechanisms ultimately enabling volume 
restoration throughout. However, under conditions in which the concentration of 
calcium becomes dangerously high, this rise may trigger communication of specific 
Ca2+ mediated signals to neighbouring cells. Calcium may also induce closure of gap 
junction channels which will ultimately serve as a potential safety mechanism; 
isolating healthy cells from dying or injured cells. In conjunction with alterations in 
intracellular calcium levels, hemichannels are also sensitive to intracellular 
acidification with exposure to either a low or high pH solution inducing channel 
closure (reviewed in Peracchia et al., 1997). 
Activity of gap junctions can also be influenced by post translational modification of 
the connexin subunits. With the exception of Cx-26 and Cx-36, all connexins are 
phosphoproteins (Saez et al., 1998.) Kinases known to be involved in modulating 
gating behaviour through phosphorylation include PKC, mitogen activated protein 
kinase (MAPK) and the cAMP dependent protein kinase (PKA). Whilst both PKC 
and MAPK have been implicated as negative regulators ofhemichannel gating, PKA 
via its effects on intracellular cAMP, has been shown to oppose the effects of both 
PKC and MAPK modulating hemichannel gating in a positive manner. Either way, 
phosphoamino acid analysis confinns the majority of these phosphorylation events to 
occur on serine residues located within the cytoplasmic loop region. An exception to 
this rule is Cx-56, since this can be phosphorylated both in the cytoplasmic loop 
region and at its C tenninal domain (Berthoud et al., 1997). 
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PKC has received considerable attention regarding it ability to act as a regulator of 
gap junction gating since it has been shown to increase Cx-43 phosphorylation and 
subsequently decrease gap junction communication. In mammalian cell lines, the 
opening of Cx43 hemichannels induced by low extracellular calcium is blocked 
following the activation of PKC (Li H et al., 1996, Liu et al., 1997). A similar 
response observed in Xenopus oocytes expressing Cx-46 (Ngezahayo et al., 1998), 
supporting the notion that PKC mediated phosphorylation is critical in regulating the 
gating behaviour of hemichannels. Furthermore, mutation of the PKC 
phosphorylation site Ser368 in Cx-43 to an alanine, results in a constituitively open 
hemichannel (8ao et al., 2004). Since both phorbol esters and PKC activating 
reagents are also capable of inhibiting gap junction intercellular communication 
these compounds are often used extensively in the lab to modulate and study gap 
junction function. Contrary to the effects of PKC, increased intracellular cAMP 
levels have been shown to increase both Cx-43 phosphorylation and Cx-43 mediated 
intercellular communication (Atkinson et al., 1995, 8urghardt et aI., 1995). 
The availability of multiple serine/threonine kinases within a cell allows for stringent 
control of intercellular communication via phosphorylation of pre-exisitng 
hemichannels. Ultimately the nature of the phosphorylation will determine the 
conformation adopted by the hemichannel, its gating properties and consequently the 
rate of gap junctional intercellular communication. 
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1.13 Aims 
Diabetic nephropathy is the leading cause of end stage renal disease in patients with 
type 11 diabetes and is associated with aberrant sodium reabsorption in the kidney 
that can result in secondary hypertension. Whilst numerous animal studies have 
reported deranged transcriptional regulation of signalling elements in sodium 
handling, unlimited availability of cells of the human cortical collecting duct would 
facilitate the identification of key signalling elements that may serve as a potential 
therapeutic target for the prevention of secondary hypertension. The overarching aim 
of this thesis was to determine those mechanisms involved in the regulation of both 
SGKI and ENaC under glycaemic conditions comparable to those observed in a type 
11 diabetic in order to determine the implications that this may have for [Na +]i levels 
and ultimately blood volume homeostasis. Specific hypothesis to be tested include: 
1. Does the human cortical collecting duct (IICD) cell line represent a useful 
modelfor the study of sodium tramlport in renal epithelia? 
• To confirm expression of all key recognition elements involved in sodium 
transport in the collecting duct e.g .. SGKl, a, p and y ENaC, thus confirming 
the Human Cortical Collecting Duct (HCD) cell line a suitable model for the 
study of renal Na+ rebasoption 
2. Are changes in SGKI and ENaC associated with glucose evoked changes in Na+ 
handling in BCD cells? 
• Assess the influences of variable concentrations of glucose on SGKl and a-
ENaC expression and localisation 
• Elucidate a role for other key signalling components e.g. TGF-p I and [Ca2+]j 
associated with hyperglycaemia in the expression ofSGKI and a-ENaC. 
• Determine the effects of high glucose on intracellular Na + levels. 
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3. Are mechanoreceptors involved in resolving physical changes to the cell 
membrane? 
• Identify and confirm the nature of the receptor involved in detection and 
transduction of cell volume changes. 
• Confirm a role for [Ca2+]j In the response to alterations in extracellular 
osmolarity in HCD cells 
4. Is cell-to-cell communication essential for efficient Na + reabsorption in the 
ReD cell? 
• Determine the mechanism by which cells of the cortical collecting duct 
communicate upon exposure to a surrogate form of osmotic stress. 
• Identify the means by which signal transmission is mediated from a discrete 
point of physical contact. 
• Assess the influence of gap junction uncouplers and purinergic receptor 
antagonists on signal transmission. 
5. Is cell-to-cell communication compromised in a pathophysiological state? Are 
the key recognition elements involved in signal transduction subject to alterations 
in expression under glycaemic conditions? 
• Confirm the effects of elevated glucose, TGF-~ 1, and [Ca2+]j on those 
signalling molecules involved in cell-to-cell communication. 
• Assess the effects of elevated glucose levels on cell-to-cell communication. 
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Chapter 2 Materials and Methods 
2.1 Materials 
Sigma Aldrich Company, Poole, U.K. rabbit serum, goat serum, dithiothreitol 
(DTT), phenylmethylsulfonylfluoride (PMSF), bromophenol blue, bovine serum 
albumin, (BSA), polyoxyethylene-sorbitan (Tween-20), ethidium bromide, 3-(N-
morpholino), sodium dodecyl sulphate (SDS), triton-X 100, hydrochloric acid (HCI), 
dimethylsulfoxide (DMSO), 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
(HEPES), ammonium persulfate (APS), N,N,N',N'-
Tetramethylethylenediamin~(TEMED), p-mercaptoethanol, fura-2 am, Pluronic F-
127, 3 aminopropyltriethoxysilan (APES), lucifer yellow, ouabain, amiloride, 
dexamethasone, insulin transferrin selenate (ITS), fetal calf serum, ionomycin, 
thapisgargin, SBF-lIAM. Transforming growth factor beta (TGF-Pl), Trypsin, 
Acetone, TRITC conjugated phalloidin, RNA mini prep kit, paraformaldehyde (PF A), 
4',6-diamidino-2-phenylindole (DAPI), Igepal-CA-630, GenElute mammalian total 
RNA miniprep kit 
Affinity Bioreagents, New Jersey, U.S. Primary antibodies (see table 2.1) 
Bioline, London, U.K. Hyperladder. 
Biogenesis, Poole, UK. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
Gibco, Paisley, UK. Dulbecco modified eagle medium (low glucose) (DMEM), 
HAMS F-12, Dulbecco modified eagle medium: HAMS nutrient mixture F-12, 1:1 
mix (DMEM F-12) 
Promega, Southamptom, U.K. Random primers, avian myeloblastosis virus reverse 
transcriptase (AMV), rRNAsin ribonuclease, deoxynucleotide triphosphates (dNTP) 
Invitrogen, Paisley, U.K. Lipofectamine, all primers (see table for details), Taq 
DNA polymerase, TRPV4 siRNA, magnesium chloride buffer (MgCh) 
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Amersham Biosciences V.K Limited, Little Chalfont, V.K. enhanced 
chemiluminescence (ECL), rainbow protein markers, Anti-mouse immunoglobulin 
horseradish peroxidase 
Eppendorf, V.S. Water, molecular biology grade 
Biorad, Hertfordshire, V.K. Protein assay reagent 
MilIipore V.K, Ltd, \Vatford, V.K. Whatman:p81 phosphoceUulose 3mm filter 
paper 
Fisher Scientific, Leicestershire, VK. Glycine, Tris (hydroxymethyl) methylamine, 
sodium chloride, HPLC grade methanol, Acetic acid. 
Santa Cruz, California, V.S. Cx-43 siRNA, primary antibodies (see table 2.2) 
The Binding site, Birmingham, UK. Primary antibodies (see table 2.2), Anti-
sheep/goat immunoglobulin horseradish peroxidase, Anti-rabbit immunoglobulin 
horseradish peroxidase 
Molecular probes, Netherlands. Alexa 488 goat anti-rabbit, Alexa 488 goat anti-
sheep. 
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2.2 Tissue culture 
2.2.1 Maintenance of HCD cells 
HCD cells were derived and supplied by Professor P.M Ronco. Cells were obtained 
from normal human kidney cortex and immortalized with SV -40 virus. Clones were 
selected using the monoclonal antibody, Ab272, which specifically recognizes 
collecting duct principal cells (1). HCD cells (passages 18-30) were maintained in 
DMEM/Hams F-12 medium supplemented with 2% fetal calf serum (FCS), 
glutamine (2 mM), 15mM HEPES, transferrin (5J.!g/ml) , Na2Se03 (5ng/ml) , insulin 
(5J.!g/ml) and dexamethasone (5xIO-8 M). Cells were grown at 37°C in a humidified 
atmosphere of 5% C02 in air in vented flasks. 
Figure 2.1 Light micrograph of HCn cells after maintenance in tissue culture: 
The human collecting duct (HCD) cell line is a polarised epithelial cell line 
expressing characteristics of the principal cells of the kidney. Panels a, and b show 
phase morphology of HCD cells in culture at x20 and x40 magnification 
respectively. 
72 
2.2.2 Subculturing 
Cells were allowed to reach 80-90% confluence and then detached by incubation 
with 3ml of phosphate buffered saline (PBS) containing O.3mM EDTA and 0.08% 
(w/v) trypsin for 3-4 minutes at room temperature. Trypsin was inactivated by the 
addition of I5ml of medium containing 5% FCS. Cells were then collected in a 
universal and centrifuged at 260g for 5 minutes. Resuspension of the cell pellet in 
media allowed for cells to be distributed as required. 
2.2.3 Freezing and thawing of cells 
Stocks of cells were maintained in liquid nitrogen. Cells were trypsinised and 
pelleted by spinning at 260g Cell pellets were resuspended in 3ml FCS containing 
10% dimethyl sulfoxide (DMSO) I.5ml aliquots were used to fill 2ml cryovials. To 
reduce ice crystal formation cells were stored at -BO°C overnight and then transferred 
to liquid nitrogen the following day for future storage. To revive cells, an ampoule 
was thawed rapidly at 37°C. The contents of this ampoule were then transferred to a 
universal containing 20mls media and cells were pelleted at 260g for five minutes. 
Cells were resuspended in 32ml fresh media and transferred into two 75cm2 flasks. 
2.3 Reverse transcriptase polymerase chain reaction (RT -peR) 
Polymerase chain reaction (PCR) is a simple yet powerful technique which allows for 
the logarithmic amplification of any known DNA sequences within a double stranded 
DNA molecule. The technique employs a pair of primers that hybridize and flank to 
sequences on opposing strands of the target. These primers are extended by a DNA 
polymerase so that a copy is made of the designated sequence. After making this 
copy, the same primers can be used again, not only to make another copy of the input 
DNA strand but also of the short copy made in the first round of synthesis, hence 
amplification becomes logarithmic. PCR consists of three general steps. 
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i. Denaturation: The reaction mixture is heated to 9SoC for a short time period 
in order to denature the target DNA into single strands enabling them to act as 
template strands for DNA synthesis. Since it is necessary to raise the 
temperature to separate the two strands, a thermo stable DNA polymerase is 
required to prevent the need for new polymerase every cycle. Taq polymerase 
is a thermo-stable DNA polymerase that was first isolated from Thermus 
aquaticum, a bacterium that grows in hot pools and can thus withstand high 
temperatures. 
11. Primer annealing: Following denaturation of the strands, the mixture is 
rapidly cooled to allow for primer binding to occur. Calculation of this 
annealing temperature is dependent on a number of factors including both 
primer length and GC content, and is calculated carefully to ensure that the 
primers bind only to the desired DNA sequences. The two parental strands do 
not re-anneal with each other since the primers are in large excess over the 
parental DNA. 
Ill. Elongation: The temperature of the mixture is raised to approximately 72°C 
and kept at this temperature for a pre-set period of time. This ensures that the 
DNA polymerase binds to and elongates each primer, ultimately copying the 
single strand templates. At the end of the incubation both parental strands 
have been made partially double stranded. 
2.3.1 RNA preparation 
RNA was prepared from 80% confluent HCD cells by acid-guanidinium extraction 
(Chomczynski et al., 1987) using a genelute mammalian total RNA miniprep kit 
(Sigma) following the manufacture's instructions. RNA was stored at -80°C 
2.3.2 Reverse transcriptase polymerase chain reaction (RT-PCR) 
Complementary DNA was synthesized by reverse transcription using a Promega 
Reverse Transcription System following an adapted method. 1 J,.lg of total RNA and 
0.5 J,.lg of random hexamers, in a final volume of 11 J,.ll, were incubated at 70°C for 5 
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minutes, and then allowed to cool slowly to 25°C to allow for primer annealing. 
Primer extension was then performed at 37°C for 60 minutes following the addition 
of Ix (final concentration) reaction buffer (50mM Tris-HCI (pH 8.3), 50mM KCI, 
IOmM MgCh, 10mM dithiothreitol and O.5mM spermidine), ImM (final 
concentration) of each deoxynucleotide triphosphates (dNTP), 40U of rRNAsin 
ribonuclease inhibitor and 15U of Avian Myeloblastosis Virus (AMV) reverse 
transcriptase in a final volume of 20Jll. The RT mixture was heated to 95°C for 5 
minutes, then 4°C for 5 minutes. An aliquot of 4JlI cDNA was used in subsequent 
PCR reactions. cDNA was stored at -20°C 
2.3.3 PCR amplification of cDNAs 
Amplification of specific cDNAs was carried out using primers specific for the gene 
of interest. PCR reactions (20JlI) were set up containing 1.5mM MgCh, I x NH4 
buffer (50mM KCI, IOmM Tris HCI pH 9, 0.1% Triton x-lOO), 0.2mM of each 
dNTP, 0.5JlM of each primer and 1 U of Taq DNA polymerase. Amplification of 
samples was performed using an initial denaturation step of 95°C (5minutes) 
followed by between 30-35 cycles consisting of one minute of denaturing at 95°C, 
one minute of annealing at the optimised temperature (50-60°C) and a one minute 
extension at 72°C. A final elongation step of 72°C for seven minutes was included in 
all PCR amplifications (see table 1 for primer details). As a negative control, 
template cDNA was replaced with RNase free water. Following amplification, PCR 
products (lOJ..ll) were mixed with 4JlI loading buffer (l mM EDT A pH 8, 
bromophenol blue 0.25% w/v, xylene cyanol 0.25% w/v, and 50% v/v glycerol) and 
run on 1 % (w/v) agarose gels containing ethidium bromide at 80 volts. PCR products 
were visualized on a Genegenius Bioimaging system UV transilluminator (Syngene 
Cambridge U.K). 
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Target Primers (5'~ 3') Direction Annealing Product Origin 
temp size 
(bp) 
SGKl AGGGCAGTTTTGGAAAGGTT F 51 699 Primer 
GCAGAAGGACAGGACAAAGC R 3 
a-ENaC GGCATCTTCATCAGGACCTACT F 50 601 Rauz et 
ACATGATCCGTAACTGCAACT R al., 
2003 
p-ENaC GTGCCAATCAGGAACATCTAA F 50 1000 Rauz et 
CACTTTCAACTCTGCTTTGCAC R al., 
2003 
y-ENaC GGGACTATCCACCTGCAAGA F 50 696 Rauz et 
CACGTGCTGCTCCACTTTTA R aI., 
2003 
TGF-pl AGAGGTCGCTTGGGAATTTT F 58 341 Primer 
TTTGGAAACCATGTCAAGCA R 3 
Cx-26 ACCTTGCTGTGCCTCAGTTT F 55 309 Primer 
TATACCAGCACCCGGAAGAC R 3 
Cx-31 TTCGGGTGACCTCATCTTTC F 55 307 Primer 
CCCGCATGTGTGTTCTTCTA R 3 
Cx-31.1 TTGCAACCTTTCCTTCTGCT F 55 392 Primer 
TTCCACAAGGGGAATCTGAG R 3 
Cx-40 ATGAGCAGTCTGCCTTTCGT F 55 338 Primer 
GGTCGCTCTTTCCCTTAACC R 3 
Cx-43 CCCGTGAGAACACCAAGTTT F 58 597 Primer 
TCACTCCAGGGCATTTCTTC R 3 
TRPV4 CCCGTGAGAACACCAAGTTT F 59 618 Primer 
TCACTCCAGGGCATTTCTTC R 3 
Table 2.1 peR primers used in this study. F= forward primer, R= reverse primer. 
All primers were supplied by invitrogen Paisley, UK. 
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2.4 SDS gel electrophoresis 
Electrophoresis is a widely available technique used for the separation of charged 
macromolecules, e.g. proteins in an electric field. The electrophoretic mobility of a 
charged particle depends on a number of factors including the overall charge of the 
molecule, its molecular weight and shape. Since the overall charge of a given 
molecule is dependent on the number of amino acid side chains available for 
ionisation at a given pH. Those molecules with a greater charge will migrate towards 
the opposing electrode faster than those molecules with a lesser charge providing they 
are of a similar molecular weight. 
Polyacrylamide gel electrophoresis (PAGE) can also be performed under denaturing 
conditions, typically in the presence of the ionic detergent Sodium Dodecyl Sulfate 
(SOS-PAGE) or under reducing and denaturing conditions (SOS-PAGE in the 
presence of a reducing agent such as dithiothreitol (DTT) or beta mercaptoethanol 
which break disulfide bonds). Prior to resolving the sample by SDS-PAGE, the 
protein sample is heated to 9SoC. By disrupting non-covalent intra- and 
intermolecular bonds, the protein is effectively rendered devoid of secondary and 
tertiary structure. Consequently, the denatured protein molecules become coated with 
the negatively charged SOS at a concentration of approximately 1.2 g SOS per gram 
of protein, thus giving the protein molecules a net unit negative charge per unit mass. 
As a result, the molecular weight of these proteins becomes the only determinant in 
their separation. 
Proteins are loaded onto a polyacrylamide gel and exposed to an electric field. The 
formation of polyacrylamide from its acrylamide monomers produces a gel with a 
sieve like effect in which proteins migrate and separate according to their size only. 
The pore sizes in the gel can be controlled by choosing appropriate concentrations of 
acrylamide and the cross linking reagent methylene bisacrylamide. The higher the 
concentration of acrylamide used the smaller the pore size in the final gel. Whilst 
small proteins will migrate fastest through the gel, larger proteins are held back by the 
cross linking in the gel and migrate at a slower rate. 
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2.4.1 Cell lysate protein preparation 
HCD cells were allowed to reach approximately 70-80% confluency. Medium was 
removed and cells were washed with sterile PBS. Using a cell scraper, cells were 
scraped into 3-4ml of a mixture of PBS and the protease inhibitor 
Phenylmethylsulphonylfluoride (PMSF) (0.5mM). Cells were pelleted at 180g for 5 
minutes. Total cell Iysates were then prepared by two different methods, dependent 
upon which antibody was to be used to probe that sample. 
1. Cells were lysed open with 250)11 lysis buffer (0.25M Tris pH 7.8, 0.5% v/v 
NP40, ImM PMSF, 5mM DTT) at 4°C disrupting the cell membrane and 
releasing both membrane and cell contents. Cells were then vortexed and 
gently agitated at 4°C for a period of 30 minutes. Cells were then spun at 76g 
for 5 minutes to pellet cell debris and the supematant aliquoted and stored at -
80°C 
2. Cell pellets were resuspended into 200-300)11 of PBS+PMSF (0.5mM). These 
preparations were then vortexed briefly and subjected to three cycles of 
freeze-thaw therefore disrupting cell integrity Samples were centrifuged at 
76g to pellet cell debris and the supematant collected. Samples were then 
aliquoted and stored at -80°C. 
2.4.2 Protein concentration determination 
Protein concentrations were determined using the Bio Rad protein Assay. This assay 
is a dye-binding assay which relies on a change of colour of the dye in response to 
various concentrations of protein. The absorbance maximum for an acidic solution of 
Coomassie® Brilliant Blue G-250 dye shifts from 465 nm to 595 nm when binding to 
protein occurs. A standard curve was prepared using BSA (0-20)1g protein). Protein 
samples (10)11) were mixed with water (790)11) and dye concentrate (200)11). This 
mixture was then left for five minutes. Samples were read on a spectrophotometer at 
595nm and protein concentrations calculated using the standard curve. 
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2.4.3 Sample preparation 
5 J.!g of protein was diluted to 10J.!1 with dH20 and mixed with 20J.!1 of sample buffer 
(125mM Tris pH 6.8, 6.4mM DTT, 20% (v/v) glycerol, 0.025% (v/v) bromophenol 
blue, 10% (v/v) water). Samples were then heated to 95°C for 5 minutes. 
2.4.4 Preparation and running of gel 
Gel equipment (Biorad) was assembled. The resolving gel was poured between the 
two glass plates and allowed to polymerise for 30-40 minutes (see table 2.2 for 
details of gel reagents). As oxygen interferes with polymerisation, a layer of water 
was gently pi petted onto the top of the gel to form an airtight seal. When 
polymerisation of the gel was complete, the stacking gel was prepared and poured on 
top of the resolving gel. A well-forming comb was inserted and the stacking gel left 
to polymerise for 15 minutes. When polymerisation of the stacking gel was 
complete, the combs were removed and the wells were washed thoroughly with 
water. Samples were then loaded into the wells of the gel and separated by sodium 
dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (4.5% stacking gel, 7.5% 
or 10% resolving gel) at 200 volts for 50 minutes in electrophoresis buffer (25mM 
Tris, I 92mM glycine and 0.1 % (w/v) SDS). 
Reagent Stacking gel Resolving gel Resolving gel 
4.5% (7.5%) (10%) 
Acrylamide (33%) 1.5ml 3ml 4ml 
1.5M Tris pH 6.8 2.5ml 
-
1.5M Tris pH 8.8 - I.5ml 3ml 
10% SDS 100J.!1 120J.!1 120J.!1 
Ammonium persulfate 40J.!1 IOOJ.!1 IOOJ.!1 
(10% w/v) 
TEMED lOJ.!1 lOllI I o III 
dH20 5.8ml 5.84ml 4.84ml 
Table 2.2 Reagents required for stacking gel and resolving gel preparation 
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2.5 Western blotting 
Western blotting is the term given to the technique by which proteins are transferred 
from the polyacrylamide gel to a more accessible medium ultimately enabling the 
detection of proteins via specific antibodies (Figure 2.2). In this procedure, a 
sandwich of gel and solid support membrane (Nitrocellulose or Polyvinylidene 
Fluoride (PVDF) is compressed in a cassette and immersed in buffer between two 
parallel electrodes. A current is passed at right angles to the gel ultimately inducing 
the separated proteins to electrophorese out of the gel and onto the solid support 
membrane. Once the proteins have been transferred to the solid support membrane, 
the membrane is referred to as a "blot". Electroblotting preserves the resolution of 
electrophoretic transfer and allows for further analysis using specific antibodies 
raised against proteins of interest. The western blot is then incubated with a primary 
antibody, visualised by enhanced chemiluminescence (EeL) using a secondary 
antibody conjugated to horseradish peroxidase (HRP). The chemiluminescent 
reaction occurs as a consequence of the ability of HRP to oxidise a peracid salt, 
raising the oxidation state of the haem group central to HRP. Reducing this to the 
ground state forms a luminol radical, which releases light. In enhanced 
chemiluminescence, enhancer molecules react with the haem group in place of 
luminolleading to the formation of enhancer radicals. These radicals in turn produce 
luminol radicals, the decay of which emits light in a reaction which is sustained for a 
far greater time period than in the absence of these enhancer molecules (Whitehead et 
al., 1979). 
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Figure 2.2 Schematic diagram to illustrate western blotting 
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2.5.1 Electrophoretic transfer 
Immobilin P membrane (Millipore) was cut to size and soaked in methanol for 3 
seconds. The membrane was then placed into water for 2 minutes and then 
equilibrated in transfer buffer (2SmM Tris, 400mM Glycine, 20% (v/v) Methanol, 21 
water) for 10-IS minutes. Two sheets of chromatography paper and fibre pads were 
also incubated in transfer buffer for IS minutes. After electrophoresis gels were also 
soaked in transfer buffer for 10 minutes. The gels and membrane were then 
assembled in a transfer cassette as follows 
Fibre pad 
Chromatography paper 
Gel 
Immobilin membrane 
Chromatography paper 
Fibre pad 
Proteins were transferred 1 hour at 100 volts; 4°C. 
2.5.2 Immunodetection 
To prevent non specific binding and reduce background, membranes were incubated 
in 20% non fat milk (marvel) w/v in PBS-Tween «PBS-T) 0.1 % v/v) for 1 hour at 
2SoC. The membrane was incubated overnight at 4°C in primary antibody made up in 
PBS-T (O.OS% v/v). After three 10 minute washes in PBS-T (0.1%), the membranes 
were incubated with the secondary antibody (horseradish peroxidase- conjugated) in 
PBS-T (O.OS%) for 60 minutes at 2SoC followed by three 10 minute washes in PBS-T 
(0.01 %) Specific proteins were detected usmg ECL detection reagent 
chemiluminescence system (Amersham Biosciences) and were visualised after 
exposure of membranes to X-ray film for 1-10 minutes 
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2.5.3 Antibody optimization and confirmation of specificity 
All pnmary and secondary antibodies were optimized to ensure an efficient 
combination of protein staining with minimal background noise. Optimization was 
achieved by testing a range of dilutions of both primary and secondary antibody (see 
table 1.3 for optimal conditions) 
Ab Species 1° dilution 2° dilution Company 
raised 
in 
a-ENaC Rabbit 1:600 1:2000 Affinity 
Bioreagents 
y-ENaC Rabbit 1:600 1:2000 Affinity 
Bioreagents 
SGKl Sheep 1:3000 1:30,000 The Binding 
Site 
TGF-pl Rabbit 1:500 1 :40,000 Santa Cruz 
GAPDH Mouse 1:20,000 1:20,000 Biogenesis 
Cx-43 Rabbit 1:200 1:3000 Santa Cruz 
TRPV4 Sheep 1:1000 1:30,000 The Binding site 
Table 2.3 Optimized antibody dilutions used for western blotting. Conditions 
were optimised for both primary and secondary antibodies to achieve optimal binding 
and minimal background noise. Primary antibodies were obtained from Santa Cruz, 
Affinity Bioreagents and The Binding Site. Secondary antibodies were obtained from 
The Binding site. (section 2.1 for further details). 
To confirm specificity of our secondary antibodies, western blots were incubated 
with both primary and secondary anti-sheep (The Binding Site) (figure 2.3 panel AI) 
or anti-rabbit (The Binding site) (figure 2.3 panel; BI). In parallel to this a second 
western in which the membrane was incubated with secondary antibody alone (figure 
2.3 panel A2 and B2) was performed. Specificity was confirmed when a band on 
only the blot probed with both primary and secondary antibody was visualised by 
ECL detection. 
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Figure 2.3 Confirmation of specificity of anti-sheep and anti-rabbit secondary 
antibodies. Membranes were incubated with a specific primary antibody and either 
anti-sheep (A 1) or anti-rabbit (B 1) secondary. In parallel, membranes from which the 
primary antibody was omitted from the overnight incubation and blots were probed 
with either anti-sheep (Panel A2) or anti-rabbit (Panel B2) secondary. 
2.6 Immunocytochemistry 
The immunocytochemical localisation of an antigen involves fixing and stabilizing 
the antigen, saturating non-specific binding sites, binding the primary antibody and 
lastly visualising the primary antibody. Following fixation of the cells, any non 
specific binding is eliminated by addition of a blocking agent. Addition of the 
primary antibody results in detection of the antigen of interest. The application of a 
fluorescent conjugated Alexa 488 secondary antibody allows for visualisation of our 
protein of interest (figure 2.4). 
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Figure 2.4 Localisation of an antigen using immunocytochemical staining. Non-specific protein binding is blocked with an appropriate 
blocking agent. Primary antibody is added to the fixed cells allowing for an interaction to form between our antigen of interest and primary 
antibody. After washing, a secondary fluorescent conjugated antibody raised against the animal in which our primary antibody is raised is added 
and viewed under a fluorescence microscope. 
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2.6.1 Preparation of APES treated coverslips 
Coverslips were cleaned in acetic acid for a period of 30 minutes and left to soak. 
Coverslips were then washed with copious quantities of distilled water. To remove 
any final traces of acetic acid coverslips were placed in 70% ethanol for 30 minutes 
followed by further washing with distilled water. Coverslips were then placed into a 
solution of 10 ml acetone mixed with 200/-l1 3-aminopropyltriethoxysilane (APES) 
and left for 5 minutes. After 3xlO minute washes, coverslips were air dried before 
being placed in 6 well plates. Finally, all plates were exposed to UV radiation for 20 
minutes to sterilise coverslips prior to plating with cells. 
2.6.2 Cell fixation 
Fixatives work by several means: formation of cross-linkages (e.g., aldehydes such 
as glutaraldehyde or formalin); protein denaturation by coagulation (e.g., acetone and 
methanol); or a combination of the above. 
Cells were grown to 80% confluence on APES treated coverslips in culture media. 
Media was removed and cells incubated at room temperature for 30 minutes with 4% 
paraformaldehyde (PF A). PF A was removed and cells were washed with PBS for 
3x 1 0 minute washes. Cells were stored for future use at 4°C in PBS and sodium 
azide to prevent any bacterial growth and contamination. 
2.6.3 Antibody staining procedure 
Cells were removed from the fridge and warmed to room temperature for 
approximately 1 hour. Any residual traces of sodium azide were removed by washing 
with PBS (3 x 10 mins). To prevent any non-specific binding, cells were incubated 
for Ihr at 25°C in a blocking solution comprised of PBS-Triton (0.01 %) (v/v), 
containing 10% (v/v) goat serum. The blocking solution was removed. Following 3 
xlO minute washes with PBS, the nuclear stain DAPI (4',6-diamidino-2-
phenylindole, dihydrochloride; 1 J..lM) was added to each coverslip for 3minutes. 
After washing with PBS (3x5 minutes), cells were incubated with the cytoskeletal 
stain TRITC-conjugated-phaUoidin diluted at 1:100 in PBS-Triton (0.01 %) for 1 
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hour at 25°C. Fo llowing further washing (3x5 minutes), cells were incubated 
overnight at 4°C with primary antibody (1: 1 00) diluted in PBS-Triton (0.01 %). 
Fo llowing antibody incubation, cells were washed with PBS and then incubated in 
Alexa 488 conjugated secondary antibody for 1 hour at 25°C in the dark. Secondary 
antibod ies were diluted (l :400) in PBS-Triton (0.01 %). Cells were washed 
(3x 1 Ominutes) and coverslips mounted in anti-fade citifluor (glycerol/PBS solution: 
Agar Scientific) on glass slides. 
2.6.4 Antibody specificity 
As with the western blots, appropriate controls were performed in which primary 
antibody was omitted from the staining process to test for the specificity of the 
secondary antibodies. Controls were performed for both secondary Alexa-conjugated 
anti-rabbit (figure 2.5/1 d) and secondary anti-sheep (figure 2.5/2d) and specificity 
confirmed when only those cells stained with both primary and secondary antibody 
fluoresced under UV light (figure 2.5/1 band 2.5/2b) 
Figure 2.5 Confirmation of specificity of secondary antibodies used in 
immunocytochemical staining. HCD cells were stained with the nuclear stain DAPI 
and a primary antibody. Staining was then visualized by addition of either a 
fluorescent conjugated secondary anti-sheep (lib) or anti-rabbit (2/b) antibody. 
Panels lid and 2/d represent staining of cells in which primary antibody was omitted. 
These images confirm specificity of our secondary antibodies. 
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2.7 RNA interference 
RNA interference (RNAi) is a phenomenon in which double-stranded RNA (dsRNA) 
suppresses expression of a target protein by stimulating the specific degradation of 
the target mRNA. RNAi is utilised by most eukaryotes in vivo for anti-viral defense, 
or gene regulation and has become an important research tool for gene silencing. 
Preliminary attempts to use RNAi in mammalian systems employed long dsRNAs as 
triggers, but led to the induction of a non-specific Type I interferon response rather 
than sequence-specific silencing. This interferon response resulted in widespread 
changes in protein expression, masking any sequence-specific effects and eventually 
leading to apoptosis. This suppression has been attributed to an antiviral response, 
which takes place through one of two pathways. In one pathway, long dsRNAs 
activate a protein kinase, PKR. Activated PKR, in turn phosphorylates and 
inactivates the translation initiation factor eIF2a, leading to repression of translation. 
In the other pathway, long dsRNAs activate RNase L, which leads to non specific 
RNA degradation. 
Following uptake into the cell, the dsRNAs enter a cellular pathway known as the 
RNA interference (RNAi) pathway (figure 2.6). The dsRNAs are then subject to 
processing by Dicer, an RNase III polymerase that cleaves the dsRNAs resulting in 
the generation of small interfering RNAs (siRNAs), short RNA duplexes of 19-21 
nucleotides with two nucleotide 3' overhangs. These siRNAs are then incorporated 
into endoribonuclease containing complexes known as RNA-induced silencing 
complexes (RISCs), unwinding in the process. Activated RISes bind to 
complementary transcripts by base pairing interactions between the si RNA anti-sense 
strand and complementary mRNA. The bound mRNA is then cleaved and sequence 
specific degradation ofmRNA results in gene silencing. 
Whilst the introduction of long dsRNA into mammalian cells initiates a potent anti-
viral response, this response can be bypassed by the introduction of siRNAs. These 
siRNas are then incorporated into the endoribonuclease containing complex (RISCs) 
as described above. 
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Figure 2.6 Simplified schematic diagram of the proposed RNA interference 
mechanism. dsRNA is introduced into a cell and becomes processed by the dicer 
enzyme to form siRNA, The siRNA forms a multicomponent nuclease complex, the 
RNA induced silencing complex (RISC). The target mRNA recognised by RISC is 
cleaved in the centre of the region complementary to the siRNA and degraded. 
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2.7.1 Transfection of IICD cells with Cx-43 siRNA 
HCD cells were, seeded at a density of 1 x 1 OS on 6 well plates and allowed to adhere 
overnight. Cells were also seeded on to APES treated coverslips in 6 well plates at 
the same density. 
The knockdown of Cx-43 was achieved by two different siRNA protocols. 
1. Transfection of cells with a pool of four Cx-43 specific siRNA duplexes (Santa 
Cruz). Transfection of siRNAs (4Jlg) was conducted using lipofectamine (4Jll) 
(lnvitrogen) following manufacturers instructions. Briefly lipofectamine and siRNAs 
were diluted into optiMEM medium (invitrogen). Diluted lipofectamine lipids were 
mixed with diluted siRNAs and the mixture was incubated for 30 minutes at room 
temperature to allow for complex formation. Mixtures were further diluted in 
optiMEM and added to each well such that the final concentration of siRNA was 
80nM. Cells were then incubated in this transfection mix for 14 hours overnight. This 
transfection mix was then replaced with the desired tissue culture media and cells 
harvested 24, 48, 72 and 96 hours after transfection. Negative controls included 
untransfected cells, lipid alone, 2 scrambled siRNAs, one of which was fluorescein 
conjugated (Santa Cruz). 
2. The siLentGene U6 cassette RNA interference System (Promega). Specific Cx-43 
and scrambled sequences were selected using the Promega design tool. U6 
expression cassettes were constructed following the manufacturers instructions. 
Transfection of the U6 DNA expression cassettes were performed using silentGene 
transfection reagent (Promega) such that the final concentration of cassettes was 
160nglml. In order to localise transfected cells, cells were co-transfected with RFP 
(0.5 Jlg pDsRed2-C 1). Cells were harvested and assayed 72 hours after transfection. 
Negative controls included untransfected cells, lipid alone, RFP alone and a 
scrambled siRNA. (These studies were performed by Dr Dianne Wheelans). 
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2.7.2 Transfection of IICD cells with TRPV4 siRNA 
Cells were allowed to grow to 40% confluence in 6 well plates or APES treated 
coverslips. Lipofectamine and TRPV4 specific siRNA (invitrogen) were diluted into 
OptiMEM medium (Invitrogen). Diluted lipofectamine lipids were mixed with 
diluted siRNAs (8j.lg) and the mixture was incubated for 30 minutes at room 
temperature for complex formation. Mixtures were further diluted in OptiMEM and 
added to each well such that the final concentration of siRNAs was 80nM. Cells were 
then incubated in this transfection mix for 14 hours overnight. This transfection mix 
was then replaced with the desired tissue culture media and cells harvested 24, 48, 72 
and 96 hours after transfection. Negative controls included untransfected cells, lipid 
alone, 2 scrambled siRNAs, one of which was fluorescein conjugated (Santa Cruz). 
2.8 Microfluorimetry studies 
2.8.1 Determination of intracellular calcium concentration [Ca2+h 
Changes in [Ca2+]i were measured by single cell dual excitation microfluorimetry 
using the fluorescent dye Fura-2/AM (Grynkiewicz et al., 1985). Fura-2/AM is a 
widely used uv-excitable fluorescent calcium indicator. Upon calcium binding, the 
fluorescent excitation maximum of the indicator undergoes a shift from 380 nm 
(Ca2+-free) to 340 nm (Ca2+-saturated), while the fluorescence emission maximum is 
relatively unchanged at -510 nm. The indicator is typically excited at 340 nm and 
380 nm respectively and the ratio of the fluorescent intensities corresponding to the 
two excitations gives a ratiometric indication of cytosolic [Ca2+k Measurement of 
calcium concentration using this ratiometric method avoids interference due to 
uneven dye distribution and photobleaching The biochemical mechanism underlying 
acetoxymethyl (AM) ester loading of Fura 2/ AM into cells is that the AM ester form 
is membrane permeant and therefore able to enter cells. Hydrolysis by esterases 
within the cell releases the fluorescent probe which is not membrane permeant and 
ultimately the probe becomes trapped within the cell. 
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Hcn cells were seeded and grown overnight on APES-coated coverslips at a density 
of 5xl04. Cells were loaded for 30 minutes at 37°C with 2.5J.lM of Fura-2/AM 
(Sigma, UK). Coverslips were washed and placed in a steel chamber, the volume of 
which was approximately 500J.lI. A single 22mm coverslip formed the base of the 
chamber, which was mounted into a heating platform on the stage of an Axiovert 200 
Research Inverted microscope (figure 2.7). 
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Figure 2.7 Hardware schematic for dual excitation single emission epi-
fluorescent microscopy. Groups of cells loaded with a ratiometric dye (e.g. Fura-
21 AM) are firml y attached to coverglass of limited thickness to allow the epi-
fluorescent objectives to record changes in fluorescence intensity. The CCD 
amplifies the photon signal and allows on-line digitised recording of fluorescence 
changes. 
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Using a Metafluor imaging workbench (Universal Imaging) fluorescent images of 
the cells within a field of view were obtained and multiple regions of interest were 
monitored (figure 2.8) 
Figure 2.8 Hen cells loaded with Fura-2/ AM. HCD cells were loaded with the 
Ca2+ fluorophore Fura-2/ AM (2.5/-lM) for 30 minute at 37°C. Cells were then placed 
into a chamber bathed in tissue culture media and placed on a UV microscope. Using 
metafluor imaging software multiple regions of interest were recorded within a single 
field of view, and subsequently numbered. This allows us to monitor elevations in 
[Ca2+]i in adjacent cells. 
Cells were illuminated alternatively at 340nm and 380nm. Emitted light was filtered 
using a 510nm long-pass barrier filter and detected using a Cool Snap HQ CCD 
charge coupled device (Roper Scientific). Changes in the emission intensity of Fura-
2/ AM expressed as a ratio of dual excitation were used as an indicator of changes in 
[Ca2+]i using established procedures. Data was collected at 3 second intervals for 
multiple regions of interest in anyone field of view. All records have been corrected 
for background fluorescence (determined from cell-free coverslip). All experiments 
were carried out at 37°C using unsupplemented DMEMlHams F -12 as the standard 
extracellular medium. 
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2.8.2 Determination of intracellular sodium concentration [Na +]i 
Changes in [Na +]i were measured by single cell dual excitation microfluorimetry 
using the fluorescent dye SBF-I /AM . SBF-I /AM is a dual excitation single emission 
dye with spectral properties similar to Fura-2/AM. SBF-IIAM is comprised of 
benzofuranyl fluorophores linked to a crown ether chelator. The cavity size of this 
crown ether confers selectivity fo r Na+ and when a Na+ ion binds to SBF-IIAM the 
indicators fluorescence quantum yield increases causing a significant change in the 
rat io of fluorescent intensities excited at 340/380 nm (boundlunbound modes of the 
dye) . Poor effi ciency of dye uptake necessitates the use of a di spersal agent. Pluronic 
F-1 27 is a non ionic surfac tant polyol that has been found to facilitate the 
so lubilisation of water in oluble dyes and other materials in physiological media. As 
figure 2.9 clearly shows, the efficiency of SBF-J /AM dye uptake into HCD cell s 
appeared to be far greater when the dye was loaded in conjunction with pluronic F-
127 as compared to loading of the dye alone. 
Figure 2.9 HCD cells loaded with the Na+ fluorophore SBF-l/AM in the absence 
and presence of pluronic F-127. Initial studies confirmed that when incubated with 
SBF-l alone, an insuffici ent loading efficiency of the dye was achieved (panels a and 
b) However, when loaded with the detergent pluronic acid, the level of fluorescence 
obtained when cells were illuminated was found to be far greater (panels c and d). 
95 
HCD cells seeded and grown overnight on APES-coated coverslips were loaded with 
20 ) .. t1 SBF/Pluronic acid (20% v/v). Cells were incubated for 90 minutes in a 
humidified atmosphere (5% C02) at 37°C. As previously stated HCDs are a 
polarized, epithelial cell model , which compensate Na+ influx via apical epithelial 
sodium channels with Na + efflux at the basolateral pole via a Na +/K+ ATPase. 
Therefore in order to resolve small changes in cytosolic Na + concentration it was 
necessary to inhibit extrusion mechanisms in both control and experimental 
conditions. Cells were incubated with the Na+/K+ ATPase pump inhibitor ouabain for 
the last 30 minutes of the incubation period. Inhibition of this Na + pump and any 
increased sodium channel activity in the apical membrane will be reflected via 
increased fl uorescence levels indicative of increased [Na +] as ions accumulate within 
the cell (figure 2.10 ). 
Figure 2.10 HCD cells loaded with the Na+ fluorophore SBF-l. HCD cells were 
loaded with SBF-J (5)...lM)/pluronic acid for I 112 hours. Cells were then placed into a 
chamber bathed in tissue culture media and placed on a UV microscope. Using 
metafluor imaging software multiple regions of interest were recorded within a single 
field of view, and subsequently numbered. This allows us to monitor elevations in 
[Na +]i, in adjacent cells. 
Changes in the emISSIOn intensity of SBF -1/ AM expressed as a ratio of dual 
excitation (see section 2.7.1) were used as an indicator of changes in [Na +]i using 
established procedures (Ref). Data was collected at 3 second intervals for multiple 
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regions of interest in anyone field of view. All records have been corrected for 
background fluorescence (determined from cell-free coverslip). All experiments were 
carried out at 37°C using un supplemented DMEM/Hams F-12 as the standard 
extracellular medium. 
2.8.3 Mechanical stimulation experiments 
Cells were allowed to adhere on APES treated coverslips overnight. Prior to 
stimulation cells were loaded with Fura-2/AM (section 2.7.1). Coverslips were the 
washed and placed in a steel chamber (constructed in house, Kings College London) 
and mounted into a heating platform on the stage of an Axiovert 200 Research 
Inverted microscope. Individual cells within a cluster (6-12 cells/cluster) were 
stimulated via touch using a femtotip electrode delivery system (Eppendorf, 
Hamburg, Germany). A microelectrode was connected to the micromanipulator using 
an electrode holder and the x40 objective was used to position the over the cell to be 
stimulated. Following stimulation [Ca2+]j was measured. Maintained Fura-2 
fluorescence, confirmed cytosolic loading and therefore membrane integrity. 
2.8.4 Lucifer yellow studies 
Lucifer yellow is a membrane impermeant fluorescent tracer with a low molecular 
weight of 457.3, making it a powerful tool to evaluate the strength of cell-to-cell 
communication via gap junctions. An individual cell within a cell cluster was 
microinjected with lucifer yellow dilithium salt (dissolved in 150mM LiClII0mM 
Hepes (pH 7.2). Cells were injected using femtotips (internal diameter 0.5±0.2J.lm) 
and the InjectmanlFemtojet 5247 delivery system. The fluorescent tracer was 
allowed to fill the injected cell and to propagate into the neighbouring cells by 
diffusion. The duration for injections was set at 3sec at an injection pressure of 2 PSI 
and a compensation pressure of 0.7 PSI. Dye transfer was recorded over a subsequent 
10minute period using Metamorph acquisition software and a Cool Snap HQ CCD 
camera. After dye transfer the electrode was removed and dye coupling evaluated by 
counting the number of fluorescent cells. An absence of dye leakage into the 
surrounding media confirmed that membrane integrity had remained intact. 
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2.9 Data Analysis 
Autoradiographs were quantified by densitometry (Total Lab 2003). Statistical 
analysis of data was performed using one-way ANOV A test with a Tukey's Multiple 
Comparison post-test. Data are expressed as arithmetic mean ± SEM and n denotes 
the number of experiments. Significance was taken as * P<0.05, ** P<O.OI, *** 
P<O.OOl. 
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Chapter 3 
Characterisation of the IICD cell line 
3.t Introduction 
Diabetes induced increases in SGKl-mediated activation of Na+ reabsorption via 
ENaC may, in part, be contributory to the development of secondary hypertension 
observed in NIDDM. Understanding how SGKl is regulated and in turn, how SGKI 
regulates ENaC mediated Na+ reabsorption may help identify novel therapeutic 
targets in the future treatment of secondary hypertension. Understanding the 
homeostatic mechanisms involved in regulating renal Na+ retrieval necessitates the 
use of readily accessible and physiologically appropriate model systems. One way to 
ensure a continuous source of material would be to immortalise renal cells of a 
defined origin and use these for experimentation. This would enable generation of a 
homogeous population; thus negating the problem of variation within culture. 
The human collecting duct (HCD) cell line (Ronco et al., 1995) was originally 
established in 1995 from a kidney that had been removed for a localized adenoma. 
Cells from the non tumorous part of the kidney were removed and digested with 
collagenase prior to culture in a defined medium at 37°C. Cells were then transfected 
with a recombinant plasmid harbouring a complete SV40 genome and cultured over 
a 4-5 week period checking for expression of SV40 antigens at each stage. The 
transformed cell population was then regularly cultured at 37°C in defined media 
plus 2% FCS. Confirmation of tubular origin was supported by immunological 
studies in which principal cells of the collecting duct were identified following 
incubation with the principal cell specific antibody mAb 272. Whilst previous reports 
have suggested this cell line to represent a suitable culture system in which to study 
the cell biology of water reabsorption (Ronco et al., 1995), little is known about the 
expression of those key signalling elements involved in Na + reabsorption, including 
their modes of regulation. 
In this chapter, I have confirmed both expression and cellular localisation of those 
key signalling elements involved in the regulation and maintenance of blood volume 
homeostasis and have demonstrated that this novel human cortical collecting duct 
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(HCD) cell line is a suitable model for the study ofNa+ reabsorption in the principal 
cells of the human collecting duct. Furthermore we have performed a number of 
studies correlating expression to function. Characterisation of the Na+ resorptive 
capacity of this novel human cortical collecting duct cell line has identified HCD 
cells as a suitable model for future studies which may enable us to gain a greater 
understanding of the transition from physiological to pathophysiological and may aid 
our knowledge and discovery of future therapeutic targets. 
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3.2 Results 
3.2.1 Expression of SGKl in HCn cells 
RT-PCR analysis was perfom1ed on three diffe rent RNA preparations from RCD 
ce ll s producing PCR products representative of SGKI mRNA at 699bp (fi gure 
3. 1A). Expression was standardized against the housekeeping gene 18SrRNA. To 
confirm that all three sets of mRNA were appropriately translated, protein expression 
was determined by western blotting using a specific, polyclonal SGK antibody. 
Western blot analyses (fi gure 3.1 B) revealed a strong band at ~50 kDa in three 
diffe rent RCD protein preparations. 
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Figure 3.1: Expression of SGKl mRNA and protein in HCD-cells. 
Panel A represents RT-PCR analyses using primers specific for human SGKl. PCR 
products of 699bp were observed in three different RNA preparations (1 , 2 and 3) 
corresponding to mRNA expression for SGKl. Western blot analyses (panel B) of 
RCD cell Iysates (51-lg protein/lane) using an antibody against human SGK 
confirmed the presence of the SGKl protein in three different protein preparations 
(1 , 2 and 3). A protein band of approximately 50kDa was detected. 
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As a control for specificity, SGKI antibody was pre-incubated at room temperature 
for 8 hours and then overnight at 4°C with a 100 fold excess of immunising SGKI 
peptide prior to addition of the antibody to the membrane, all other steps in the 
procedure were identical. Preabsorption of the primary antibody completely 
abolished the signal upon ECL detection (figure 3.2) 
SGK 
30 
1 2 
Figure 3.2 Peptide adsorbed antibody abolished SGKl protein detection by 
western blotting. A protein band of approximately 50kOa (SGK) was detected in an 
HCD protein preparation (panel 1), whilst pre-incubation with the peptides abolished 
any signal upon ECL detection (panel 2). 
3.2.2 The localization of SGKl in HCD cells 
The distribution of SGKl in HCO cells under standard tissue culture conditions was 
examined by fluorescence immunocytochemistry using the nuclear stain OAPI 
(blue), the cytokeletal stain phalloidin (red) and an anti-SGKI antibody (green). The 
results can be seen in figure 3.3. 
In figure 3.3/panel c, SGKl appears to be localized predominantly to the nucleus 
with diffuse staining throughout the cytoplasm. The overlay image in panel d 
illustrates a high degree of co-localization between the nucleus and SGKI. 
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Figure 3.3: Immunocytochemical staining of SGKl in HCD-cells. Panels a, and 
b and c show nuclear (DAPI, blue) cytoskeletal (TRITC phaloidin, red) and SGK l 
(Alexa-488 green) staining respectively. Panel d depicts an overlay of SGKI 
immunolocalization (Alexa-488 green), cytoskeletal staining (TRITC-conjugated 
phalloidin; red) and nuclear staining (OAPI; blue). SGKI appears to be 
predominantly localized to the nucleus with diffuse staining throughout the 
cytoplasm. An overlay image in panel d shows co-localization of the nuclear stain 
OAP] and SGKI in the cell nucleus. 
3.2.3 SGK localization is regulated in a stimulus dependent 
Recent evidence suggests that the subcellular localization of SGK I is crucial in 
SGK I mediated regulation of cell function (Firestone et al., 2003). Changes in the 
localization pattern are dependent on both the activating stimulus and tissue specific 
function of SGKI. (Firestone et aI. , 2003). Immunocytochemical staining performed 
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on cells treated with dexamethasone and/or FCS (section 3.4-3 .6) confirmed 
subcellular localization of SGKI in HCO cells to be dependent upon the stimuli 
present. Under standard culture conditions, SGKl appears to be localized to both the 
nucleus and cytoplasm (figure 3.4). Removal of dexan1ethasone (5 x 1O-8M) from the 
growth media and addition of 10% FCS restricted SGKI to the nucleus (figure 3.6). 
Conversely removal of FCS (2%) from the media induced cytosolic localization of 
SGK 1 (figure 3.5) with no nuclear localization. 
Figure 3.4: Immunocytochemical staining of SGK in HCD-cells following 
treatment with FCS (2%) and dexamethasone ( 5 x to-8M) for 24hrs. Panels a, 
and b show nuclear (OAP I, blue) and SGK (Alexa-488 green) staining respectively. 
Figure c depicts an overlay and shows a high degree of co-localization between SGK 
and the nucleus. SGK protein was detected with a polyclonaJ antibody and staining 
was visuali sed using an Alexa 488 conjugated secondary. SGK (b) appears to be 
predominantly localized to the nucleus with diffuse staining throughout the 
cytoplasm. 
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Figure 3.5: Immunocytochemical staining of SGK in HCD-cells following a 24 hr 
incubation in serum free media, supplemented with Dexamethasone 5 x to-8M. 
HCD cells were incubated with DMEMlHAMS F-1 2 (serum free) supplemented with 
dexamethasone 5x 10-8 M fo r 24hrs. Panels a and b show nuclear (OAPI, blue) and 
SGK (Alexa-488 green) staining respecti vely. Panel c depicts an overlay of SGK 
immunolocalization (green), and nuclear staining (OAPI; blue). SGK protein was 
detected with a polyclonal antibody and staining was visualised using an Alexa 488 
conjugated secondary. Removal ofFCS restricted SGK localisation to the cytosol and 
minimised nuclear co-locali sation (panel c) 
Figure 3.6: Immunocytochemical staining of SGK in HCD-cells following a, 24 hr 
incubation with 10% FCS. HCO cells were treated OMEMlHAMS F-1 2 
supplemented with 10% FCS for a period of 24hrs. Panels a and b show nuclear 
(OAPI, blue) and SGK (Alexa-488 green) staining respectively. Panel c depict an 
overlay of SGK localization (green), and nuclear staining (OAPI; blue). SGK protein 
was detected with a polyclonal antibody and staining was visualised using an Alexa 
488 conjugated secondary. Addition of FCS and removal of dexametha one (5 x 10-
gM) localized SGK to the nucleus with minimal cytoplasmic staining (panel c). 
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3.2.4. a-ENaC expression in HCD cells 
RT-PCR and western blotting were used to confirm that a-ENaC subunit was 
expressed at both the mRNA and protein level. 
RT-PCR analysis was performed on three different RNA preparations from HCD 
cells producing PCR products at 601 bp (figure 3.7 A). Western blotting was used to 
confirm that mRNA were appropriately translated. Membranes were probed with an 
anti- a-ENaC polycIonal antibody and ECL detection revealed a strong band at 
approximately 97kDa in three different HCD protein preparations (figure 3.7 B) 
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Figure 3.7: Expression ofa-ENaC mRNA and protein in HCD-cells. 
Panel A represents RT-PCR analyses using primers specific for human a-ENaC. 
PCR products of 601 bp were observed in three RNA preparations (1 , 2 and 3) 
corresponding to mRNA expression for a-ENaC. Western blot analyses of cell HCD 
celllysates (panel B, 5~g protein/lane) using an antibody against a-ENaC confirmed 
the presence of the protein in three protein preparations (1 , 2 and 3). A protein band 
of approximately 97 kDa was detected. 
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Specific ity of the primary antibody was confirmed by blocking a-ENaC antibody 
with an excess of immunising peptide (100 fold excess) at room temperature for 8 
hours and then overnight at 4°C prior to staining the cells for immunocytochemistry 
(figure 3.8). Pre-incubation of the primary a-ENaC antibody with the a-ENaC 
peptide abo li shed any staining 
Figure 3.8: Peptide adsorbed antibody abolished the detection of a-ENaC 
staining by immunocytochemistry. Double staining of RCD cells with an anti- a -
ENaC antibody (panel I.b) and the nuclear stain DAPI (panel l.a) gave rise an 
overlay image (panel l.c) in which co-localization between OAPI and a ENaC was 
observed in the cell nucleus. Pre-incubation of the a-ENaC antibody and peptide was 
found to abolish any visible staining when visualized by fluorescence microscopy 
(panel 2.b) giving rise to an overlay image (panel 2.c) in which only staining of the 
nucleus was apparent. The faint degree of staining observed in panel b is indicative 
of background non specific autofluorescence. 
3.2.5 Localization of the a-ENaC subunit in HCD cells 
The distribution of the a-ENaC subunit in HCD cells under standard culture 
conditions was examined by fluorescence immunocytochemistry. Cells were stained 
with an anti-a ENaC polyclonal antibody (figure 3.9 panel c). Panels a, and b show 
nuclear and cytoskeletal staining respectively whilst panel c, confirms the a-subunit 
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to be predominantly localized to the cytoplasm. Panel d represents an overlay and 
shows that there is no co-localization between a-ENaC and the nuclear stain DAPI. 
The noticable difference in localization of a-ENaC in figure 3.9c as compared to that 
observed in fi gure 3.8b is a consequence of a change in culture conditions. Under 
standard culture conditions a-ENaC appears predominantly cytoplasmic however an 
overnight period of FCS deprivation prior to treatment results in an, a-ENaC which 
is retained in the nucleus. 
Figure 3.9: Immunocytochemical staining of a-ENaC in HCn cells. 
Panels a, and b and c show nuclear (OAPI, blue) cytoskeletal (TRITC phalloidin, red) 
and a-ENaC (Alexa-488 green) staining respectively. a-ENaC (c) appears to be 
predominantly localized to the cytoplasm. An overlay image in panel d shows that 
there is no co-localisation between a-ENaC and the nucleus. 
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3.2.6 ~-ENaC expression in HCD cells 
Having confinned expression of the a subunit, the next stage was to repeat these 
studies for both the P and y subunits. To confinn expression of the p-ENaC subunit 
at the mRNA level; RT-PCR analysis was perfonned on three different RNA 
preparations from HCD cells and gave rise to PCR products at 1000bp (figure 3.10). 
To date, there is no commerciall y available antibody against p-ENaC that works well 
in western blotting. 
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Figure 3.10: Expression of ~-ENaC mRNA in HCD-cells. 
RT-PCR analyses using primers specific for human p-ENaC detected PCR products 
of 1000 bp in three RNA preparations (1 , 2 and 3) corresponding to mRNA 
expression for p-ENaC. 
3.2.7 Localization of the ~-ENaC subunit in HCD cells 
Immunocytochemistry assessed the distribution of p-ENaC in HCD cells. Data 
suggest the localization of the p-ENaC subunit different to that previously observed 
for the a-ENaC subunit (section 3.2.5). Immunocytochemistry confinned the P 
subunit to be predominantly localized to the nucleus with marginal staining in the 
cytoplasm (figure 3.11 c). The slight degree of co-localization observed in panel d 
refl ects an overlap in wavelength emission intensities between the p-ENaC antibody 
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and the TRITC-conjugated phalloidin, confirmed in previous studies m which 
phalloidin was omitted fro m the staining procedure (data not shown). 
Figure 3.11: Immunocytochemical staining of f3-ENaC in Hen cells. Panels a 
and b and c show nuclear (DAPI, blue) cytoskeletal (TRITC phalloidin, red) and ~­
ENaC (Alexa-488 green) staining respectively. ~-ENaC (panel C) appears to be 
predominantly localized to the nucleus. Panel d depicts an overlay and shows co-
localization between the nucleus and ~-ENaC subunit. 
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3.2.8 y-ENaC expression in HCD cells 
xpression of the y subunit at both the mRNA and protein level, were confirmed by 
RT-PCR and westel1l blotting respectively. Panel A of figure 3.12 illustrates y-ENaC 
mRNA expression in 3 di fferent RNA preparations, with PCR products of 696 bp 
obtained in each preparation. Panel B confirms translation of mRNA into protein 
giving ri se to a doublet at approximately 75kDa representative ofy-ENaC. The 
nature of the double band i discussed later in section 3.3 
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Figure 3.12 Expression ofy- ENaC mRNA and protein in HCD-cells. 
Panel A represents RT-PCR analyses using primers specific for human y-ENaC. PCR 
products of 696bp were observed in three RNA preparations (l , 2 and 3) 
corresponding to mRNA expression for the y-ENaC subunit. Westel1l blot analyses 
of HCD cell lysates (panel B, 5~g protein/lane) using an antibody again t human 
y- NaC confirmed the presence of the protein in three protein preparations (1 , 2 and 
3). A doublet of approximately 75 kDa was detected. 
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As a control for specificity, anti-y-ENaC antibody was pre-incubated at room 
temperature for 8 hours and then, overnight at 4°C with a 100 fold excess of 
immunising y-ENaC peptide prior to addition of the antibody to the membrane, all 
other steps in the procedure were identical. Preabsorption of the primary antibody 
completely abolished the signal upon ECL detection (figure 3.13, panel 2) 
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Figure 3.13 Peptide adsorbed antibody abolished y-ENaC protein expression 
detection by western blotting. A doublet of approximately 75kDa (y-ENaC) was 
detected in two different HCD protein preparations (panel I), whilst pre-incubation 
with the peptide abolished any signal upon ECL detection (Panel 2). 
3.2.9 The localization ofy-ENaC subunit in HCn cells 
Localization ofy-ENaC subunit in HCD cells was assessed by immunocytochemistry 
and is similar to that observed for the p-ENaC subunit (section 3.2.7). Figure 
3.14/panel c clearly shows the y subunit appears to be predominantly localized to the 
cell nucleus with diffuse staining throughout the cytoplasm. 
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Figure 3.14: Immunocytcochemical staining of y-ENaC in HCn cells. Panels a, 
and b and c show nuclear (DAPI, blue) cytoskeletal (TRlTC phalloidin red) and y-
ENaC (Alexa-488 green) staining respectively. y-ENaC (panel c) appears to be 
predominantly nuclear. Panel d shows co-localization between the nucleus and 
y NaC. 
3.2.10 Functional expression of EN aC in HCn cells 
Transcellular transport ofNa+ mediated by the ENaC is a 2-step transport process, of 
which ENaC represents the rate-limiting step (Eaton et al. , 1995). Those cells 
expressing the ENaC allow entry of Na + into the cell, whilst a Na +/K+ ATPase 
expressed in the basolateral membrane allows for electrogenic extrusion of Na + in 
exchange for K+. Ouabain and amiloride, antagonists of the Na +/K+ ATPase pump 
and ENaC respectively, will bind to, inhibit and thus prevent influx/efflux of Na + 
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into the cell ultimately raising/lowering [Na+]j levels respectively. Furthermore, 
dexamethasone, a synthetic glucocorticoid, has been previously reported to exert 
stimulatory effects over the ENaC thus raising Na+ as a consequence of increased 
entry across the apical membrane. 
In order to assess changes in Na + transport in HCD cells, single cell micro fluorimetry 
was used to measure changes in cytosolic sodium in response to mediators of ENaC 
function. Cells were loaded with the sodium fluorophore SBF-I and the detergent 
pluronic acid for a period of 90 minutes. Basal readings for [Na+]j were taken, prior 
to and following modulation of the activity of these sodium transporters via 
commercially available agonists arid/or antagonists Cells were pre-incubated for 90 
minutes with either one of the following three drugs or a combination of each; 
ouabain (lOOIlM), dexamethasone (5xI0-8M) and amiloride (1IlM). Incubation with 
one or more of these compounds gave rise to variable [Na+]j levels in HCD cells, the 
results of which are clearly shown in figure 3.15. 
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Figure 3.15: Assessing sodium transport in HCD cells. Panel A represents an 
overview of the results shown in more detail in B-F and illustrates [Na Ji in HCD cells 
under variable conditions and demonstrates that amiloride only marginally inhibits 
[Na +]i levels (E), thus supporting a role for the involvement of ENaC. Both 
dexamethasone (5 x 1O-8M) (B) and ouabain (I OO~M) (C) increase [Na li levels the 
effects of which are additive (D). However, readings obtained for dexamethasone and 
ouabain in the presence of amiloride are lower than those compared to dexamethasone 
and ouabain alone, thus highlighting furthermore the ability of this compound to 
reduce [Na+]i through inhibition of the ENaC. Results represent mean ± SEM. n=6 ** 
P<O.Ol , *** P<O.OOl 
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Incubation of HCD cells with dexamethasone (5x1O-8M), would be expected to raise 
[Na +]i levels as a consequence of increased ENaC open probability, an effect 
mediated by the short tenn effects of aldosterone in vivo (Alvarez de la Rosa et al., 
1999). Whilst dexamethasone (5 xI0-8M) appeared to only partially increase [Na+]i 
levels through its stimulatory effect on the ENaC (figure 3.l5/B) (102 % ± as 
compared to control 100% ± 0.02%), the Na+/K+ ATPase pump inhibitor ouabain 
(100~M) increased [Na+]i levels by 8% (107.8% ± 1.4% n = 6 P< 0.0001) (figure 
3.15/C). However, the effects of these two drugs together evoked the largest increase 
in [Na+]i. Statistical analysis of this microfluorimetric data con finned that [Na+]i 
levels in HCD cells were found to be approximately 20% higher in those cells which 
had been treated with both dexamethasone and ouabain (figure 3.15/D) as compared 
to those cells under control conditions (120% ± 0.16% n = 6 P< 0.01). 
Contrary to this, incubation with the ENaC antagonist amiloride was found to 
attenuate [Na+]i levels (figure 3.15/E) reducing levels by approximately 8% ( 91.7% 
± 0.02% n=6 P<O.OOI). Whilst incubation with ouabain and dexamethasone 
increased [Na+]i levels, co-incubation of these compounds with amiloride attenuated 
this induction(l 05% ± 1.06% n=6 P<O.OI %) (figure 3.15/F ). 
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3.3 Discussion 
The aim of this chapter was to characterise and establish a suitable model for the in 
vitro study of the biology ofNa+ reabsorption. We have confirmed both SGKI and 
ENaC expression in a novel human cortical collecting duct (HCD) cell line, and 
assessed function in response to a series of commercially available agonists and 
antagonists of the apically located ENaC and the basolateral Na+/K+ ATPase. 
RT-PCR and western blot analysis both confirmed SGKI expression at both the 
mRNA and protein level respectively, whilst under standard tissue culture 
conditions, immunocytochemistry localized SGKI predominantly to the cell nucleus 
with diffuse cytoplasmic staining. Variability in SGKI localisation has been 
demonstrated in numerous cell types (Firestone et al., 2003) and is thought to be 
dictated by the nature of the stimuli present. The rationale behind this 
compartmentalisation is explained by the availability and accessibility of this protein 
to its substrate targets, a mode of cellular control which can be clearly explained by 
looking more closely at its varied role within the cell. Recently reported to play a key 
role in intracellular cross talk through which cell surface receptors, nuclear receptors 
and cellular stress pathways all converge to control a wide variety of cellular 
processes (Firestone et al., 2003). 
Two key stimuli known to alter SGKI localisation are glucocorticoids and serum, 
both of which reportedly stimulate the rapid transcription of the SGKI gene through 
direct promoter activity (Firestone et al., 2003). Whilst serum stimulation will induce 
cells to progress through the cell cycle, treatment with glucocorticoids will induce 
stringent growth arrest. Consequently, the localisation of SGKI will switch 
depending upon the requirements of the cell at any given time. In the presence of 
serum, SGKI is thought to shuttle between the nucleus and cytoplasm in synchrony 
with the cell cycle, the transport of which is associated with Sand G2/M phase and 
occurs following its interaction with the nuclear receptor importin-alpha (Firestone et 
al .• 2003), a specific SGKI interacting protein that associates with SGKI through 
nuclear localisation signals in its cargo proteins. This receptor-cargo complex; 
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through interactions with importin-beta is subsequently transported into the nucleus 
(Firestone et al., 2003). In contrast, treatment with glucocorticoids, known to induce 
a G 1 cell cycle arrest, was found to induce an SGKI that becomes localized and 
retained to the cytoplasmic compartment. In agreement with previous studies my 
data indicates that compartmentalisation of SGKl is controlled stringently in a 
stimulus-dependent manner in my cell line. Coupled with the fact that SGKl has a 
short half-life of approximately 20 minutes (McCormick et al., 2005), HCD cells 
appear well equipped to respond appropriately to extracellular cues, enabling quick 
retrieval from the system upon removal of the stimulus. 
Regulated by SGKI, the epithelial sodium channel expressed in the apical membrane 
of the principal cells is comprised of three partly homologous subunits, a, p and y 
that are inserted into the membrane with a proposed stoichiometry of 2a: 1 p: 1 y. 
Expression of all three subunits of the ENaC was confirmed in HCD cells at both the 
mRNA and protein level using RT-PCR and western blot analysis. Lack of 
availability of a suitable p-ENaC antibody for detection via western blotting meant 
that we were unable to confirm p-ENaC protein expression via this method. The 
higher molecular weight band observed on the western blot for y-ENaC is likely to 
reflect important issues of ENaC biology (discussed below) and has been cited 
previously (Knepper et al .• 1999, Neilson et al .• 2001). Whilst the exact reason for 
this higher molecular weight band remains to be elucidated, the 72kDa band is 
thought to correspond to the expected molecular weight based on the open reading 
frame of the cloned y ENaC cDNA (Canes sa et al .• 1994). The higher molecular 
weight band is thought to represent the glycosylated and inactive form of the subunit 
since treatment of cells with PNGase, a compound known to induce deglycosylation 
has been shown to induce a induce a shift in molecular weight from 85kDa to 72kDa 
in rat kidney cells (Knepper et al.. ). Deglycosylation by a GPI serine protease; 
channel activating protease (CAPI) (Rossier et al .• 1997) is thought to cleave in the 
early portion of the extracellular loop, thereby activating the ENaC through increased 
open state probability (Hess et al .• 1998), 
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Immunocytochemistry of each subunit revealed a localisation pattern different to that 
reported previously (Harger H et al., 2001). However, consistent with previous 
findings (Nielson et al., 2001, Loffing J et al., 2000) was a difference in the 
localisation between the a subunit as compared to both p and y. a-ENaC appeared to 
be predominantly perinuclear with some degree of cytoplasmic staining, whilst the p 
and y subunits appeared to be confined to the nucleus with diffuse staining 
throughout the cytoplasm. The physiological significance of the heterogeneity in 
subcellular localisation remains to be established, but does suggest differences in the 
regulation of all three sub units of which could be attributed to a number of factors. 
The a, p and y subunit are synthesised and glycosylated in the endoplasmic 
reticulum. Prior to leaving the golgi, they heteromultimerise and traffic together to 
the cell surface (reviewed in Snyder 2005). However, only the a-subunit is critical to 
formation of a fully functional Na+ channel and only expression of the a-subunit is 
regulated by aldosterone (Masilamani et al., 1999). Increased plasma aldosterone 
levels have been associated with a marked increase in the abundance of a ENaC 
protein in kidneys, whilst exerting no effect on p and y subunit expression. 
Differences in a-subunit localisation may reflect this level of regulation by 
aldosterone in conjunction with the requirement of expression for channel formation. 
Confirmation of both SGKl and ENaC expreSSIOn In the HCD cell line was 
accompanied by the functional data obtained by SBF-lI AM microfluorimetry. The 
ability to measure [Na+]j levels in this cell line, in conjunction with a wide array of 
commercially available antagonists and agonists, enabled for pharmacological 
intervention of both the ENaC and Na +/K+ ATPase. The ability to mimic a 
pathophysiological state may pave way for a clearer understanding of those key 
signalling elements whose level of regulation is subject to compromise under 
conditions of osmotic stress. 
In conclusion, the results from this chapter have demonstrated that the HCD cell line 
represents a physiologically appropriate model in which to study ENaC mediated 
Na+ reabsorption in the human collecting duct. 
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Chapter 4 
SGKl and ENaC: a potential role in the progression and 
development of diabetic nephropathy and renal hypertension 
4.1 Introduction 
In type 2 diabetes mellitus, insulin insensitivity results in fluctuating levels of 
hyperglycaemia, and in extreme cases glycosuria. Previous reports have already 
established the deranged transcriptional regulation of SGK I under conditions of both 
hyperglycaemia and diabetic nephropthy (Kumar et al., 1999, Lang et al., 2000). 
These observations have led to the supposition that SGKI may function as a potential 
candidate in the development of hypertension associated with diabetes. 
The molecular and cellular events that give rise to both structural and functional 
complications of diabetic nephropathy include the release of a number of different 
growth factors and cytokines. Amongst these regulators is Transforming Growth 
Factor Beta (TGF-p 1). With powerful fibrogenic actions resulting from both 
stimulation of matrix synthesis and inhibition of matrix degradation, TGF-p 1 has 
been demonstrated to play a role in the transcriptional control of SGK 1. 
Hyperglycaemic-induced TGF-p 1 formation together with osmotically-driven 
increases in SGKI (Bell et al., 2000, Waldegger et al., 1997, Waldegger et al., 
2000) provide a link between poorly controlled plasma glucose and the development 
of excess ENaC-mediated Na+-resorption that underlies secondary hypertension as 
seen in some diabetics (reviewed in Marshall et al., 2004). 
In addition to these glucose mediated effects on TGF-p I, glucose is also known to 
acutely increase the concentration of intracellular calcium ([Ca2+]i) in rat proximal 
tubular cells (Symonian et al., 1998). Whether these, calcium induced changes evoke 
alterations in both SGKl and ENaC expression in human cortical collecting duct 
(HCD) remains to be elucidated. Consequently, whilst there is considerable evidence 
relating high glucose levels to deranged sodium resorption in the kidney, the 
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mechanisms by which these elements jointly promote the pathophysiological changes 
characteristic of diabetic nephropathy requires further clarification. 
In the chapter, I have used the previously characterised human cortical collecting 
duct (HCD) cell line as a model in vitro system to assess the effect of high glucose, 
TGF-pI and cytosolic Ca2+ on SGKI and ENaC expression. We have correlated 
these changes to single-cell determination of [Na +]i and suggested a potential series 
of events that may explain how deregulated Na + re-uptake may contribute to the 
pathogenesis of secondary hypertension associated with diabetic nephropathy in type 
2 diabetes mellitus. 
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4.2 Results 
4.2.1 Exposure of lieD cells to elevated levels of glucose induces an up-
regulation in SGKl protein expression. 
Previous studies (section 3.2.1) confinned that HCD cells express SGKI at both the 
mRNA and protein level. To test for a role of glucose in SGKI protein expression, 
HCD cells were incubated for 2 days in a low glucose (SmM) medium for 2 days. 
After an overnight period of serum starvation cells were then treated with 25 mM 
glucose for 24 and 48 hours. Cells grown in 25mM glucose exhibited increased 
SGKI expression to 185% ± 18.8% of control (5mM) at 24 hours and to 261.8% ± 
5.71 of control at 48 hours as confinned by densitometric analysis (n=3, P<O.OI, see 
figure 4.1). 
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Figure 4.1: Up-regulation of SGKl protein expression in increased 25mM 
glucose. HCD-cells were incubated in 5mM or 25mM glucose for 24 and 48hours. 
(A) Representative western blot analysis using an anti-SGKI antibody illustrates an 
upregulation in protein expression at both 24 (lane 2) and 48 hours (lane 3) as 
compared to control conditions at 5mM (lane I). (B) Statistical analysis of changes 
in SGKI protein expression. Results represent mean ± SEM; n=4; ** P< 0.01. 
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4.2.2 High glucose induced a change in the localization of SGKl 
Immunocytochemistry was used to assess if alterations in protein expression 
correlated with a change in localization. Under contro l conditions, in which FCS 
been depleted from the culture media, SGKl , as expected, was found solely in the 
cytoplasm (figure 4.2 Al2). Exposure to high glucose altered the localization pattern 
so that SGK 1 became predominantly localized to the nucleus after 48 hours 
incubation in high glucose (figure 4.2 C/2). 
Figure 4.2: Localisation of SGKl following 25mM glucose treatment. 
Immunocytochemistry demonstrated that elevated levels of glucose cause a hift in 
the cellular distribution of SGKl. Under control conditions (row A) and glucose 
treatment at 24 hours (row B) SGKl resides solely in the cytoplasm (panel Al2, B/2 ) 
whilst following gluco e treatment at 48 hours (row C) the localisation of SGKl 
becomes predominantly nuclear (panel C/2). An overlay image (panel C/3) shows 
that at 48 hours co-localisation between SGKl and the nucleus (stained with OAP!). 
124 
4.2.3 Up-regulation of a-ENaC expression in high glucose. 
Having confirmed a stimulatory effect of glucose on SGKI expression, . To test for a 
ro le of glucose in a -ENaC protein expression, HCD cells were incubated for 2 days 
in a low glucose (SmM) medium for 2 days. After an overnight period of serum 
starvation cells were then treated with 25 mM glucose for 24 and 48 hours. Cells 
grown under high glucose conditions exhibited increased a -ENaC expression at both 
24 and 48 hours. This increase in protein expression amounted to 144.4% ± 7.98% 
of control (SmM) at 24 hours and 167.4% ± 11.2% of control at 48 hours (n=4,** 
P<O.O 1, see figure 4.3). 
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Figure 4.3: Up-regulation of a-ENaC protein expression in response to high 
glucose. HCD-cells were incubated in SmM and 2SmM glucose for 24 and 48 hours. 
(A) Representative western blot analysis using an anti-a-ENaC antibody (B) analysis 
of changes in a-ENaC protein expression. Results represent mean ± SEM; n=4; ** 
P< 0.01. 
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4.2.4 a -ENaC localisation appears to change following a 48 hour exposure to 
elevated levels of glucose. 
The localisation of a -ENaC was determined to assess any correlation at 24 and 48 
hours with the increased protein expression levels observed fo llowing exposure to 
elevated levels of glucose. Under control conditions (5mM), (serum free), a -ENaC 
was predominantly localized to the cell nucleus (figure 4.4 A!2). However, fo llowing 
a 48 hour incubation period with high glucose (25 mM), a -ENaC was distributed 
between both the nucleus and cytoplasm (figure 4.4 C/2). 
Figure 4.4: Localisation of a-ENaC following 25mM glucose treatment. 
Immunocytochemistry demonstrated that elevated levels of glucose cause a shift in 
the localisation of a -ENaC. Under control conditions a -ENaC resides solely in the 
nucleus (panel A2) whilst fo llowing glucose treatment for 48 hours the localization 
of a -ENaC becomes both nuclear and cytoplasmic (panel C/2). An overlay image 
(panel C/3) shows co-localization between a -ENaC and the nucleus (stained with 
DAPI). 
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4.2.5 Expression ofTGF-J31 in HCD cells. 
RT-PCR analysis and Western blotting were used to confirm TGF-J31 expression in 
HCD cells. RT-PCR analysis of several RNA preparations from HCD cells revealed 
PCR products representative of TGF-J31 mRNA (figure 4.5A). Protein expression 
was determined by Western blotting (figure 4.5B). Western blot analyses revealed 
bands at approximately 45Da representative of the non-secreted form of TGF -131. 
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Figure 4.5: Expression of TGF-J31 mRNA and protein in HCD-cells. Panel A 
represents RT-PCR analyses using primers specific for human TGF-J3 1. PCR 
products of 340bp were observed in three RNA preparations (1, 2 and 3) 
corresponding to mRNA expression for TGF-J31 in HCD cells. Negative controls 
included water. Western blot analyses of HCD cell lysates (panel B, 5~g 
protein/lane) using an antibody against human TGF-J31 (panel B, lane 2) confirmed 
the presence of the protein in 3 different preparations in HCD cells. A protein band 
of approximately 45kDa was detected. 
As a control for specificity we pre-incubated the primary anti-TGF -131 antibody with 
a 100 fold excess of the TGF-J31 immunising peptide for 8 hours at room temperature 
and then overnight at 4°C prior to addition of the antibody to the membrane, all other 
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steps in the procedure were identical. Competition of the pnmary antibody 
completely abo li shed the signal upon ECL detection (figure 4.6) 
66-
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Figure 4.6: Peptide adsorbed antibody abolished TGF-J31 protein expression 
detection by western blotting. A protein band of approximately 45kDa was 
detected in an HCD protein preparation (panel 1), whilst pre-incubation with the 
peptide abolished any signal upon ECL detection (panel 2). 
4.2.6 Elevated levels of glucose increase expression levels of the non secreted 
form ofTGF-I31 
Previous reports have demonstrated that hyperglycemia is associated with a number 
of raised signaling intermediates, involving the powerful fibrogenetic cytokine TGF-
PI (Hoffman et al. , 1998). Involved in the transcriptional control of GKl, 
hyperglycaemic-induced changes in TGF-p 1 expression implicate this cytokine as a 
possible mediator of the deranged transcriptional regulation of SGKI observed in 
diabetic nephropathy (Lang et al., 2000).To test for a role of glucose in TGF-p 1 
protein expression, HCD cells were incubated for 2 days in a low glucose (5mM) 
medium. After an overnight period of serum starvation cells were then treated with 
25 mM glucose for 24 and 48 hours. I observed a significant increase in TGF-p 1 
(non-secreted form) 187.7% ± 8.4 % at 48 hours as compared to control (100%) 
(figure 4.7). 
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Figure 4.7: Exposure of Hen cells to 25mM glucose induces an upregulation in 
the non-secreted form of TGF -p 1. HCD-cells were incubated in 5mM (lane 1) and 
25mM glucose for 24 (lane 2) and 48 hours (lane 3) (A) Representative Western blot 
analysis using a human anti-TGF-pI antibody (B) analysis of changes in TGF-pl 
protein expression. Results represent mean ± SEM; n=4; ** P< 0.01. 
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4.2.7 TGF-J3I and the calcium ionophore Ionomycin up-regulate SGKl protein 
expression levels over a 24 hour time period 
Previous reports have suggested that raised [Ca2+]j and increased circulating levels of 
the cytokine TGF-J31 play a role in the pathophysiology of hyperglycemia, many 
studies have attributed the upregulaton of SGKI observed upon exposure to elevated 
levels of glucose in various cell types to be linked to TGF-J31 intermediates (Lang et 
al., 2000). 
To assess the effects of TGF-J31 and raised intracellular calcium on the regulation of 
SGKl protein expression, cells were incubated for a 24 hour incubation with either 
TGF-J31 (2ng/ml) or with the Ca2+ ionophore ionomycin (1 J.lM). All treatments were 
performed on cells which had been previously subject to a low glucose treatment (as 
described in section 4.2.7 to negate any stimulatory effects of high glucose and 
serum deprived overnight. 
Treatment of HCD cells with ionomycin (1 J.lM) was found to significantly increase 
SGKl protein expression to 262±6.0% and 263.7±22.8% of control at 6 and 8 hours 
respectively. Expression levels returned to near basal by 24 hours (figure 4.8 A and 
B) (n=4 P<O.OOI). 
The effect of TGF-J31 was found to be less significant than that observed following 
application of ionomycin, with SGKl levels elevated at 8 hours to 128 ± 13.01 % as 
compared to control (figure 4.8 C and D) (n = 4 P < 0.001). 
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Figure 4.8: Treatment of Hen cells with the calcium ionophore ionomycin and the growth factor TGF-J31 results in increased 
SGKl protein expression. HCD cells were incubated with either ionomycin (11-lM) or TGF-J31 (2nm) for incubation periods of 4, 6, 8 12 
and 24 hours. (A and C respectively). Statistical analysis of changes in SGKl protein expression (B and D). Results represent mean ± SEM; 
n=4; ** P< 0.01. 
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4.2.8 Application of TGF-f31 to Hen cells and raised intracellular calcium 
increased, a-ENaC protein expression. 
Treatment of HCD cells with ionomycin (lIlM) resulted in increased a-ENaC protein 
expression levels over a 24 hour incubation period, with expression significantly 
marked to 175±5.5% of control at 6 hours (n=4 P<O.OOI). Whilst expression was 
clearly elevated above basal levels at both 4 (135±1%) and 8 hours (136±7.333%) 
expression was not found to be statistically significant (figure 4.9 A and B). 
Administration ofTGF-pl (2ng/ml) over a 24 hour period was also found to increase 
a-ENaC expression at 6 hours, 159.7 ± 9.8% as compared to control, pointing to a 
role albeit direct or indirect for both [Ca2+]j and TGF-pl in the regulation of SGKl 
and a-ENaC protein expression. (figure 4.9 C and D). 
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Figure 4.9: Treatment of HCD cells with the calcium ionophore ionomycin and the growth factor TGF-p 1 results in increased a.. 
ENaC protein expression.:HCD cells were incubated with either ionomycin (1 j.lM)) or TGF-p 1 (2nm) for incubation periods of 4, 6,8 
12 and 24 hours. (A and C respectively). Statistical analysis of changes in a.-ENaC expression (B and D). Results represent mean ± SEM 
n=4; ** P< 0.01. 
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4.2.9 HCD-cells exposed to 25mM glucose exhibit increased rNa+]i measured by 
Na + microfluorimetry 
To detennine if there was any functional correlation between these increased SGKI 
and ENaC levels and [Na+]i under conditions comparable to hyperglycaemia [NaJi 
was measured in HCD cells which had been cultured under low and high glucose 
conditions. Intracellular sodium levels were found to be significantly elevated 
fo llowing 24 (11 3±1%) and 48 (l1 4±1%) hours exposure to 2S mM glucose, as 
compared to cells cultured in low (SmM) glucose (see fi gure 4.10). This data taken 
in conjunction with that described previously suggest that increases in [Na +]i 
expression in response to high glucose after 48 hours may be mediated via the 
increased expression of both SGKI and a-ENaC. 
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Figure 4.10: Hen cells exposed to elevated levels of glucose exhibit increased 
intracellular sodium levels. HCD cell s were incubated in 5 or 25mM glucose for 24 
and 48 hours. Cells were then pre-incubated with the Na+/K+ ATPAse inhibitor 
ouabain (I OOIlM). Basal levels of intracellular Na + were measured in SBF -l/pluronic 
loaded HCD cell s and variability in [Na Ji between glucose treatment was asse sed. 
Results represent mean ± SEM; n=4 ' ** P< 0.01. 
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4.4 Discussion 
Exposure of renal epithelial cells to changes in osmolality necessitates the initiation 
of cell volume regulatory processes, activation of which serves to restore cell volume 
preserving both integrity and function. Inability to resolve these changes may have 
serious repercussions for sodium transport and the development of secondary 
hypertension associated with renal diseases such as diabetic nephropathy. In the 
current chapter I have investigated the expression of key signalling elements 
involved in Na+ reabsorption under control and high glucose conditions as seen in 
Type 11 diabetes. 
I have confirmed that incubation with glucose, the Ca2+ -ionophore ionomycin and 
the cytokine TGF-p I evoked a time-dependent increase in both SGKJ and aENaC 
protein expression. These molecular changes were correlated to an increase in N a + -
uptake at the single-cell level. These data offer a potential explanation for glucose-
evoked Na+-resorption and the contributory role of SGK) and ENaCs in 
development of secondary hypertension, commonly linked to diabetic nephropathy. 
Hyperglycaemia has been associated with the generation of elevated cytosolic 
calcium in a number of diverse cell types from both animal and human models of 
diabetes (Symonian et al., 1998, Lee et al., 2006, Demerdash et al., 1996). Changes 
in [Ca2+]i instigate and mediate a plethora of cell-specific signal-response cascades 
within cells. Whilst a number of theories concerning the mechanisms by which 
glucose serves to increase [Ca2+]i have been proposed in various cell types 
(Demerdash., 1996, Symonian et al., 1998), the exact nature of these pathways 
responsible for the effect of hyperglycaemia remain unclear. This link between 
hyperglycaemia and raised [Ca2+]i led me to investigate the effect of raised [Ca2+]i 
on expression of signaling elements identified in chapter 3. Direct elevation of 
[Ca2+]i via ionomycin significantly increased SGKJ protein expression after 6-8hrs, 
a finding consistent with previous studies in DAN-G pancreatic tumor cells (Klingel 
et al., 2000). Similarly, glucose-mediated SGKJ transcription in 3T3 mouse 
fibroblasts is reportedly abolished in the presence of the calcium channel blocker 
nifedipine (Lang et al., 2000), further confirming a role for increased [Ca2+]i as a 
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downstream component of the hyperglycaemic induced increase in SGKJ 
expression levels reported previously (Lang et al., 2000) and in this chapter. 
Once inside the cells, the metabolism of glucose can be ascribed to a number of 
pathways, all of which are linked intracellulary (Brownlee et al., 2001). In addition 
to evoking increases in [Ca2+]j, glucose also increases the de novo synthesis of 
diacylglycerol (DAG) eliciting downstream activation of protein kinase C/mitogen 
activated protein kinase (PKC/MAPK) (Whiteside et al., 2000). Diacylglycerol, a 
powerful signalling molecule whose formation stems from glycolytic intermediates, 
is involved in the promotion of those intracellular signalling events relative to the 
pathogenesis of diabetic nephropathy and mediates its effects through the protein 
kinase PKC (LeRoith et al., 2004, Brownlee 2000). The application of PKC 
mimetics to cells accompanied by a subsequent rise in SGKJ transcription has led to 
the supposition that PKC in conjunction with raised [Ca2+]j may regulate 
transcriptional control of SGKJ as downstream components of the hyperglycaemic 
response. 
PKC has emerged as a potential regulator of many aspects of the development and 
progression of diabetic nephropathy and reportedly plays a key role in TGF-p 
expression through its actions on the transcription factor complex AP-I (Weigert et 
al., 2003). TGF-pl, a multi functional cytokine known to be increased in type 2 
diabetics, reportedly mediates the development of renal hypertrophy and excessive 
matrix deposition, implicating this cytokine as a key mediator in the development of 
diabetic nephropathy (Ziyadeh 2000, Sharma et al., 1995, Ricci et al., 2006). Whilst 
the downstream targets of TGF-PJ remain largely elusive, the cell hypertrophy 
observed upon TGF-p 1 upregulation may be in part be regulated by SGKJ since 
TGF-p 1 reportedly alters SGKJ gene transcription (Lang et al., 2000), an effect 
believed to be mediated via p38 MAPK (Bell et al., 2000, Waldegger et al., 2000). 
This further implicates TGF-p I as a component in renal cell hypertrophy, providing 
a link between increased SGKI expression observed following application of PKC 
mimetics. Observed PKC driven increases in SGKJ expression may therefore be 
mediated via TGF-p I. This relationship is supported in the current study by the 
changes in SGKJ expression observed following exogenous application of TGF-p 1 , 
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an effect known to be reduced in the presence of a TGF-p 1 neutralising antibody 
(Lang et al., 2000). The temporal relationship between Ca2+ and TGF-p-evoked 
increases in SGKJ -expression are consistent with previous reports highlighting a 
causative link between these key signalling elements. 
Whilst it is well established that glucose increases the de-novo synthesis of TGF-p 1 
(Di Paolo et al., 1996, Hoffman et al., 1998, Yung et al., 2006) TGF-p 1 has recently 
been reported to increases expression of the insulin-independent glucose transporter 
GLUT 1 (Mogyorosi et al., 1999). The link between GLUT 1 mediated glucose 
uptake and TGF-p 1 may be pivotal to the pathogenesis of diabetic nephropathy, with 
both TGF-p I and GLUTl having demonstrated a mutualistic relationship (Rocco et 
al., 1992), an effect more pronounced under conditions representative of high 
glucose. The glucose stimulated TGF-p I increase of the insulin-independent glucose 
transporter GLUTI (Inoki et al." 1999) in turn leads to enhanced expression ofTGF-
PI (Mogyorosi et al., 1999, Brosius et al., 2005) Consequently, GLUTI-mediated 
increases in TGF-p 1 expression will promote and further exacerbate the rate of 
glucose uptake under conditions of hyperglycaemia, contributing to the pathogenesis 
of diabetic nephropathy. This feed forward build up of TGF-p I may provide the link 
between glucotoxicity and cell dysfunction in diabetic nephropathy, with TGF-p I 
mediating glucose-evoked cellular hypertrophy whilst stimulating extracellular 
matrix biosynthesis, two hallmarks of diabetic renal disease. 
Whilst the transient nature of the TGF-p I-evoked response may reflect glucose 
toxicity associated with exogenous application of high concentrations of the 
cytokine, perforation of the cell membrane by the Ca2+-ionophore is likely to have 
multiple non-specific effects that ultimately impair cell function. These effects may 
offer a potential explanation as to why SGK} expression appears to respond to 
changes in Ca2+ and TGF-p I before elevated glucose, even though Ca2+ and TGF-p I 
are downstream of hyperglycaemia. 
SGKI promotes Na + re-absorption via the epithelial sodium-channel (ENaC). This 
tetrameric channel resides in the cytoplasm; bound to Nedd 4-2, (Snyder et al., 
2002). Phosphorylation of SGK} via a PI3-K dependent pathway facilitates binding 
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of Nedd4.2 to SGKJ thereby dissociating the Nedd 4-2/ENaC complex. This 
dissociation allows for release of the ENaC consequently reducing degradation of the 
ENaCs, facilitating both translocation and insertion into the cell membrane 
(Debenoville et al., 2001). This widely accepted association between SGKJ and 
ENaCs leads me to assume that these glucose-, Ca2+_ and TGF-p-evoked changes in 
aENaC should mimic those already reported for SGKJ, an assumption supported by 
the current study. The net effect of altered ENaC-expression would be an increase in 
Na+-reabsorption. It seems reasonable therefore to assume that any glucose-evoked 
increase in a-ENaC expression may result from reduced degradation, as opposed to 
increased gene transcription. Although at the single-cell level these changes in Na + 
re-uptake are small, across the epithelium, they represent a potential mechanism to 
explain as to how hyperglycaemia may lead to the development of secondary 
hypertension commonly seen in diabetic nephropathy (Marshall et al., 2004). 
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Chapter 5 
TRPV 4-evoked alterations in intracellular calcium levels 
5.1 Introduction 
Prolonged exposure of kidney epithelial cells to changes in both osmolality and fluid 
shear stress has led to a number of suggestions concerning the mechanisms involved 
in both detecting and transducing these stimuli. Most cells are thought to be sensitive 
to both osmotic and mechanical stimulation. Originally linked to mechanosensation 
in vertebrates the transient receptor potential (TRP) cation channel family is a group 
of proteins expressed in a wide variety of cell types and are gated by a broad range of 
ligands (Clapham et al., 1995, Clapham et al., 1995, Vriens et al., 2004). One 
member, TRPV4, is the mammalian homologue of the OSM-9 gene and was first 
discovered in nematodes unable to detect and respond to potentially harmful osmotic 
gradients (Gong et al., 2004). TRPV4 is a Ca2+ permeable channel abundantly 
expressed in the kidney, skin, lung epithelium, vascular endothelium and liver. 
Originally identified as an osmotically activated channel (Strottmann et al., 2000, 
Wissenbach et al., 2000, Liedtke et al., 2000) TRPV4 responds to a wide variety of 
stimuli including mechanical stress, heat, endogenous ligands and synthetic agonists 
such as 4a.-phorbol 12, 13-didecanoate (4a-PDD). 
A reduction of extracellular osmolarity will induce a degree of cell swelling in most 
animal cells. Within minutes of exposure to this hypotonic stress, cells will attempt 
to reduce their cell volume via a regulatory volume decrease (RVD). This hypo-
osmotic induced cell swelling has been linked to a rise in cytosolic calcium in 
various volume-regulating cell types including human bronchial (HBEs) and human 
embryonic kidney cells (HEKs) (Fernandez-Fernandez et al., 2002, Rohloff et al., 
2003, Tine! et al 2002). This rise in [Ca2+]j permits the loss of electrolytes, typically 
K+ and cr through Ca2+ dependent channels with the subsequent loss of osmotically 
obliged water, thereby allowing the cell to restore its volume preserving both 
structure and function. 
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Since stretch evoked activation of the mechanosensitive channel TRPV 4 initiates an 
increase in [Ca2+]i and RVD has been shown to be Ca2+ dependent (Rothstein et al., 
1992, Christensen et al., 1987), the hypotonic activation of TRPV 4, with a 
concomitant rise in [Ca2+k (Becker et al., 2005, Nilius et al., 2004) has implicated 
this Ca2+ permeable cation channel as a possible mediator in cellular osmoreception, 
aiding cell volume recovery via RVD. 
In this chapter, single cells within cell clusters were challenged by physical 
deformation to assess the degree of changes in cytosolic calcium and confirm the 
nature by which this signal was detected. Data supports the hypothesis that cells of 
the human collecting duct express functional receptors for detecting 
mechanical/osmotic stress (TRPV4). I show that TRPV4, like several other TRP 
channels is modulated by both extra and intracellular Ca2+ and in the absence of 
TRPV4, touch evoked stimulation fails to evoke a rise in [Ca2+]i. Taken together 
these data suggest that TRPV 4 may function as an important mediator in aiding cell 
volume recovery, serving to detect and respond accordingly to osmotically induced 
signals by instigating a calcium dependent signal that ultimately restores cell volume. 
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5.2 Results 
5.2.1 Mechanical stimulation of lieD cells evoked a transient increase in [Ca2+]i 
Previous studies suggest that increased extracellular osmolarity; initiates a Ca2+ 
dependent cell volume recovery process otherwise known as a regulatory volume 
decrease (RVD). In the current study touch was used as a surrogate to osmotic stress 
in order to determine the effect of membrane stretch on [Ca2+]j levels in HCD cells. 
HCD cells were loaded with 2.5 /-lM of the Ca2+ fluorophore Fura-2/AM and subject 
to mechanical stimulation with a micro-electrode. Physical stimulation of a single 
HCD cell in culture (Fig 5.1 A) evoked an increase in cytosolic calcium. The 
response was rapid in onset but transient, returning to basal levels even in the 
continued presence of the stimulus. Propagation of this intercellular Ca2+ wave 
(Figure 5.1 B) from the initial point of stimulation through tiers of surrounding cells 
illustrates co-operativity between these HCD cells and is indicative of a high degree 
of cell-cell communication. 
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Figure 5.1: Generation of calcium transients in Hen cells upon touch evoked stimulation. HCD cells were loaded with Fura 2 and 
multiple regions of interest recorded (S.IA). Touch evoked stimulation of an HCD cell within this cluster evoked a transient increase in 
[Ca2+k Panel C demonstrates the rapid spread of a touch-evoked Ca2+ -transient between HCD-cells upon physical perturbation. A single 
cell is mechanically stimulated at ' 0 sec' at subsequent time-intervals (0-9 sec), the Ca2+-signal propagates away from the point of 
stimulation into neighboring cells. The generation of calcium transients and the resultant elevation in [Ca2Ji in each cell is shown in the 
trace in panel B. Data is represented as estimated change in cytosolic calcium (~ [Ca2Ji) recorded as a ratio of 340/380 nm excitation. 
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5.2.2 HCD cells express the mechanoreceptor TRPV4 
Having shown that HCD cells respond to touch by increasing [Ca2+]i' initial studies 
looked to confirm the nature of the receptor responsible for both detection and 
transduction of this mechanically induced signal. RT-PCR (figure 5.2A) and western 
blot analysis (figure 5.2B) confirmed expression of the mechanoreceptor TRPV4 at 
both the mRNA and protein level. 
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Figure 5.2 Expression ofTRPV4 mRNA and protein in HCD-cells. 
Panel A represents RT-PCR analyses using primers specific for human TRPV4. PCR 
products of 618 bp were observed in three different RNA preparations (1, 2 and 3) 
corresponding to mRNA expression for TRPV4. Western blot analyses of HCD cell 
lysates (panel B, 51lg protein/lane) using an antibody against human TRPV4 
confirmed the presence of the protein in 3 different preparations. A protein band of 
approximately 120KDa (TRPV4) was detected. 
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As a control for specificity we pre-incubated the primary anti -TRPV4 antibody with 
with a 100 fo ld excess of immunising TRPV 4 peptide at room temperature for 8 
hours and then overnight at 4°C, all other steps in the procedure were identical. 
Competition of the primary antibody completely abolished the signal upon ECL 
detection (figure 5.3). 
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Figure 5.3 Peptide adsorbed antibody abolished TRPV 4 protein detection by 
western blotting. A protein band of approximately 120kDa was detected in an HCD 
protein preparation (panel 1), whilst pre-incubation with the immunising peptides 
abolished any signal upon ECL detection (panel 2) 
5.2.3 An elevation in cytosolic [Ca2+] in response to touch evoked stimulation 
involves extracellular Ca2+ entry across the plasma membrane 
The generation of this mechanosensitive cytosolic [Ca2li response has previously 
been described in a number of cell types, including airway epithelia (Sanderson et 
al. , 1990), mammary epithelia (Enomoto et al., 1992) and aortic endothelia (Demer 
et al. , 1993) and has been reported to involve both extracellular Ca2+ entry/and or 
Ca2+-release from intracellular stores. 
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Section 5.2.1 illustrated increased [Ca2+]i, in HCD cells upon touch evoked 
stimulation. This increase in [Ca2+k could occur as a direct result of either release 
from intracellular stores, an influx of calcium across the plasma membrane or a 
consequence of both. Consequently, the present study investigated the absolute 
requirement of extracellular Ca2+ on touch-evoked changes in [Ca2+]i. 
To examine the role of Ca2+ -influx in mediating touch evoked changes in [Ca2+li, 
cells were bathed in calcium free media containing the calcium chelator EGT A 
(ImM) and an individual cell was mechanically stimulated (as described in section 
2.8.3). Following stimulation, touch-evoked changes in [Ca2+]i were still observed 
under Ca2+-free conditions, and as expected the signal propagated rapidly throughout 
the cell cluster (Figure 5.4B). Upon removal of extracellular Ca2+ the extent of signal 
propagation was unaltered indicating that in the absence of extracellular calcium 
these cells are still able to respond to osmotic perturbations. However, the basal-to-
peak amplitude of the response was only 35% (Figure 5.4D) of that obtained in the 
presence of extracellular calcium (Figure 5.4 0.21 ± 0.03 as compared to 0.60 ± 0.12 
n = 6 separate experiments for each treatment P< 0.01). 
My finding that exposure to a calcium free solution did not abolish the rise in [Ca 2+]i 
following touch evoked stimulation of an HCD cell indicates that an influx of 
extracellular Ca2+ across the plasma membrane is not solely responsible for the 
generation of this increased [Ca2+k. The contribution of intracellular Ca2+ stores to 
the increase in [Ca2+]i was further assessed by depletion of intracellular calcium 
stores through inhibition of the Ca -ATPase pump in the endoplasmic reticulum with 
thapsigargin (lIlM) (Thastrup et al., 1990). Prior to touch evoked stimulation, HCD 
cells were bathed in Ca2+ free media following a 60 minute pre-incubation with 
Thapsigargin. Cells were then subject to touch evoked stimulation and [Ca2+]i levels 
recorded .. Following the chelation of calcium in the extracellular media and the 
inhibition of the Ca2+-ATPase with thapsigargin, touch evoked stimulation of HCD 
cells failed to evoke a rise in [Ca2+]i (figure 5AC) thus highlighting the importance of 
calcium mobilisation from Thapsigargin sensitive stores in generation of this calcium 
signal. As the figure clearly illustrates, [Ca2+]i transients were completely negated 
following both the removal of extracellular calcium from the extracellular media and 
depletion of intracellular stores. 
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Figure 5.4 Changes in [Ca2+]j evoked by mechanical stimulation involve both intracellular store release and extracellular calcium. Trace 
A is representative of control conditions. Trace B illustrates a reduced basal to peak amplitude of the response observed upon stimulation of 
those cells bathed in a calcium free environment. Trace C represents the response to membrane perturbation upon extracellular Ca2+ removal and 
inhibition of IP3 sensitive stores. Data is represented as estimated change in cytosolic calcium (change in [Ca2J i) recorded as a ratio of 
340/380nm excitation for fura-2. Statistical analysis (D) (n=3 ** P<O.OI *** P <0.001) 
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5.2.4 Knockdown ofTRPV4 expression with siRNA technology 
Touch evoked stimulation of HCD cells evoked a transient increase in [Ci+]i. This 
rapid response instigates the generation of calcium transients throughout 
neighbouring cells, a response thought to be crucial in aiding cell volume recovery 
(Tinel et al., 2002). Responsible for detecting this osmotically induced signal is a 
stretch/mechanically activated receptor in the cell membrane, upon which, exposure 
to changes in osmolarity evokes a series of downstream calcium dependent signalling 
pathways ultimately restoring cell volume thus maintaining blood volume 
homeostasis. TRPV4, originally identified as a mechanoreceptor yet since, been 
shown to be receptive and activated upon exposure to hypotonic stress, led to seeking 
confirmation of expression levels in our collecting duct cell line of this protein. Both 
RT-PCR and western blot analysis confirmed TRPV4 expression. 
The ability of these cells to respond to osmotic perturbation in conjunction with 
TRPV 4 expression, led to the hypothesis that this receptor may be responsible for 
detection and subsequently transduction of an osmotically induced signal in the 
collecting duct cells of the kidney. To test this hypothesis; we employed siRNA 
technology to knock down TRPV4 expression in HCD cells. 
The availability of three different siRNAs (invitrogen) led to initial optimisation in 
determining both the siRNA capable of achieving the greatest knockdown ofTRPV4 
expression and subsequently the concentration (80f.lg, 120f.lg 160f.lg) at which the 
transfection procedure appeared to be the most efficient. HCD cells were transfected 
with individual siRNAs or a combination of all three over a time course of 24, 48, 72 
and 96 hours (figure 5.5). Of the three siRNAs transfected into the cell, siRNA I, 
appeared to give the greatest knockdown in TRPV 4 expression. The percentage 
knockdown was greatest at both 24 and 48 hours and it was found that variability in 
the concentration did not affect knockdown efficacy. Thus for future experiments it 
was decided that cells would be transfected with siRNA 1 (80flg) and for a time 
period of 24 hours. 
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Figure 5.5: Optimisation of TRPV 4 knockdown with siRNA. HCD cells were 
transiently transfected with one of three TRPV 4 siRNAs over a period of 24, 48, 72 
amd 96 hours. The above blot represents TRPV 4 expression post 24 hours 
transfection. siRNA I (lane I) appeared to give the greatest percentage knockdown 
of TRPV 4 expression as compared to control conditions (lane 5). siRNA 2 (lane 2) 
and siRNA 3 (lane 3) appeared to exert little effect over the expression of TRPV4, 
whilst a combination of all three (lane 4) gave a result similar to that observed with 
siRNA 1. Appropriate controls of cells only (lane 5), cells + scrambled DNA (lane 6) 
and cells + lipofectamine (lane 7) were performed. 
Having determined which si RNA was able to achieve the greatest percentage 
reduction in TRPV4 expression, HCD cells were then transfected with siRNA I 
(80llg) for 24 hours in preparation for functional analysis via microfluorimatry 
studies. Cells were seeded onto both 6 well plates and on APES treated coverslips. 
24 hours post transfection, cells were harvested for protein analysis and 
microfluorimetry experiments performed on those cells which had been seeded down 
on coverslips (see section 5.2.6). 
Western blot analysis (figure 5.6A) confirmed that transfection of HCD cells with 
TRPV 4 siRNA 1 resulted in approximately a 40 % reduction in TRPV 4 expression 
(figure 5.6B). 
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Figure 5.6: siRNA Knock-down of TRPV4 expression in Hen cells. Western 
blot analyses of HCD cell Iysates (5f.!g protein/lane) using an antibody against 
human TRPV4 (l20kDa) confirmed siRNA knock-down ofTRPV4 expression in 
lane 4, as compared to control cells (lane 1, untransfected cells; lane 2, cells 
transfected with lipid alone; lane 4, cells transfected with scrambled siRNA). 
Knock-down reduced TRPV4 expression to approximately 65% of control (cells+ 
scrambled) (panel B). Results represent mean ± SEM n=4. 
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5.2.5 TRPV4 knockdown inhibits touch evoked changes in [Ca2+]j 
Transiently transfecting cells with siRNA for TRPV4 significantly reduced TRPV4 
protein expression in HCO-cells to approximately 65 % of control (figure 5.7) as 
confinned by western blot analysis. Studies perfonned by Or Oianne Wheelans in 
which Red Fluorescent Protein and anti-TRPV 4 were co-transfected enabling 
identification of single transfected cells within a cluster of HCD-cells (figure 5.7C 
and 5.7D; representative of 4 separate experiments). Mechanical stimulation of an 
individual anti-TRPV4 cell (RFP-tagged cell-2) failed to significantly elevate [Ca2+]j 
as previously observed under control conditions. However, mechanical stimulation of 
a non-transfected cell, cell-l (figure 5.7B), elicited a rapid increase in [Ca2+]j, (figure 
5.70). Transfection with lipid, RFP alone or scrambled siRNA sequences did not 
alter responses to touch (Experiments performed by Dr Paul Squires). These data 
suggest that knock-down ofTRPV4 expression inhibits the cells ability to both detect 
and respond to osmotically induced signals via a Ca2+ dependent mechanism. 
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Figure 5.7 Knock-down of TRPV4 expression prevents touch-evoked changes in [Ca2+]i. The cell cluster was visualised either as a phase 
image CA,) loaded with fura-2 CB), optimised for RFP CC), and as an overlay of fura-2 fluorescence and RFP (D). Mechanical stimulation of a 
non-transfected cell C cell-I, F) evoked an increase in [Ca2li (trace G). Touch-evoked stimulation failed to significantly elevate [Ca2li in the 
RFP-tagged cell-2. These experiments were performed by Dr Dianne Wheelans and Dr Paul Squires. 
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5.3 Discussion 
To avoid excessive alterations of cell volume, cells have developed and utilised a 
number of volume regulatory mechanisms. These mechanisms adjust cell volume by 
modifying a series of cellular functions, activating either a regulatory volume 
decrease (RVD) or a regulatory volume increase (RVI) (Montrose-Rafizadeh et al., 
1991). The inability to mount an efficient and appropriate RVD or RVI will result in 
either excessive cell shrinkage or cell swelling. The exposure of renal epithelial cells 
for example to changes in osmolarity necessitates the need for the initiation of cell 
volume regulatory processes, activation of which serves to restore cell volume 
preserving both integrity and function of the nephron. 
Expressed in the kidney, the recently cloned transient potential cation channel 
(TRPV4) is gated by changes in extracellular osmolarity or membrane stretch 
(Strottman et al., 2000). These mechanosensitive channels have a role in sodium re-
absorption and regulate cell volume via a Ca2+ dependent mechanism (McCarty et 
al., 1991, Christensen et al., 1987). The inability to resolve changes in osmolarity or 
flow could have serious repercussions to sodium transport and may instigate 
secondary hypertension associated with renal diseases such as diabetic nephropathy. 
The current chapter examined the effect of touch evoked changes on intracellular 
calcium in a human collecting duct (HCD) cell line and assessed the contribution of 
both extra and intracellular calcium in aiding cell volume recovery. I have confirmed 
that cells of the human collecting duct (HCD) express functional TRPV4 
mechanoreceptors, capable of transducing physical stimulation into transient changes 
in cytosolic calcium [Ca2+li. a finding consistent with previous data linking 
membrane stretch in A6 cells to an elevation in [Ca2+]i as part of the regulatory 
response to a decrease in cell volume (Urbach et al., 1999). Touch evoked stimulation 
of HCD cells evoked a transient increase in [Ca2+]j, that propagated into adjacent 
cells. Through RNAi technology and single cell imaging, I have shown that 
transmission of this calcium signal is mediated via gap junctions comprised of the 
protein connexin 43 (Cx-43) (See chapter 6) (Hills et al., 2006a). This 
synchronisation of activity is indicative of a high degree of cell-to-cell 
communication. 
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To fully understand the mechanisms associated with cell volume recovery it is key to 
determine how stimulus-response elements e.g. TRPV4; transduce changes in the 
physical state of the cell into intracellular signals that are able to propagate and 
regulate the function of the entire epithelium. 
A primary function of the kidney is to maintain an osmotic equilibrium during the 
transition from diuresis to antidiuresis when cells become osmotically challenged. 
The response of cells to hypo-osmolality is believed to be a two-step process 
involving detection of increased cell volume via increased membrane stretch, 
accompanied by alterations in intracellular solute content. The end goal is restoration 
of cell volume via initiation of a Ca2+ dependent regulatory volume decrease (RVD). 
(Wong et al., 1986, Christensen et al., 1987, Mccarty et al., 1991, Tinel et al., 2002). 
The degree of cell swelling observed in those cells equipped to regulate their volume 
is accompanied by the subsequent loss of cr and K+ via the coordinated activation of 
cr and K+ channels (Okada et al., 2001). Associated with this hypo-osmotic 
response is a rise in [Ca2+]j, shown in many cell types to be the driving force behind 
increased Ca2+ dependent K+ channel activity (Montroze-Rafizadeh et al., 1991). In 
conjunction with previous data in which cells from the thick ascending loop of Henle 
(TALH) and human cervical cancer cells failed to regulate their cell volume in Ca2+ 
free medium (Shen et al., 2001, Tinel et al., 2002), I can hypothesise that Ca2+ serves 
as a key mediator in regulation of this recovery mechanism. Changes in [Ca2+]i can 
occur via both Ca2+influx and/or Ca2+ mobilisation pathways, both of which have 
been associated with RVD in various cell types. Certain cell types rely solely on 
calcium influx alone, a notion further supported by the cell's inability to avoid steep 
osmotic gradients in the presence of calcium channel blockers nifedipine and 
verapamil (Wong et al., 1986), whilst contrary to these findings other cell types 
reportedly require the release of Ca2+ from intracellular stores (Terreros et al., 1992). 
However, depletion of these intracellular stores can also, through store operated 
calcium entry, induce calcium influx across the plasma membrane resulting in a 
biphasic Ca2+ response in which the early transient phase of store mobilisation is 
maintained via a sustained phase of Ca2+ influx (Tinel H et al., 1994, Tinel H et al., 
1997). 
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The current study provides supporting evidence of a role for TRPV 4 in regulating 
cell volume through a Ca2+ dependent mechanism. Since increases in [Ca2+]j can 
result from entry of Ca2+ from the extracellular space or release of Ca2+ from 
intracellular stores, the present study investigated the absolute requirement of 
extracellular Ca2+ on touch-evoked changes in [Ca2+k 
In the absence of extracellular calcium the basal-to-peak amplitude of touch-evoked 
changes in [Ca2+]j was significantly lower than that evoked by the same stimulus in 
calcium containing conditions. My finding that exposure to a calcium free solution 
did not abolish the [Ca2+]i transient upon membrane perturbation highlighted a role 
for intracellular calcium stores in generation of this response. Previous studies have 
suggested that the rise of [Ca2+]i during cell swelling is a consequence of both 
TRPV4-mediated Ca2+-influx (Liu et al." 2006, Strottman et al.,2003), and Ca2+_ 
induced Ca2+-release (CICR) from thapsigargin-sensitive intracellular stores, 
(Urbach et al., 1999). Current data suggest that although Ca2+ -influx is not essential 
in eliciting a rise in [Ca2+]i' Ca2+-entry potentiates the amplitude of the increase in 
[Ca2+]i' a potential requirement for initiation of a RVD response (Jakab et al., 2002, 
Okada et al., 2001, Rothstein et al., 1992, Urbach et al., 1999). The reduced [Ca2+]i 
response observed in HCD cells in both the absence of extracellular calcium and 
upon inhibition of the ATPase with thapsigargin, highlights a role both plasma 
membrane Ca2+ entry and the release from intracellular stores. Knockdown of 
TRPV 4 via siRNA prevented the generation of touch-evoked changes in [Ca2+]i and 
supports my hypothesis that TRPV 4 is essential in transducing osmotic signals into 
changes in [Ca2+] that stem from both thapsigargin sensitive store release and Ca2+ 
entry across the membrane. 
In conclusion, in the current study, I have shown that touch evoked stimulation of 
TRPV4 channels in HCD cells initiates a rise in cytosolic calcium levels, a 
consequence of both intracellular store release and [Ca2+]i influx. Together these are 
able to instigate an RVD ultimately restoring cell volume. In conditions in which 
there appears to be a deregulation of cell volume regulatory mechanisms, for 
example in end stage renal failure, previously associated with Type 11 diabetes, a 
reduced capacity for detecting alterations in the surrounding osmotic state 
accompanied by diminished cell-to-cell communication may further enhance the 
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damaged status of the cell ultimately contributing to the development of renal 
disease. 
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Chapter 6 
A role for gap junctions in HCD ceU-to-ceU communication 
6.1 Introduction 
Exposure of renal epithelial cells to changes in osmolality initiates cell volume 
regulatory processes, which restore cell volume, preserving both integrity and 
function. In Type 11 diabetic patients presenting with glycosuria, exposure to a 
hypotonic extracellular milieu will induce cell swelling. Compensatory mechanisms 
possessed by the cell ensure that cell volume is restored via instigation of a calcium 
dependent RVD (McCarty et al., 1991). Since the renal tubule is responsible for the 
regulation and control of cellular solute composition, effective reabsorption across 
the renal epithelia is a prerequisite for cell volume constancy and therefore requires 
the collective efforts of cells operating in unison. 
In chapter 5 touch evoked stimulation was employed as a surrogate form of osmotic 
stress and single cells within cell clusters were challenged by physical deformation to 
assess the degree of change in cytosolic calcium. Touch evoked stimulation was 
found to induce a transient increase in [Ca2+]j through the mechanoreceptor TRPV4. 
However, in the continued presence of the stimulus, a high degree of co-operativity 
between these cells was illustrated via transmission of the calcium signal away from 
the original discrete point of contact throughout the cell cluster. This suggests a 
possible role for gap junctions in mediating transmission. Gap junctions facilitate 
intercellular communication allowing for the transfer of ions and small molecules 
such as Ca2+ and nucleotides between coupled cells (Goodenough et al., 1996). Cell-
to-cell communication of this type ensures the integration of metabolic and 
physiological activities allowing for adaption of function to match the immediate 
needs of cells within a cluster (Haefliger et al., 2004). In this chapter I assess the 
role of Cx-43 mediated gap-junctions in the transfer of touch-evoked Ca2+ -waves 
between HCD cells. 
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6.2 Results 
6.2.1 Expression of connexins in Hen cells. 
My former suggestion that propagation of a touch-evoked Ca2+ dependent signal is 
consistent with previously reported high levels of connexin expression in renal 
epithelia. RT -PCR analysis confirmed expression of Cx-26, Cx-31, Cx-31.1, and Cx-
40 at the mRNA level in HCD cells (figure 6.1) 
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Figure 6.1: RT-PCR analysis of connexins in HCD cells. Panels, A B, C and D 
represent RT-PCR analyses using primers specific for human Cx-26 Cx-31 , Cx-31.1 
and Cx-40 respectively. PCR products were observed in three different RNA 
preparations (1, 2 and 3) corresponding to mRNA expression for each connexin. A 
negative control was performed with water. 
6.2.2 HCD cells express the gap junction protein Cx-43 
Cx-43 has been reported as showing predominant expression levels in the collecting 
duct (Guo et aI. , 1998). Studies confirmed the presence of Cx-43 mRNA and protein 
in HCD cells. RT-PCR analysis of several RNA preparations from HCD cells 
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revealed PCR products representative of Cx-43 mRNA (figure 6.2A) giving rise to a 
band at 597bp. Protein expression was determined by Western blotting (figure 6.2B). 
Western blot analyses revealed a band at approximately 43kDa representative of that 
expected for Cx-43. 
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Figure 6.2: Expression of Cx-43 mRNA and protein in HCD-cells. Panel A 
represents RT-PCR analyses using primers specific for human Cx-43. PCR products 
were observed in three different RNA preparations (1, 2 and 3) corresponding to 
mRNA expression for Cx-43. Western blot analyses (panel B) of HCD cell Iysates 
(51-lg protein/lane) using an antibody against human Cx-43 confirmed the presence of 
the Cx-43 protein in three different protein preparations (1 ,2 and 3). A protein band 
of approximately 43kDa was detected. 
As a control for specificity I pre-incubated the primary anti-Cx-43 antibody with the 
Cx-43 immunizing peptide prior to addition of the antibody to the membrane, all 
other steps in the procedure were identical. Competition of the primary antibody 
completely abolished the signal upon EeL detection (figure 6.3). 
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Figure 6.3 Expression of Cx-43 protein in HCD-cells. Western blot analyses of 
HCD cell lysates (lane 2, 5~g protein/lane) using an antibody against human Cx-43 
confirmed the presence of the protein giving rise to a protein band of approximately 
43kDa. The control included Cx-43 antibody pre-absorbed with a lOO-fold excess of 
immunising peptide (lane 2). 
6.2.3 The localization of Cx-43 in HeD cells 
The distribution of Cx-43 in HCD cells was examined by immunocytochemistry 
(figure 6.4). Immunofluorescence staining with a polyclonal antibody against Cx-43 
confirmed that Cx-43 protein expression was localized to the cell membrane with 
intense perinuclear staining as represented in overlay image (panel c). 
Figure 6.4: Immunocytochemical staining of Cx-43 in HCD-cells. HCD cells 
were stained with a polyclonal antibody against human Cx-43. Panels A and B show 
nuclear (DAPI, blue) and Cx-43 (Alexa-488 green) staining respectively. Panel C 
depicts an overlay of Cx-43 immunolocalization (green) and nuclear staining (blue). 
Note the intense Cx-43 staining at the cell periphery. 
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6.2.4 Touch evoked changes in cytosolic calcium in HCD cells. 
There are numerous reports that mechanical stimulation of a single cell within a cell 
cluster results in a propagated increase in [Ca2+]j that spreads via gap junctions 
through several tiers of surrounding cells (Sanderson et al., 1994). In chapter 5 touch 
evoked stimulation was employed as a surrogate form of osmotic stress to determine 
the effect on [Ca2+]j. Physical stimulation of a single HCD cell evoked an increase in 
cytosolic calcium (Section 5.2.1). Transmission of this touch evoked [Ca2+]j signal 
away from the point of stimulation led to the supposition that gap junctions may play 
a role in cell-to-cell communication between HCD cells and may therefore mediate 
transmission of this touch evoked Ca2+ signal. Having established that HCD cells 
exhibit high basal levels of connexin expression (section 6.2.1), function was 
assessed via Ca2+ micro fluorimetry. I examined the effect of touch evoked 
stimulation on the propagation of touch-evoked Ca2+ -signals in the presence and 
absence of the gap junction uncoupler heptanol. As previously observed, touch 
evoked stimulation under control conditions evoked a transient increase in [Ca2+]j 
(figure 6.3 A and B) which propogates throughout the cell cluster. In the presence of 
the gap junction uncoupler heptanol (ImM) physical stimulation of an individual 
HCD-cell evoked a transient increase in cytosolic calcium. However, this signal 
failed to propagate to neighbouring cells (figure 6.3 C and D) supporting our 
hypothesis that functional gap junctions are a requirement in mediating transmission 
of this touch evoked Ca2+ - signal. 
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Fi~ure 6.5: Changes in [Ca2+h in HCD-cells evoked by mechanical stimulation. Panel A demonstrates the rapid spread of a touch-evoked 
Ca +-transient within a 16 cell cluster of HCD-cells. A single cell is mechanically stimulated at 0 seconds. The evoked Ca2+-signal propagates 
away from the point of stimulation into adjacent cells (3 , 6 and 9 seconds). Elevation in [Ca2+]i in each cell is shown in panel B. Panel C shows 
data from a similar experiment in a cluster of 8 HCD-cells following application of the gap-junctional uncoupler heptanol. Note that over a 
similar time-course (0-9 seconds) touch-evoked changes in [Ca2+]i no longer propagate into adjacent cells. These data are confirmed in panel D, 
which shows the lack of a Ca2+ -response in all cells except that cell directly stimulated by mechanical stress. Data is represented as estimated 
change in cytosolic calcium (change in [Ca2+]i) recorded as a ratio of 340/380nm excitation for fura-2/AM. Results are representative of 5 
separate experiments. 
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6.2.5 Dye transfer between cells. 
To further determine the role of gap-junctions in cell-to-cell communication within 
my model , Lucifer yellow was injected into an individual HCD-cell and dye spread 
within the cell cluster was monitored. As seen in figure 6.5 (upper panel), within 
3minutes Lucifer yellow had permeated away from the site of injection into coupled 
cells. Application of the gap-junctional uncoupler heptanol (lmM; lower panel) 
prevented any dye spread between neighbouring cells. Data repre entative of 3 
separate experiments. 
Figure 6.6: Lucifer yellow dye transfer between Hen cells. 
The transfer of Lucifer yellow suggests direct cell-to-cell communication between 
coupled HCD-cells. The monochrome plates illustrate phase images of HCD-cell 
clusters. The fluorescence (fluorescein) image of the same cell clusters following 
single-cell injection with Lucifer yellow is shown at 0 minutes (upper and lower 
panels). The same field of view is recorded 3 minutes after injection of the dye either 
in the absence (3 minutes, upper panel) or pre ence (3 minutes, lower panel) of 
heptanol (lmM). Note: dye spread into neighbouring cells is only seen in the absence 
of the gap-junctional uncoupler. 
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6.2.6 Optimisation of siRNA knockdown of Cx-43 in HCn cells 
To confirm a role for Cx-43 in mediating signal transmission, RNAi technology was 
employed. HCD cells were transfected with Cx-43 siRNA (Santa Cruz). Conditions 
were optimised for both RNA and lipofectamine content and efficiency of Cx-43 
knockdown monitored over 24, 48, 72 and 96 hours. To determine transfection 
efficiency, cells were also transfected with a scrambled RNA conjugated to a 
fluorescein dye enabling us to visualise and determine percentage DNA uptake into 
the cell (figure 6.7). Fluorescence microscopy confirmed a transfection rate of 
approximately 70%. 
Figure 6.7 Transfection of HCn cells with fluorescein conjugated scrambled 
siRNA. Cells were transfected with scrambled siRNA conjugated to fluorescein, 
Panel A represents a phase image of an HCD cell cluster (x 100), whilst panel B and 
panel C represent the positive cells. Transfection visualised at xl 00 and x20 
magnification respectively. 
Having optimised for siRNA (80J..lg) and Lipofectamine (4J..lI) (see chapter 5), a series 
of time course studies were devised in which cells were transfected over a 24, 48, 72 
and 96 hours. Appropriate controls were set up in which cells were left either 
untreated or incubated with the transfection reagent alone, to ensure that any gene 
knockdown was a direct result of RNA inhibition as opposed to an artefact of the 
transfection procedure. Western blot analysis (figure 6.8) confirmed successful Cx-
43 knockdown following siRNA transfection at 24, 48 hrs, 72 and 96 hours. 24 hours 
post transfection was used for the following experiments. 
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Figure 6.8 siRNA knockdown of Cx-43 in HCn cells. Cells were transfected with 
Cx-43 siRNA for 24, 48, 72 and 96 hours. Cells were harvested and western blot 
anaylsis used to determine the level of protein knockdown in my cells. Cx-43 
protein expression was successfully knocked down at 24 and 48 hours (panel A lane 
3) and 72 and 96 hours (panel B lane 3). Lane 1 is representative of untreated HCD 
cells. Lane 2 represents cells post-incubation with lipofectamine. Lane 3 represents 
siRNA transfected cells. 
6.2.7 siRNA knockdown ofCx-43 in HCn cells 
Cells were transfected with a mix of siRNA (80llg) and lipofectamine (41l1) and left 
for 24 hours. Controls were set up of untreated cells, cells incubated with transfection 
reagent alone and cells transfected with scrambled siRNA. 
Western blot analyses of HCD cell lysates (figure 6.9A) confirmed siRNA knock-
down of Cx-43 expression (lane 3) as compared to cells under control conditions. 
Densitometric analysis confirmed approximately a 50% reduction in expression as 
compared to control conditions (cells + scrambled siRNA) (figure 6.9B) 
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Figure 6.9 Knockdown of Cx-43 expression: In panel A western blot analyses of 
HCD celllysates (5)lg protein/lane) using an antibody against human Cx-43 (43kDa) 
confirmed siRNA knock-down ofCx-43 expression in lane 3, as compared to control 
cells (lane 1, untransfected cells; lane 2, cells transfected with lipid alone; lane 4, 
cells transfected with scrambled siRNA). Knock-down reduced Cx-43 expression to 
approximately 50% of control (cells + scrambled) (B). Results represent mean ± 
SEM; n=3; *** P< 0.001. 
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6.2.8 Cx-43 siRNA knockdown 
6.2.8.1 Knock-down of Cx-43 expression prevents cell-to-cell communication 
Following optimization of transfection procedure, RCD cells were transfected as 
described in section 6.2.6 with either control (scrambled) siRNA or Cx-43 siRNA. 
Cell s were then micro injected with membrane impenneant Lucifer yellow. Whilst 
Lucifer yellow spread from the point of injection throughout the cell cluster with 
scrambled siRNA, dye transfer was prevented in those cells transfected with Cx-43 
siRNA (figure 6.10). 
Figure 6.10: Lucifer yellow dye transfer between transfected HCn cells. The 
transfer of Lucifer yellow suggests direct cell-to-cell communication between 
coupled RCO-cells. The monochrome plates illustrate phase images of RCD-cell 
clusters. The fluorescence image of the same cell clusters following single-cell 
injection with Lucifer yellow is shown at 0 min. The same field of view is recorded 
three minutes after injection of the dye RCO cells transfected with scrambled siRNA 
(C), or in Cx-43 knockdown HCD cells (D). Note; dye spread into neighbouring 
cells is only seen scrambled siRNA cell clusters. 
In conjunction with these experiments, mechanical stimulation of an individual cell 
within a cluster of anti-Cx-43 transfected RCD-cells evoked a transient increase in 
cytosolic Ca2+ that failed to propagate into neighbouring cells (figure 6.11B). A 
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similar experiment using scrambled DNA (figure 6.11A) failed to negate cell-to-cell 
communication ofCa2+-signals between coupled HCD-cells. 
Two further controls were performed on untreated cells (figure 6.12A) and cells pre-
incubated with transfection reagent (figure 6.128). As expected, touch evoked 
stimulation evoked a transient increase in intracellular calcium at the discrete point 
of contact and subsequently propagated throughout adjacent cells in the cluster. 
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Figure 6.11 Knock-down of Cx-43 expression prevented intercellular communication of touch-evoked changes in [Ca2+h. Mechanical 
stimulation of an individual cell transfected with scrambled siRNA evoked a transient increase in cytosolic Ca2+ that propagated into 
neighbouring cells CA). A similar experiment using Cx-43 siRNA (B) evoked a transient increase in cytosolic Ca2+. Failure of this signal to 
propogate between coupled HCD-cells suggests that knock-down ofCx-43 expression reduces cell-to-cell communication in HCD-cells. NB . 
..t.. denotes point of mechanical stimulation. 
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Figure 6.12 Signal transmission upon touch evoked stimulation is unaltered in cells treated with transfection reagent. Mechanical 
stimulation of an individual cell within a cluster of HCD-cells evoked a transient increase in cytosolic Ca2+ that propagated into 
neighbouring cells CA). Touch evoked stimulation ofHCD cells which has been treated with transfection reagent lipofectamine evoked a 
similar response, confirming that lipofectamine has no effect on Ca2+ signalling CB). 
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6.2.8.2 Knockdown of Cx-43 in H CD cells following co-transfection with 
anti-Cx-43 siRNA and Red Fluorescent Protein (RFP) using the siLentGene 
U6 Cassette RNA Interference System. 
In a series of supporting experiments perfonned by Dr Dianne Wheelans, the U6 
strike cassette system was employed (Hills et al., 2006a). Co-transfection with 
red fluorescent protein (RFP) and anti-Cx-43 enabled identification of single 
transfected cells within a cluster of H CD-cells (figure 6.13). Mechanical 
stimulation of a non-transfected cell (cell-I, panel A) evoked an increase in 
[Ca2+]j that propagated between other, non-transfected, coupled cells (figure 6.13 
trace A). The touch-evoked signal failed to significantly elevate [Ca2+]j in the 
transfected cell (RFP-tagged cell-2 panel B). However, mechanical stimulation 
of cell-2 elicited a rapid increase in [Ca2+]j, (figure 6.13 trace B) indicating that 
Cx-43 knock-down, did not interfere with the cell's ability to respond to touch. 
Transfection with scrambled siRNA (figure 6.14) did not alter responses to touch. 
These data further confinn that knock-down of Cx-43 expression reduced cell-to-
cell communication in HCD-cells. 
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Figure 6.13. Knock-down of Cx-43 expression prevents intercellular communication of touch-evoked changes in [Ca2+]i. The cell cluster 
was visualised either as a phase image (A,) loaded with fura-2 (B), optimised for RFP (C), apd as an overlay of fura-2 fluorescence and RFP (D). 
Mechanical stimulation of a non-transfected cell (cell-I , F) evoked an increase in [Ca2Ji that propagated between other, non-transfected, coupled 
cells (trace A). The touch-evoked signal failed to significantly elevate [Ca2Ji in the RFP-tagged cell-2. To confmn cell viability the micro-
electrode was repositioned to stimulate transfected cell-2 (0). Mechanical stimulation of cell-2 elicited a rapid increase in [Ca2Ji, (trace B). 
These experiments were performed by Dr Dianne Wheelans and Dr Paul Squires. (Hills et al., 2006a) 
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Figure 6.14 Transfection of HeD cells with scambled siRNA fails to negate touch evoked generation of an intracellular calcium signal: 
The cell cluster was visualised either as a phase image (A,) loaded with fura-2 (B), optimised for RFP (C), and as an overlay of fura-2 
fluorescence and RFP (D). Mechanical stimulation of a transfected cell (cell-I , F) evoked an increase in [Ca2Ji that propagated between other, 
non-transfected, coupled cells (trace A). These experiments were performed by Dr Dianne Wheelans and Dr Paul Squires (Hills et al 2006a). 
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6.2.9 Cell-to-cell communication in Hen cells is not mediated via paracrine 
release of A TP 
The generation of calcium transients upon mechanical stimulation of the cell 
membrane has been linked to one of two pathways. Whilst the first pathway involves 
transmission of a secondary messenger, either Ca2+ or Ins (1,4,5) P3 through gap 
junctions (Enomoto et al., 1992), the second pathway involves the release of A TP 
into the extracellular medium (Cotrina et a/., 1998). Through its paracrine activities 
A TP is able to act on its corresponding P2 purinergic receptors expressed on the cell 
membrane, subsequently eliciting a rise in [Ca2+]j (Bidet M et aI., 2000). 
To examine the role of purinergic-receptors in intercellular communication, I 
repeated the touch evoked calcium studies in the presence/absence of suramin, an 
established blanket purinoreceptor antagonist. Application of suramin (50IlM; a 
concentration known to block P2 purinergic receptors (Hauge-Evans et al., 2002) 
failed to negate touch evoked changes in intracellular calcium (figure 6.15) 
suggesting that cell-to-cell communication was independent of A TP mediated 
paracrine mechanisms. A bolus of A TP demonstrated the expression of functional 
purinergic receptors. Transmission of the touch evoked signal in the presence of 
suramin in conjunction with the siRNA knock down studies would suggest that 
whilst contributory effects of A TP to signal transmission cannot be dismissed, gap 
junctions appear to play the predominant role in cell-to-cell communication of those 
cells in the collecting duct. 
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Figure 6.15: Suramin has no effect on touch-evoked changes in [Ca2+]j in HCD-
cells. In the top panel cells were pre-incubated with the P2 purinergic receptor 
antagonist suramin (50~M) for 20min. Cells were then transferred to the microscope 
where fresh suramin was applied. A TP (50~M final bath concentration) was applied 
as a single bolus. There was no discernable change in cytosolic Ca2+. Subsequent 
touch-evoked changes were obtained in the continued presence of suramin.(n=3). In 
a separate series of experiments ATP alone (50~M bolus; bottom panel) evoked a 
rapid, transient increase in [Ca2+]j (n=3). The data indicate that HCD-cells express 
functional P2-purinergic receptors, but that these are not responsible for mediating 
touch-evoked changes in [Ca2+Ji, 
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6.3 Discussion 
Intracellular calcium is critical in cell volume regulation and cell-to-cell 
communication. My results demonstrated that touch evoked stimulation of an HCD 
cell evoked an increase in intracellular calcium that propagated as an intercellular 
calcium wave throughout the cluster. These observations suggested a high degree of 
cell-to-cell communication and implicated a possible role for gap junctions in 
mediating signal transmission. 
In the current chapter the distribution and expression of the gap junction protein Cx-
43 was examined. HCD cells express Cx-43 at both the mRNA and protein level. Cx-
43 immunoreactivity was localized to both the perinuclear and membrane region of 
HCD cells. Uuncoupling of gap-junctions, using heptanol, attenuated the transfer of 
Ca2+ signals and Lucifer yellow dye transfer between cells. These data suggest a high 
degree of organisation between cells of the human collecting duct, which is in part 
mediated via the direct transfer of information through Cx-43 mediated gap 
junctions. 
Generation of a calcium wave following mechanical stimulation has been reported 
previously in various cell types including airway epithelia (Sanderson et al., 1990), 
mammary epithelia (Enomoto et al., 1992), glial cells, (Charles et al., 1993) and 
aortic endothelia (Demer et al., 1993). Two models have been proposed by which 
these intercellular calcium waves may be transmitted. Firstly, either inositol 
triphosphate and/or calcium diffusion between adjacent cells via gap junctions 
mediated propogation (Sanderson et al., 1990, Boitano et al., 1992). In conjunction 
with my previous findings (chapter 5), there are numerous reports of mechanical 
stimulation evoking a rise in [Ca2+]j as a direct consequence of both Ca2+ release 
from intracellular stores and the influx of extracellular Ca2+ through mechanically-
activated channels. Propagation of this mechanically induced signal has subsequently 
been shown by to be mediated via gap junctions (Churchill et al., 1996). The 
alternative model suggests that a local diffusable synchroniser could mediate co-
operativity between cells via a paracrine route. It is well documented that mechanical 
stress not only elicits a rise in [Ca2+]j (Sachs et al., 1992) but can also result in the 
release of ATP. A number of studies have suggested that ATP can be released 
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through hemichannels into the extracellular space (Cotrina et al 1998) and previous 
reports in isolated basophilic leukaemic cells and hepatocytes have reported 
propogation of this ATP calcium evoked signal. Unlike the intracellular mode 
therefore which relies on gap junctions to pass Ca2+ and/or Ins (1,4,5) P3 from cell to 
cell as a means of communication, the extracellular mode of cell-to-cell 
communication involves the release of ATP; which subsequently acts as a secondary 
messenger diffusing to (Hoyle, 1999). 
Lucifer yellow and microfluorimetry studies in the presence of the gap junction 
uncoupler heptanol further support my hypothesis that signal transmission in HCD 
cells is mediated via gap junctions. Further clarification as to whether a gap junction 
or P2 receptor mediated pathway contributed to the transmission of calcium waves 
was assessed by RNAi technology. In HCD cells transfected with anti-Cx-43 
siRNA, touch evoked stimulation evoked a transient increase in [Ca2+]j that failed to 
propagate and Cx-43 knock down attenuated Lucifer yeIlow dye transfer suggesting 
that Cx-43 comprised gap junctions represent the predominant means by which HCD 
cells communicate. However, since connexins have been shown to be directly 
involved in controlling the release of ATP (Cotrina et al., 1998), knockdown of Cx-
43 expression may negate this response, thus whilst confirming a role for gap 
junctions in signal transmission they prevent us from a direct assessment of whether 
signal transmission is a direct result of A TP release from the hemichannels as 
opposed to direct transfer of signalling intermediates through gap junctions. To 
further support my data and eliminate a role for ATP and thus the extracellular route 
as the predominant pathway in enabling transmission of an osmotically induced 
signal in HCD cells, micro fluorimetry was performed on HCD cells in which a bolus 
of A TP had been administered post pre-incubation with the P2 receptor blocker 
suramin. As expected, in the presence of suramin, the addition of A TP failed to 
evoke a calcium response due to P2 receptor inhibition. However, upon touch evoked 
stimulation in the presence of suramin, the efficacy and velocity of mechanically 
evoked calcium waves were unaltered, indicating an alternative mechanism by which 
these cells are able to communicate. The data presented in this chapter suggest that 
whilst a possible contribution to signal transmission via the paracrine activities of 
A TP should not be dismissed, gap junctions through an intracellular messenger such 
as Ca2+ or Ins (1,4,5) P3 appear to form the predominant means by which HCD cells 
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are able to co-ordinate their activity. Although HCD cells express several members 
of the connexin family (section 6.2.1), failure of touch evoked stimulation in a Cx-43 
siRNA transfected cell to generate a signal which propagates throughout, indicates 
that these other connexins are unable to compensate in such situations in which Cx-
43 may become redundant. 
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Chapter 7 
Glucose-evoked alterations in connexin-43-mediated cell-to-cell 
communication 
7.1 Introduction 
Gap junctions play an important role in cell-to-cell communication, allowing for the 
transfer of both small ions and molecules between adjacent cells. Cell-to-cell 
coupling allows surrounding cells to lock into a particular frequency of cellular 
activity, ensuring a simultaneous response across the epithelial layer. The co-
ordination of cellular activity via cell-to-cell coupling is a pre-requisite for the 
maintenance of cell homeostasis. In the kidney, efficient and appropriate re-
absorption of sodium within the cortical collecting duct (CC D) depends upon an 
integrated response of the entire epithelium. If compromised, the consequences are 
severe, with dramatic repercussions for both cell volume homeostasis and 
functionality of the nephron. The loss of compensatory mechanisms, there to protect 
from renal damage may result in overt complications associated with diabetic 
nephropathy and end stage renal disease (ESRD). Injury or loss in number of visceral 
epithelial cells of the renal glomeruli (podocytes) as a consequence of 
glomerulosclerosis or renal disease results in increased Cx-43 expression in rats 
(Yaoita et al., 2002). This up-regulation of Cx-43 expression is also seen in 
inflammatory renal disease (Hilliis et al., 1997) and in the kidneys of hypertensive 
rats (Haefliger et al., 2001). However, compensatory renal growth in mice has been 
associated with a transient decrease in gap-junction expression and cell-to-cell 
communication (Li et al., 2002). Cell-to-cell communication within retinal micro-
vessels is reduced in streptozotocin-induced diabetic rats (Oku et al.; 2001), a 
situation also observed in vascular cells (Inoguchi et al., 2001) and bovine aortic 
endothelial cells in response to elevated glucose (Inoguchi et al.; 1995, Kuroki et al.; 
1998). These changes in connexin expression may have important repercussions for 
macro-vascular dysfunction seen in diabetes such as macro angiopathy, whilst the 
glucose-dependent down-regulation of Cx-43 protein expression and gap-junctional 
mediated intercellular communication between bovine retinal pericytes (Li et al., 
2003), endothelial cells (Femandes et al., 2004) and rat retinal epithelial cells 
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(Gomes et al.; 2003) indicates a role in micro-vascular complications such as 
diabetic retinopathy. 
In the current chapter I have assessed the effect of high glucose on both Cx-43 
expression and Cx-43 mediated cell-to-cell coupling. 
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7.2 Results 
7.2.1 Up-regulation of Cx-43mRNA and protein expression in response to high 
glucose. 
Previous studies in bovine retinal cells (Fernandes et al., 2004) and rat 
microvascular endothelial cells (Sato et al 2002) have shown that intercellular 
communication may be reduced under conditions of high glucose. This reduced level 
of gap junctional intercellular communication (OJIC) has been linked to decreased 
levels of Cx-43 expression in various cell types (lnoguchi et al., 2001, Kuroki et al., 
1998). In chapter 6 (section 6.2.1), I confirmed that HCD cells express Cx-43 at both 
the mRNA and protein level. In this chapter I have examined the effect of glucose on 
Cx-43 expression and function. To test for a role of glucose in Cx-43 expression, 
HCD cells were incubated in a low glucose (5mM) medium for 2 days. After an 
overnight period of serum starvation cells were then treated with 25 mM glucose for 
24 and 48 hours. RT-PCR analysis demonstrated cells grown in high glucose 
medium had significantly increased Cx-43 expression at the RNA level at both 24 
hours and 48 hours (figure 7.1, 146.2 % ± 8.49 % as compared to 48 hours at 186.8 
% ± 7.8%). 
Western blot analysis confirmed that cells grown in high glucose medium exhibited 
increased Cx-43 protein expression at both 24 (175.2 % ± 15.2 %) and 48 hours 
(234 % ± 12.7 %) of control (5mM) at 48 hours (figure 7.2). 
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Figure 7.1 Effect of high glucose on Cx-43 mRNA expression. HCD cell were 
incubated in 5mM (low glucose) or 25mM (high glucose) glucose for period of 24 
and 48 hours. Representative RT-PCR anaJysis (A) products were obtained at 596bp 
fom cells which had been treated with high glucose for periods of 24 (lane 2) and 48 
hours (lane 3). (B) Statistical analysis confirmed mRNA expression was increased at 
both 24 and 48 hours. Results represent mean ± SEM; n=3; * P<0.05 , ** P< 0.01. 
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Figure 7.2: Effect of high glucose on Cx-43 protein expression. HCO-cell were 
incubated in 5mM and 25mM glucose for 24 and 48 hour. (A) Representative 
western blot analysis using an anti-Cx-43 antibody illustrated an upregulation in 
protein expression at both 24 (lane 2) and 48 hours (lane 3) as compared to control 
conditions at 5mM (lane 1). (8) Statistical analysis of changes in Cx-43 protein 
expression. Results represent mean ± SEM; n=4; ** P< 0.01. 
To control for glucose induced osmotic alterations, HCO cells were incubated in 
mannitol (20mM). After 48 hours mannitol was found to increase Cx-43 expression 
by only 29% of the glucose evoked change seen under identical experimental 
conditions (figure 7.3). 
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Figure 7.3: Exposure of HCD cells to mannitol (2SmM) for 48 hours 
upregulated Cx-43 protein expression. HCD-cells were incubated under control 
(S mM) conditions and 2S mM glucose and 2SmM mannitol for 48hours. (A) 
Representati ve Westem blot analysis using an anti-Cx-43 antibody illu trate 
upregulation in protein expression under both high glucose (lane 2) and high 
mannitol (lane 3) conditions as compared to control conditions at SmM (lane 1). (B) 
Analysis of changes in Cx-43 protein expression. Results represent mean ± EM; 
n=3; ** P< 0.0]. 
7.2.2 Prolonged exposure to glucose returns Cx-43 expression levels to near 
basal. 
Cells were incubated with a low glucose (SmM) medium for 2 days and then serum 
starved ovemight. They were then incubated in high (2 SmM) glucose for 8 days. 
Following an 8 day period of elevated glucose exposure, Cx-43 expression in HCD 
cells retumed to near basal levels (fi gure 7.4). Restoration of Cx-43 expression may 
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represent compensatory mechanisms employed by HCD cells to maintain both cell 
structure and integrity. 
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Figure 7.4: Cx-43 protein expre sion in HCD cells after an 8 day incubation in 
high glucose. HCD-cell s were incubated in 5mM and 25mM glucose for 8 days (A) 
Representative Western blot analysis using an anti-Cx-43 anti body illustrate no 
difference in Cx-43 expre sion under both control (lane 1) and high glucose 
conditions (lane 2). (B) Statistical analysis of changes in Cx-43 protein expres ion. 
Resul ts represent mean ± SEM; n=4 P>O.05 
7.2.3 E levated levels of calcium up-regulate C x-43 expression 
Cells were placed in a low glucose (5mM) media for 2 days and then serum starved 
overnight. The fo llowing day cells were treated over a 24 hour time course with the 
calcium ionophore ionomycin Cl ~M) for 4 6, 8, 12 and 24 hours. Ionomycin induced 
a time-dependent increase in Cx-43 expression and was significantly increased at 
both 6 (282.7% ± 18.5 %) and 8 (403 .7 % ± 25.7 %) hours. 
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Figure 7.4 Effect of elevated calcium on Cx-43 protein expre ion in HCn 
cells. HCD-cells were incubated with ionomycin (1 IlM) over a 24 hour time 
period. (A) Representative Western blot analysis using an anti- x-43 antibody 
(8) statistical analysis of changes in Cx-43 protein expression. Result represent 
mean ± SEM; n=3; * P<0.05 , ** P< 0.01. 
7.2.4 The cytokine TGF-~l down-regulates Cx-43 expression. 
TGF-~ I, a cytokine with powerful fibrogenetic effects is key in the development of 
renal hypertrophy, with glucose induced upregulation of both TGF-p mRNA and 
protein observed in both diabetic animal models and diabetic nephropathy (Sharma 
et ai. , 1995, Rocco et al. , 1992). To assess any contribution by TGF -~ I to the 
glucose mediated upregulation of Cx-43, HCD cells were treated as described 
previously (7.2.2) and incubated with the cytokine for 4, 6, 8, 12 and 24 hours. 
Application of TGF-p 1. (2nglml) to HCD cells exerted a biphasic response. At 4, 6 
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and 8 hours TGF-p I inhibited Cx-43 expression, but at 12 and 24 hours Cx-43 
expression was increased although none of the changes reached statistical 
significance. This increase at 12 and 24 hours may represent degradation of the 
original bolus of TGF-p applied. Incubation of RCD cells with vehicle (V) had no 
effect over Cx-43 expression. 
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Figure 7.5 The cytokine TGF-pl (2nglml) altered Cx-43 protein expression 
over a 24 hour time period in Hen cells. Application of TGF -P 1 (2ng/ml) induced 
both a down-regulation and up-regulation in Cx-43 protein expression level over a 
24 hour time period (panel A). Statistical analysis (panel B) of Cx-43 expres ion. 
Results represent mean ± SEM; n=3. 
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7.2.5 Application of the Na+/IC ATPase inhibitor ouabain induces 
reorganization of the actin cytoskeleton. 
Since TGF-p 1 has been implicated in reorganisation of the cytoskeleton, an effect 
which could possibly have implications for gap junction expression and ultimately 
cell-to-cell communication, I employed the Na+/K+ ATPase inhibitor ouabain as a 
means to induce cell swelling and thus assess the effects that this compound exerted 
over both cytoskeleton arrangement and ultimately Cx-43 expression. This was done 
to establish as to whether TGF-p 1 may be most likely mediating its effects via a 
change in cellular architecture due to reorganisation at the cell periphery and 
ultimately shape changes. HCD cells were incubated with the Na+/K+ ATPase pump 
inhibitor ouabain for periods of 2, 4 and 6 hours. Cells were fixed with PF A and 
stained with TRITC-conjugated phalloidin to confinn stress induced cytoskeletal 
reorganisation. Figure 7.6/panel I b demonstrates cytoskeletal organisation in HCD 
cells under control conditions and illustrates a dense diffuse network of F-actin 
filaments spanning the dimension of each cell. These filaments fonn the so called 
membrane cytoskeleton which serves to maintain both the shape and integrity of the 
cell. Following 2, 4 and 6 hour treatment with ouabain, a dramatic reorganisation of 
the actin cytoskeleton within the cell was observed (figure 7.6 2b, 3b, 4b 
respectively). Addition of ouabain reorganises these filaments and fonns stress fibres 
to strengthen the cell periphery. This re-organisation became increasingly apparent as 
the incubation period with ouabain increased. These data highlight a distinct 
relationship between the cytoskeleton and cell volume recovery. 
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Figure 7.6: Immunocytochemical staining of the cytoskeleton in HCD cells 
following a 2 4, and 6 hr incubation with ouabain (lOOJ.lM). HCD cell were treated 
over a period of2, (row 2), 4 (row 3) and 6 hr (row 4) with the Na+/K+ ATPase pump 
inhibitor ouabain and stained with a TRITC phalloidin stain. Row 1 represents tho e 
cells under control conditions. Panels a and b show nuclear (DAPI) and cytoskeletal 
(TRITC phalloidin) staining respectively. Panel c repre ents an overlay image at each 
time point and clearly shows a distinct re-organi ation of the actin cyto keleton a the 
incubation period with ouabain increases. 
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7.3.6 The Na+/K+ ATPase pump inhibitor ouabain downregulated Cx-43 
expression 
Already proven to induce cytoskeletal rearrangement, most likely to be mediated via 
an increase in cell vo lume, the application of ouabain ( I OO~M) wa further used to 
assess if reorgan isation of the cytoskeleton could account for TGF-13 1 mediated 
down-regulat ion of Cx-43. Administration of ouabain down-regulated Cx-43 
expression at, 4, 6 and 8 hours (figure 7.7 A). Western blot analysis revealed that 
treatment of HCD cells with Ouabain decreased Cx43 expression (84.4 % ± 16.9%) 
(36.2% ± 18.1 %) (12.6% ± 24.8) at 4 , 6 and 8 hours respectively relative to control 
(figure 7.7B). 
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Figure 7.7 Application of ouabain to HCD cell induced a rapid downregulation 
in Cx-43 protein expression over an 8 hour time period. HCD cell were 
incubated with the Na+/K+ ATPase pump inhibitor ouabain for 2 4 and 6 hours. 
Ouabain induced a down-regulation in Cx-43 expression at 2, 4, and 6 hours (panel 
A). Statistical analysis (panel B) confirmed that reduction in protein expres ion was 
significant at 6 and 8 hours. Results represent mean ± SEM; n=3;*** P< 0.001. 
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7.2.7 Acceleration in the velocity of Ca2+-signals between HCD-cells exposed to 
high glucose. 
An association between increased Cx-43 expression in high glucose medium and 
GJIC activity was assessed by comparing the rate of spread of a mechanically 
induced calcium signal, in cells cultured under control (5mM) and high glucose 
(25mM). As previously observed (section 5.1), mechanical stimulation of HCD cells 
evoked an increase in [Ca2+k that propagated between cells within a cluster. The 
transmission rate of touch-evoked Ca2+-transients between coupled cells was 
accelerated following exposure to high glucose, providing a functional correlate to 
increased Cx-43 expression. Propagation was significantly elevated at 48 hours, 
(321 % ± 18.8 %) in cells treated with 25 mM glucose (figure 7.8 and figure 7.9) 
* 
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Figure 7.8 Acceleration of touch evoked Ca2+ signals between HeD cells by high 
glucose. HCD cells were incubated in 5 or 25mM glucose for 24 and 48 hours. Cells 
were then mechanically stimulated and the speed of transmission of the resultant 
Ca2+ transient assessed (Ilrn!s).Results represent mean ± SEM; n=3 * p<O.05. 
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Fi~ure 7.9 Transmission of touch evoked Ca2+ transientsare accelerated in high glucose (25mM). The speed of propagating touch evoked 
Ca + signals between adjacent cells in HCD clusters was significantly elevated following 48 hours exposure to 2SmM glucose (trace B), as 
compared to cells cultured in low (SmM) glucose (trace A). Trace A clearly shows that in control cells, upon touch evoked stimulation the 
generation of Ca2+ transients in neighbouring cells, indicative of the speed at which this touch evoked signal propagates is far slower than in 
those cells cultured in high glucose. 
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7.3 Discussion 
Previous studies (chapter 5) have shown that mechanical stimulation of HCD cells 
evoked a transient increase in [Ca2+k Transmission of this calcium signal throughout 
the cell cluster indicated a high degree of cell-to-cell communication and led to the 
supposition that gap junctions may mediate transmission of this mechanically evoked 
signal. In collecting duct epithelium, cell volume regulation is linked to Na + 
absorption and depends upon detection of osmotic and mechanical stresses. A loss of 
cell-to-cell communication could potentially reduce the ability of renal epithelia to 
respond appropriately to changes in cell volume and may provide a link between 
deranged Na + reabsorption and the pathophysiological changes associated with some 
renal diseases such as diabetic nephropathy in which hypertrophy and elevated 
glucose are characteristic traits. The deregulation of connexin expression is a 
widespread feature in cell coupling changes associated with various diseases (Hillis 
et al., 1997, Haefliger et aI., 2001). Of these, the variability ofconnexin expression 
arising from hyperglycaemia in diabetes has been extensively studied (Li et al., 2003, 
Malfait et aI., 2001, Inoguchi et al., 2001). 
In this present chapter I examined the effect of touch on the generation of 
intracellular calcium signals in HCD cells and investigated the role of Cx-43 
mediated gap-junctions in propagating these signals under control and high glucose 
conditions. Previous reports have demonstrated that exposure to high glucose down 
regulates intercellular communication by enhancing both phosphorylation and 
degradation of Cx-43 in several cell types (Sato et al., 2002, Hilliis et al., 1997, 
Inoguchi et al., 2001), however here I show that increased glucose increased Cx-43 
expression. A recent report in which the expression of Cx-43 was studied in 
glomerular podocytes (Yaoita et al., 2002) subjected to puromycin aminonucleoside 
(PAN) nephrosis, a model of nephrotic syndrome, demonstrated an increase in Cx-43 
expression that correlated with increased GJIC activity, thus raising the possibility 
that cells throughout the nephron may respond in a different manner to cells of other 
tissue types e.g. aortic endothelial cells and retinal pigmental epithelial cells, both of 
which have shown down-regulated levels of both Cx-43 expression and GJIC ( 
Kuroki et al., 1998, Malfait et al., 2001). 
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Elevated glucose has been shown to decrease gap junctional conductance and disrupt 
cellular homeostasis in a variety of cell systems (Ngezahayo et al., 1990, Sato et al., 
2002). In streptozotocin-induced diabetic rats, dye spread in retinal micro-vessels 
was reduced in the absence of exogenous insulin (Oku et al., 1990). Similarly, 
glucose-dependent down regulation of Cx-43 expression and GJIC has been reported 
in bovine retinal pericytes (Li et al., 2003), endothelial (Femandes et al., 2004), and 
epithelial cells (Gomes et al., 2003, Malfait et al., 2001, Inoguchi et al 1995, 
Kuroki et al., 1998) demonstrated that 24hr exposure to high glucose evoked a 
protein kinase C-dependent decrease in GJIC in bovine aortic endothelial cells, a 
finding later supported by studies in streptozotocin-induced diabetic rats (Inoguchi et 
al., 2001). However, the inhibitory effects of hyperglycaemia on Cx-mediated cell-
to-cell communication in various micro-vascular and macro-vascular models are not 
so apparent in other tissues. In a rat osteosarcoma cell line, a 72hr exposure to 
25mM glucose had no effect on touch-evoked spread of Ca2+-transients (Gomez et 
al., 2000), whilst it has been long established that high glucose increased the 
expression of gap-junctions in pancreatic f3-cells (Meda et al., 1990). 
In the current study, sub-48hr exposure of HCD-cells to high (25mM) glucose 
generated a marked increase in Cx-43 protein expression and cell-to-cell 
transmission velocity for touch-evoked Ca2+-transients. The upregulation of Cx-43 
expression was only partially attributable to the osmotic effect of the sugar since 
similar concentrations of mannitol elicited only a 29% increase in Cx-43 expression 
under identical experimental conditions. Therefore glucose must work directly via a 
different signaling pathway to induce Cx-43 expression. 
Intercellular communication is dependent upon several different factors and the mere 
up-regulation of Cx-43 molecules is not necessarily indicative of increased GJIC. 
Since Cx-43 expression has previously been linked to increased [Ca2+]j and [Ca2+]j is 
known to be elevated under conditions ofhyperglycemia, (Symonian et al., 1998) I 
examined a role for cytosolic calcium in the regulation of Cx-43 expression in our 
model. In the present study, Cx-43 expression increased in response to elevated 
cytosolic calcium following ionomycin treatment and although this finding is 
contrary to that previously reported in osteoblast-like cells in culture, which showed 
reduced dye spread in the presence of the ionophore A23187 (Schirrmacher et al., 
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1996), both studies suggest that functional expreSSlon of gap-junctions is Ca2+_ 
dependent. Previous studies perfonned by D' Andrea et al .. (2002) demonstrated 
both increased Cx-43 expression and dye transfer in articular chondrocytes incubated 
with Interleukin-l (lL-l). IL-l evoked a dose dependent increase of [Ci+]i which 
when chelated abolished the increased Cx-43 expression, data which further supports 
a role for [Ca2+]i in Cx-43 expression. Up-regulation of Cx-43 expression in cells 
obtained from human renal biopsies of patients with inflammatory 
glomerulonephritis paralleled that of the intercellular adhesion molecule (lCAM-l) 
(Tonon et al .• 2002). Cell surface adhesion molecules play vital roles in numerous 
cellular processes. Some of these include: cell growth, differentiation, 
embryogenesis, immune cell transmigration and response, and cancer metastasis. 
There is growing evidence that intercellular adhesion precedes and may even be a 
prerequisite in enabling the fonnation of fully functional gap junctions (longen et al .• 
1991, Mege., 1988). The upregulation of both Cx-43 and ICAMs in renal biopsies 
would support this observation implicating a role for both intercellular adhesion 
molecules and Cx-43 in tubulointerstitial inflammation (Hillis et al.. 1997). The 
cadherins, a class of calcium dependent adhesion molecules, mediate homotypic cell-
cell adhesion and are thought to act in a coordinated fashion with connexins, 
allowing for gap junction assembly and the subsequent communication between 
them. Taken in conjunction with previous data and the findings of this chapter, both 
hyperglycaemia and raised [Ca2+]j may mediate their effects on Cx-43 through 
regulation of these intercellular signalling molecules whose subsequent expression 
allows and enables for the fonnation of Cx43 comprised gap junctions. 
The cytokine TGF-f31 has powerful fibrogenetic effects, and is thought to be 
involved in the development of renal hypertrophy, with glucose induced upregulation 
of both TGF-f31 mRNA and protein having been found in diabetic models (Ricci et 
al.. 2006). Studies have confinned that the most important contributor to the 
development of nephropathy is hyperglycaemia (Mogyorosi et al .• 1999, Marshall et 
al.. 2004), with increased intracellular glucose metabolism promoting the 
pathological changes characteristic of those observed in diabetic nephropathy. The 
uptake of glucose into cells is mediated by a series of glucose transporters expressed 
within the cell membrane (Heilig et al .. 1995). Glucose stimulated TGF-f3 has been 
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shown to induce upregulation of the insulin-independent glucose transporter GLUTl 
(Mogyorosi et al., 1999, Ricci et al., 2006) thus leading to the supposition that TGF-
p may provide the link between glucotoxicity and cell dysfunction in diabetic 
nephropathy. 
Application of TGF-p 1 inhibited Cx-43 expression. Although eliminating TGF-p as 
a downstream component of the glucose induced increase in Cx-43 expression, 
previous reports have highlighted a role for TGF-p in cytoskeleton remodelling and 
cell-to-cell interactions (Border et al., 1993). Administration of the Na + /K+ ATPase 
pump inhibitor ouabain was found to re-organise the cytoskeleton of HCD cells. 
These changes probably reflect an attempt by the cell to restore cell volume through 
initiation of cell volume regulatory mechanisms, therefore preserving membrane 
rigor and allowing for both cell and blood volume to be restored. Ouabain down-
regulated Cx-43 expression comparable to that observed upon application ofTGF-p, 
thus leading to a supposition that the effects ofTGF-p may be mediated through the 
effects induced on the cell's cytoskeleton. Disruption or re-organisation of the 
architectural framework would inhibit both gap junction expression and assembly. In 
further support of this hypothesis, the application of TGF-p to proximal tubular cells 
has been reported to induce both actin microfilament rearrangement and disassembly 
of tight junctional complexes (Border et al., 1993). This downregulation of Cx-43 
expression in HCD cells upon TGF-p application may therefore be an artefact of 
cytoskeletal reorganisation induced by TGF-p as opposed to a direct effect of this 
cytokine. 
Whilst the application ofTGF-p downregulates Cx-43 expression, indicating that this 
cytokine does not function as a downstream component of the response to high 
glucose over a 48 hour incubation period, the overall effect of acute high glucose up-
regulates Cx-43 expression, most likely mediated via increased [Ca2+]i. Increases in 
Cx-43 mediated coupling between cells may act to maintain epithelial integrity and 
prevent immediate and overt renal damage in the short term. Whether this increase in 
GJIC serves to be of benefit or detriment to the overall functioning of the nephron 
remains to be elucidated. 
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Chapter 8 
Discussion 
Alterations in the resorptive capacity of renal epithelia to sodium can have severe 
implications for kidney function and may be involved in the development and 
pathogenesis of secondary hypertension associated with Type 11 diabetes. To clarify 
underlying mechanisms that predispose an individual to deranged Na+ reabsorption 
and ultimately hypertension, we need to better understand how sodium handling is 
regulated. 
The overarching aim of this thesis was to elucidate mechanisms involved in renal 
Na+ handling in a novel cell line of the human cortical collecting duct and to 
determine potential mechanisms by which these cells identify and transduce 
osmotically induced signals,that instigate cell volume recovery mechanisms, 
preserving both structure and function in this distal region of the nephron. In chapter 
3, studies confirmed that HCD cells express SGKI and the <l, p and y subunits of the 
epithelial sodium channel ENaC. Furthermore, single-cell determination of [Na +]i 
confirmed this cell line as a suitable model for assessing functional changes in Na + 
transport mediated via the ENaC, activity of which is principally regulated by the 
serum and glucocorticoid-regulated kinase SGKI. SGKI is known to phosphorylate 
the neural precursor cell expressed developmentally down-regulated ubiquitin 
protein ligase Nedd 4.2 (Debonneville et al., 2001, Snyder et al., 2002). SGKI-
mediated phosphorylation causes Nedd4.2 to release ENaC to the membrane where it 
increases Na+ uptake. Intensive research into diabetic nephropathy and resultant 
secondary hypertension; has identified SGKI as a key signalling element whose 
expression in the kidney is upregulated in both diabetics and models of diabetic 
nephropathy (Kumar et aI., I 999). In type 11 diabetes mellitus, insulin insensitivity 
results in fluctuating levels of hyperglycaemia and is preceded by glycosuria. 
Previous reports have already established the deranged transcriptional regulation of 
SGKI in response to hyperglycaemia (Lang et al., 2000) and since activation is PI-3 
kinase dependent (Park et al 1999), this could have severe repercussions for the 
levels of SGKI activity in those Type 11 diabetic patients presenting with 
hyperinsulinaemia. Consequently I have assessed the effect of glucose on the 
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expression of these key signalling elements. Consistent with previous findings in 
mouse fibroblasts (Lang et ai, 2000), high (25mm) glucose induced a dramatic 
upregulation in both SGKl and ENaC protein expression in HCn cells over 48 
hours. These data suggest a potential role for deranged transcriptional control of 
SGKl in aberrant sodium reabsorption under conditions comparable to 
hyperglycaemia, a supposition supported by microfluorimetric studies which 
confirmed that Hcn cells cultured in high glucose exhibited increased intracellular 
sodium levels. 
Whilst there is considerable evidence relating high glucose levels to deranged 
sodium reabsorption in the kidney (Wang et al., 2005, Lang et al., 2000, Kumar et 
al., 1999), the mechanisms behind this regulation remain to be elucidated and thus 
require further clarification. As discussed in chapter 1, the metabolism of glucose 
impinges on a number of cell-specific signal-response cascades within cells. Through 
increasing de novo synthesis of diacylglycerol, hyperglycaemia has been associated 
with increased PKC and raised [Ca2+]j levels (LeRoith et al., 2004, Brownlee 2000). 
Elevated circulating levels of glucose have also been associated with the release of a 
number of growth factors and cytokines known to be involved in promoting the 
pathogenesis of diabetic nephropathy, amongst these is the transforming growth 
factor-~ (TGF-~l) (Cohen MP et al., 1998, Di Paolo S et al., 1996, Hoffman BB et 
al., 1998). PKC, through increased binding of the transcription factor AP-l to the 
TGF-~ 1 promoter, is the most likely mediator in the hyperglycaemic induction of 
this cytokine (Kim SJ et al., 1990, Weigert C et al., 2003). Treatment of H CD cells 
with both TGF-~1 and the calcium ionophore ionomycin evoked a time dependent 
increase in both SGKl and a-ENaC expression. Whether increased a-ENaC levels 
represent increased protein translation or a reduction in Nedd4-2 proteasomal 
mediated degradation remains to be confirmed and forms the basis for future work. 
Irrespective of the precise mechanism regulating the increase in protein expression 
these data, are further confirmed by studies in mouse fibroblasts in which the 
addition of decorin, a TGF-~ 1 neutralising antibody; and nifedipine, a calcium 
channel blocker have been used to assess contributory effects of both TGF-~ 1 and 
calcium as downstream components of the glucose response (Lang et aI., 2000). This 
stimulatory effect of TGF-~1 on SGKI expression is thought to be mediated by 
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increased binding of the Spl transcription factor to the SGKI promoter, controlled 
upstream by p38 MAPK (lrvine SA et al., 2005). Increased activity of p38MAPK 
has been shown to be rapidly induced under conditions of both hyperglycaemia and 
hypertonicity (lgarashi et al., 1999). High glucose can activate p38 MAPK by 
pathways similar to hyperosmolarity because the addition of 16.5 mM mannitol to 
5.5mM glucose also significantly increases p38 MAPK activities (lgarashi et al., 
1999). Studies by Waemtges et al (2002) on fibrotic lung tissue have demonstrated 
the effect of TGF -P I on SGK I transcription to be blunted in the presence of the p38 
kinase inhibitor SB203580 (Waemtges et al., 2002). 
Hypo-osmotic polyuria which follows glycosuria as a result of osmotic drag in 
uncontrolled diabetics; exposes the renal epithelial to increased hypertonicity as the 
urine flows through the nephron and results in cell shrinkage at the apical side of the 
membrane. SGKI has been suggested as a possible mediator of the hyperosmotic 
response to high glucose, a response mediated by p38 MAPK (Waldegger S et al 
1997, Waldegger S et al., 2000, Bell et al., 2000). These findings indicate that p38 
MAPK can be activated by glucose levels commonly encountered in diabetic patients 
as well as by extremely high levels of glucose when the effects of osmotic stress are 
significant. These results indicate that TGF-p I utilises the same signalling pathway 
in stimulating SGKI transcription as p38 MAPK. Hyperglycaemic-induced TGF-p I 
formation together with osmotically-driven increases in SGKI (Waldegger S et al., 
1997, Waldegger S et al., 2000, Bell et al., 2000) provide a link between poorly 
controlled plasma glucose and the development of excess ENaC-mediated Na+-
reabsorption that underlies secondary hypertension as seen in some diabetics 
(reviewed in Marshall et al., 2004). 
In addition to its effects on TGF-p I, glucose is also known to acutely increase the 
concentration of intracellular calcium ([Ca2+]i) (Symonian M et al., 1998). How 
raised levels of calcium evoke alterations in both SGKI and ENaC expression in 
human cortical collecting duct (HCD) remains to be elucidated. However, since 
calcium is able to increase PKC activity, it seems feasible that the contribution of 
calcium to the glucose induced upregulation of both SGKI and ENaC may stem from 
its ability to enhance TGF-pI transcription through increased AP-I binding. Thus 
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TGF-~ I is the key player in mediating these hyperglycaemic induced changes in 
intracellular Na+ levels through regulating SGKI and ENaC expression. However, 
the addition of TGF -~ I neutralising antibodies in hyperglycaemia fails to completely 
negate the glucose driven increase in SGKI (Lang et aI2000). In conjunction with a 
further reduction in the response upon blockade of voltage gated calcium channels by 
nifedipine (Lang et ai, 2000), it would appear that calcium, albeit through its 
interaction with TGF-~ I, may signal via a separate and unidentified signalling 
cascade, a hypothesis which forms the basis of future work. 
In conclusion, I have used a novel model in vitro system to assess the effect of high 
glucose, TGF-~ I and cytosolic Ca2+ on SGKI and a-ENaC expression (Hills et al 
2006b). I have correlated these changes to single-cell determination of [Na +]i and 
suggest that glucose induced upregulation of SGKl expression and activity, in 
conjunction with increased a-ENaC expression may represent a critical step in 
aberrant renal sodium handling seen in Type 11 diabetes. TGF-~I, Ca2+ and p38 
MAPK are all known to be up-regulated under conditions of hyperglycaemia. Data 
presented both in this thesis and in previous studies suggest a critical role for all three 
signalling molecules in the role and regulation of both SGKI and a-ENaC. Thus in 
suggesting a potential series of events to explain glucose-evoked changes in Na + re-
uptake, it seems likely that DAG, PKC and Ca2+, combine to increase transcription of 
TGF-~ I. Cross talk between the TGF-~ I and MAPK signalling cascades results in 
the overall activation of p38 MAPK and SGKI transcription through activation and 
increased binding of the transcription factor spl to the SGKI promoter (Bell et al., 
2000). These increased levels, which we know are accompanied by increase 
intracellular sodium levels, may have dramatic repercussions for normal kidney 
function, contributing to the pathogenesis of secondary hypertension associated with 
diabetic nephropathy in Type 11 diabetes mellitus. 
Whilst the effect of high glucose on SGKI, ENaC and increased intracellular sodium 
identifies potential mechanisms that are partially, if not completely responsible for 
regulation of renal sodium handling under those conditions associated with the 
development of secondary hypertension, it is crucial to remember that diabetic 
nephropathy is a also linked to both structural and functional disturbances that 
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damage renal function (Wolf et al., 2003). Understanding how cells of the nephron 
coordinate their activities to ensure efficient and appropriate absorption, is central to 
understanding how these structural changes may impinge on normal function under 
conditions of high glucose. 
The obvious question when determining how cells respond to changes in their 
extracellular environment is to question how these cells detect physiologically 
appropriate stimuli and instigate 'a signal which can then propagate to neighbouring 
cells ensuring minimal damage throughout. Utilising touch as a surrogate form of 
osmotic stress in conjunction with Ca2+ micro fluorimetry I have examined how 
HCD-cells respond and communicate this activity when osmotically challenged. 
Touch evoked stimulation evoked a calcium-dependent response, which propagated 
throughout neighbouring cells. The ability to detect and respond to physical 
deformation at the cell membrane is mediated via the transient receptor potential 
channel TRPV4 (Gong et al., 2004), a cation permeable channel which is activated 
upon exposure of the cell to a hypoosmotic environment. Unlike SGKI which is 
activated upon cell shrinkage and through its actions on the ENaC and Na+/K+ 
ATPase (Alvarez dela Rosa et al., 2006, Snyder et al., 2002) is able to restore cell 
volume through Na+ and water influx, TRPV4 serves as a counterregulatory 
mechanism. Activated upon cell swelling, TRPV4 mediates Ca2+ influx triggering 
activation of numerous signalling cascades which together aim to restore cell volume 
through instigation of a RVD. Mechanical stimulation of an HCD cell evoked a 
transient increase in calcium which subsequently has been shown to be critical in the 
response of cells to hypoosmolarity allowing for instigation of a RVD (Becker D et 
al., 2005). Knockdown studies ofTRPV4 using siRNA technologies later confirmed 
that this TRP channel was indeed responsible for detecting membrane stress in HCD 
cells (see chapter 5). Whilst hyper-osmotic urine will potentially cause epithelial cell 
shrinkage which will in turn activate SGKI (Bell et al., 2000), hypoosmotic polyuria 
will cause an increase in urinary flow rate. This increased flow may be detected by 
mechanical receptors such as TRPV 4 in the epithelial membrane, thereby raising 
intracellular calcium levels. Whilst under physiological conditions the actions of 
TRPV4 and SGKI counteract one another, in a pathophysiological state such as type 
11 diabetes, constitutive activation of both SGKI and TRPV4 as a result of those 
factors discussed previously, may serve to further exacerbate the state of cell 
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swelling through enhanced transcription of our key signalling elements. 
Subsequently, the rate of Na+ reabsorption will increase and the ability of the 
principle cells to regulate blood volume homeostasis may be lost. 
Moreover, stimulation of a single cell within a cluster generated a calcium signal that 
propagated into neighbouring cells, confirming synchronous behaviour indicative of 
a high degree of cell-to-cell communication. Whilst the contribution of a local 
paracrine synchroniser could not be ruled out, data suggested direct gap-junction 
mediated intercellular communication was responsible for co-ordinating activity 
between cells. Gap junctions represent a well established model by which numerous 
cell types communicate and exist in multiple isoforms with variable tissue 
expression. The loss of propagating Ca2+ transients between cells which had been 
pre-treated with heptanol and the heptanol-sensitive spread of the dye between cells, 
provided initial confirmation that these cells were communicating directly via gap 
junctions. 
Whilst RT-PCR confirmed mRNA expression of several connexins, my studies 
focussed on the expression and involvement of Cx-43 in GJIC, a protein which has 
been shown to exhibit high basal expression in the collecting duct (Guo et al., 1998). 
siRNA and Ca2+ microfluorimetric studies confirmed that Cx-43 forms the functional 
gap junction involved in the transmission of the intercellular Ca2+ wave in HCD 
cells. As with heptanol studies, stimulation of a Fura-2 loaded cell exhibiting 
knockdown of Cx-43 expression, evoked a transient increase in calcium that failed to 
propagate into neighbouring cells. Dye spread was also inhibited in those cells 
lacking functional Cx-43. How the Ca2+ wave diffuses across gap junctions remains 
to be elucidated, but could depend upon diffusion of either Ca2+ or InsP3, the latter of 
which interacts with JP3 receptors to release intracellular Ca2+ from the endoplasmic 
reticulum (ER), generating calcium release from stores. Over the past decade there 
have been numerous reports of the involvement of Cx-43 in mediating signal 
transmission in response to mechanical stress (Suadican et aI, 2000, Fry et aI2001). 
Although some reports have demonstrated that propagation of a Ca2+ dependent 
signal still occurs through Cx-43 comprised junctions, other studies have highlighted 
a role for both Cx-43 mediated gap junctions and ATP mediated-P2Y receptor 
activation (Suadicine et al 2000). Hemichannel ATP release and the subsequent role 
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of this nucleotide in regulating calcium signalling (Cotrina et al 1998) initiated a 
series of studies in which the paracrine release of A TP in generation of touch evoked 
calcium transients was investigated. Suramin, a P2Y receptor antagonist failed to 
block touch-evoked propagation of Ca2+ transients in HCn cells and further 
suggested the importance of direct Cx-43 mediated gap junction communication in 
synchronising activity across monolayer cultures ofHCn cells. 
Elevated glucose has been shown to decrease connexin expression, gap junctional 
conductance and disrupt cellular homeostasis in a variety of cell systems. Cx-43 
mediated cell-to-cell coupling was examined in HCn cells under high glucose. 
Contrary to previous findings in glomerular mesangial and retinal endothelial cells 
(Zhang et al., 2006, Fernandes et al., 2004) acute 48 hour incubation in high glucose 
increased Cx-43 expression levels in HCD cells. However, chronic incubation 
reduced Cx-43 expression to near basal after an 8 day period, thus identifying the 
existence of compensatory mechanisms. In the context of an uncontrolled diabetic 
presenting with fluctuating periods of hyperglycaemia, Cx-43 expression levels are 
most likely to vary depending upon the duration and nature of the hyperglycaemic 
episode and although after 8 days of continuous high glucose, connexin expression 
returns to near basal, a simple fall and sudden rise in blood glucose levels may; again 
be enough to trigger this stimulatory response that was observed following acute 
glucose treatment. Whilst these data conflict with previous reports of downre!,TUlatory 
and inhibitory effects on both expression and gap junction coupling respectively (Li 
et al 203), increases in Cx-43 functional expression may act to maintain epithelial 
integrity and prevent immediate and overt renal damage in the short term. Loss of 
this signal over time however may contribute to the development of renal disease and 
diabetic nephropathy. 
In conclusion, the data presented in this thesis has identified and characterised a 
novel human collecting duct, confirming these cells a suitable model for the study of 
sodium reabsorption in principal cells of the cortical collecting duct. Offering 
advantages over primary tissue of availability and ease of genetic manipulation, I 
have controlled the extracellular environment to mimic that of conditions associated 
with hyperglycaemia, e.g. increased glucose, TGF-p 1 and intracellular Ca2+, and 
have subsequently identified key signalling elements involved in the detection of 
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those changes which we believe are associated with progression from euglycaemia to 
hyperglycaemia. Regulation of sodium via the ENaC in the collecting duct is critical 
and must be maintained to prevent excessive reclamation of solutes which will 
ultimately predispose an individual to the development of secondary hypertension. I 
have identified how cells of the collecting duct communicate at a synchronous level 
of activity to maintain the appropriate overall working of the cortical collecting duct 
thereby contributing to the overall function of the nephron. Molecular and 
microfluorimetric techniques have been used to assess the effect of 
pathophysiological conditions on both expression of signalling elements and 
electrolyte levels within the cell and in doing so has enabled us to construct a 
proposed pathway by which in type 11 diabetes deranged regulation of cell volume 
regulated signalling elements may arise. 
Establishing a model of which we can gain a greater understanding into the way in 
which these mechanisms are controlled will hopefully enable future manipulation 
and therapeutic modulation of downstream targets whose activity, if we can control, 
may prevent widespread damage throughout the kidney, thereby preventing and 
inhibiting those changes associated with the structural and functional disturbances of 
diabetic nephropathy. 
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Chapter 9 
Future Work 
The overarching goal of this thesis was to gain an insight into the mechanisms 
involved in renal sodium handling in a human cortical collecting duct cell line and 
establish how these mechanisms may become compromised under conditions of high 
glucose as associated with type 11 diabetes. Initial studies characterised this novel cell 
line and highlighted how cells of the human collecting duct responded in a high 
glucose environment comparable to that observed in type II diabetes. Although 
extensive this thesis highlights several areas for further investigation. 
In Chapter 3 we confirmed expression of SGKl and the three principal subunits of 
the ENaC. However, an important signalling molecule involved in SGKI mediated 
regulation of ENaC is Nedd4.2 (Debonneville et al., 2001). Nedd4.2 as previously 
discussed, is a ubiquitin ligase that resides in the cell bound to the ENaC. Only when 
SGKl is rendered active through PI3-K dependent phosphorylation does Nedd4.2 
dissociate from ENaC allowing apical insertion (Park et al., 1999). Confirmation of 
Nedd4.2 expression in response to various treatments would enable further 
delineation as to whether the increased a-ENaC expression observed in response to 
high glucose, TGF-~ and ionomycin presented in chapter 4 was a consequence of 
either increased transcription or a reduction in Nedd4.2 mediated proteasomal 
degradation. 
Glucose-evoked upregulation of both SGKl and a-ENaC at 24 and 48 hours led to a 
series of experiments in which I identified possible downstream components of the 
glucose induced response. Application of TGF-~ and Ionomycin evoked a time 
dependent increase in SGKI and a-ENaC expression. In order to assess the 
contribution of these agonists would require incubation of HCD cells in a 25mM 
glucose medium in the presence of a TGF-~ neutralising antibody, a calcium channel 
blocker and lastly both antibody and blocker. If the neutralising antibody negated the 
glucose response this would suggest that calcium is either a downstream component 
of the TGF-~ pathway or is involved directly in TGF-~ transcription. However, if, 
the antibody failed to negate the response it would seem likely that calcium may be 
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contributing to the TGF-p response via a separate and unidentified pathway. The 
upregulation of SGKI in response to TGF-p co-incides as previously discussed with 
the work of Lang (Lang et al., 2000). These effects are believed to be mediated via 
p38 MAPK and have been shown to be blunted in the presence of pharmacological 
inhibitors of p38 MAPK (Waerntges et al., 2002). Application of p38 MAPK 
inhibitors in the presence of TGF-p would confirm a role for p38 MAPK in 
mediating the effects of TGF-p. Leading on from these studies, future work would 
aim to identify the isoforms involved and potential cross talk between the signalling 
pathway of TGF-p and the regulation of hSGK expression in response to osmotic 
stress, both of which have been reported to mediate their effects via p38 MAPK. 
In chapter 5 we confirmed that HCD cells express the mechanosensitive TRPV4. 
TRPV4 has been implicated as a potential osmosensor and thus may have a role in 
cell volume recovery. Incubation of cells in solutions of variable osmolarity would 
enable us to determine via western blotting, if this increased activity accompanied by 
a rise in [Ca2+]i in response to osmotic stress, is matched by an increase in TRPV4 
expression at the cell membrane. Immunocytochemical analysis would highlight any 
re-distribution ofTRPV4 channels at the cell membrane. 
Finally, in chapter 6 we confirmed that the touch evoked calcium signal propogates 
throughout Hcn cells via Cx-43 mediated gap junctions. In chapter 7 we assessed 
the effect of high glucose on increasing both Cx-43 expression and GJIC. Although 
ionomycin increased Cx-43 expression, TGF-p reduced expression. This may reflect 
the ability of the cytokine to rearrange cytoskeletal elements (Border et al., 1993). 
Immunocytochemical studies confirmed that Ouabain, a Na+/K+ ATPase inhibitor 
can induce cytoskeletal re-arrangement, an effect most likely mediated via alterations 
in cell volume. Application of Ouabain to Hcn cells was also found to down-
regulate Cx-43 expression. Therefore could TGF-p, like Ouabain, play a role in 
cytoskeletal reorganisation which would undoubtedly have implications for gap 
junction expression and localization. Future studies would involve confirmation of a 
role for TGF-p in regulation of the cytoskeleton, paralleled by studies in which cells 
were exposed to solutions of variable hypo-osmolarity, thereby confirming that the 
effects of both TGF-p and ouabain were cell volume mediated. 
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